WO1997046707A2 - System and method for monitoring for dna amplification by fluorescence - Google Patents
System and method for monitoring for dna amplification by fluorescence Download PDFInfo
- Publication number
- WO1997046707A2 WO1997046707A2 PCT/US1997/009620 US9709620W WO9746707A2 WO 1997046707 A2 WO1997046707 A2 WO 1997046707A2 US 9709620 W US9709620 W US 9709620W WO 9746707 A2 WO9746707 A2 WO 9746707A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluorescence
- sample
- temperature
- probes
- biological sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5082—Test tubes per se
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0832—Geometry, shape and general structure cylindrical, tube shaped
- B01L2300/0838—Capillaries
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1838—Means for temperature control using fluid heat transfer medium
- B01L2300/1844—Means for temperature control using fluid heat transfer medium using fans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6482—Sample cells, cuvettes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00237—Handling microquantities of analyte, e.g. microvalves, capillary networks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N21/0303—Optical path conditioning in cuvettes, e.g. windows; adapted optical elements or systems; path modifying or adjustment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N21/07—Centrifugal type cuvettes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/025—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having a carousel or turntable for reaction cells or cuvettes
Definitions
- This invention relates generally to apparatus for rapid control of the PCR sample with monitoring of the progress of the reaction. More specifically, the present invention relates to thermal cycling apparatus which allows rapid PCR to be rapidly carried out while monitoring the reaction.
- Cyclic DNA amplification using a thermostable DNA polymerase, allows automated amplification of primer specific DNA, widely known as the "polymerase chain reaction.” Automation of this process requires controlled and precise thermal cycling of reaction mixtures usually contained in a plurality of containers. In the past, the container of preference has been a standard, plastic microfuge tube.
- microfuge tubes which are generally used have disadvantages.
- the material of the microfuge tubes, their wall thickness, and the geometry of microfuge tubes is a hindrance to rapid heating and cooling of the sample contained therein.
- the plastic material and the thickness of the wall of microfuge tubes act as an insulator between the sample contained therein and the surrounding medium thus hindering transfer of thermal energy.
- the geometry of the microfuge tube presents a small surface area to whatever medium is being used to transfer thermal energy.
- U.S. Patent No. 3 , 616 , 264 to Ray shows a thermal forced air apparatus for cycling air to heat or cool biological samples to a constant temperature.
- the Ray device is somewhat effective in maintaining a constant temperature within an air chamber, it does not address the need for rapidly adjusting the temperature in a cyclical manner according to a temperature versus time profile such as is required for biological procedures such as the polymerase chain reaction.
- U.S. Patent No. 4,420,679 to Howe and U.S. Patent No. 4,286,456 to Sisti et al. both disclose gas chromatographic ovens.
- the devices disclosed in the Howe and Sisti et al. patents are suited for carrying out gas chromatography procedures but do not provide thermal cycling which is substantially any more rapid than that provided by any of the earlier described devices. Rapid thermal cycling is useful for carrying out many procedures. Devices such as those described in the Howe and Sisti et al. patents are not suitable for efficiently and rapidly carrying out such reactions quickly.
- PCR polymerase chain reaction
- PCR requires temperature cycling of the sample. Not only does the prior art, as explained above, carry out temperature cycling slowly, the prior art also ignores the underlying principles which allow PCR to work and could be used to make PCR even more useful. Thus, it would be an great advance in the art to provide methods and apparatus which are particularly adaptable for rapidly carrying out PCR and analyzing the reaction which is taking place, particularly if such reaction is analyzed as it is taking place, that is in real time.
- the present invention seeks to realize the following objects and advantages. It is an object of the present invention to provide an apparatus for accurately controlling the temperature of biological samples.
- the present invention is an apparatus particularly suited for subjecting biological samples to rapid thermal cycling in order to carry out one or more of a number of procedures or processes.
- the apparatus includes a means for holding a biological sample.
- the means for holding a biological sample, or a sample chamber is provided with an insulation means for retaining thermal energy and also a means for heating the interior of the sample chamber.
- a high wattage incandescent lamp functions as a means for heating the interior of the sample chamber.
- a thermal insulator lines the interior of the sample chamber and functions to retain the heat generated by the lamp within the sample chamber and serves as an insulation means.
- the preferred apparatus includes a means for forcing air into the sample chamber and a means for dispersing the air forced into the sample chamber.
- a high velocity fan functions to force air into the sample chamber and a rotating paddle functions to disperse the air into the chamber.
- a means for venting allows the air to escape from the sample chamber taking the unwanted heat with it.
- the present invention allows heating and cooling of a sample to take place both quickly and uniformly.
- the apparatus of the present invention includes a control means for operating the apparatus through the desired time versus temperature profile.
- the present invention is particularly well suited for carrying out automated polymerase chain reactions.
- inventions include a closed loop hot fluid compartment and a reaction compartment.
- the reaction compartment is located within the hot fluid compartment and can be accessed through a venting door for allowing the insertion of samples in capillary tubes which may contain a reaction mixture for the polymerase chain reaction.
- a heating coil is also located in the compartment and is regulated by a programmable set-point process controller via a thermocouple sensor which is also located in the compartment at a position directly adjacent the reaction compartment.
- the heat coil is located up-stream of the reaction compartment, and a fan is located up-stream of the heat coil, such that, fluid blown across the heat coil by the blower unit passes through the reaction compartment and into the intake side of the blower unit in closed loop fashion.
- Baffles may be located between the heat coil and the reaction compartment in order to cause uniform homogenous mixing of the heated fluid before it passes through the reaction compartment.
- the fan may be placed downstream of the heating coil but before the reaction compartment.
- the fan blades serve as baffles to mix the heated fluid.
- the controller activates a solenoid that opens the venting door which vents fluid out of the compartment and allows cool (ambient) fluid to enter and cool the samples.
- the controller of the present invention allows the chamber, and subsequently the samples located in the sample compartment therein, to pass through a predetermined temperature cycle corresponding to the denaturation, annealing and elongation steps in the polymerase chain reaction.
- the apparatus of the present invention allows rapid optimization of denaturation, annealing, and elongation steps in terms of time and temperature, and shortened time periods (ramp times) between the temperatures at each step
- the present invention particularly decreases the total time required for completion of polymerase chain reaction cycling over prior art thermal cycling devices while at the same time significantly increasing specificity and yield.
- the present invention provides methods and apparatus for continuous fluorescence monitoring of DNA amplification
- optical components are combined witn structures to provide rapid temperature cycling in order to continuously monitor DNA amplification by a variety of different fluorescence techniques.
- Glass capillay sample tubes, and composite plastic/glass sample tubes, allow rapid heat transfer from air (30 cycles in less than 15 min) and simultaneous optical monitoring of the reaction. Fluorescence is acquired continuously from a single sample or alternately from multiple samples on a rotating carousel with all of the samples being simultaneously subjected to rapid thermal cycling.
- fluorescence during DNA amplification was monitored by: 1) the double strand-speciflc dye SYBRTM Green I, 2) a decrease in fluorescein quenching by rhodamine after exonuclease cleavage of a dual-labeled hybridization probe, and 3) resonance energy transfer of fluorescein to Cy5TM by adjacent hybridization probes. Fluorescence data acquired once per cycle allow quantification of initial template copy number if fluorescence specificity and amplification efficiency are known
- embodiments of the present invention which monitor temperature, time and fluorescence continuously throughout each cycle thus producing a 3 -dimensional spiral.
- This 3 dimensional spiral can be reduced to temperature vs . time, fluorescence vs. time, and fluorescence vs. temperature plots.
- Fluorescence vs. temperature plots of hybridization probes discriminate between the cumulative, irreversible signal of exonuclease cleavage and the temperature- dependent, reversible hybridization of adjacent probes. Using double strand dyes, product denaturation, reannealing and extension can be followed within each cycle.
- the present invention provides that fluorescence monitoring of PCR is a powerful tool for DNA quantification. Cycle-by- cycle monitoring using dsDNA dyes does not require unique probes and allows quantification over a large dynamic range. Sequence specific fluorescent probes offer enhanced specificity and can be used to quantitate very low copy numbers of template. There are at least two classes of sequence specific, fluorescent oligonucleotide probes that are useful in PCR. The mechanism of signal generation naturally separates them into either hydrolysis or hybridization probes By monitoring the fluorescence once each cycle, either probe system can be used for quantitation. Continuous monitoring of fluorescence allows acquisition of melting curves and product annealing curves during temperature cycling.
- fluorescence monitoring optical components are combined with a rapid thermal cycler to be used to acquire DNA melting curves during PCR by fluorescence monitoring of double-strand DNA specific dyes.
- Plotting fluorescence as a function of temperature as the thermal cycler heats through the dissociation temperature of the product gives a DNA melting curve.
- the shape and position of this DNA melting curve is a function of GC/AT ratio, length, and sequence, and can be used to differentiate amplification products separated by less than 2°C in melting temperature. Desired products can be distinguished from undesired products, including primer dimers.
- Analysis of melting curves can be used to extend the dynamic range of quantitative PCR.
- the present invention provides apparatus and methods for rapid cycle PCR with combined amplification and complete quantitative analysis in under fifteen minutes and more preferably in under ten minutes.
- the present invention provides a method for real time monitoring of a polymerase chain reaction amplification of a target DNA sequence and, as well, a method for analyzing a target DNA sequence of a biological sample for DNA sequence polymorphisms, heterozygosity or mutations.
- the method comprises the steps of amplifying the target sequence by polymerase chain reaction in the presence of two nucleic acid probes that hybridize to adjacent regions of the target sequence, exciting the sample with light at a wavelength absorbed by the donor fluorophore and detecting the fluorescence emission from the sample.
- One of the probes is labeled with an acceptor fluorophore and the other probe is labeled with a donor fluorophore of a fluorescence energy transfer pair such that upon hybridization of the two probes with the target sequence, the donor and acceptor fluorophores are within 0 to 25 nucleotides of one another.
- the polymerase chain reaction itself comprises the steps of adding a thermostable polymerase and primers for the targeted nucleic acid sequence to the biological sample and thermally cycling the biological sample between at least a denaturation temperature and an elongation temperature.
- the fluorescence from the sample is monitored as a function of the temperature of the sample.
- the donor fluorophore is fluorescein.
- One acceptor fluorophore particularly suitable for use with fluorescein is Cy5.
- a method of real time monitoring of a polymerase chain reaction amplification of a targeted nucleic acid sequence in a biological sample is also useful for analyzing a target DNA sequence in a biological sample for DNA sequence polymorphisms, heterozygosity or mutations.
- the method comprises the steps of
- nucleic acid primers and a nucleic acid probe comprising one of said primers and the probe are each labeled with one member of a fluorescence energy transfer pair comprising an acceptor fluorophore and a donor fluorophore, and wherein the labeled probe hybridizes to an amplified copy of the target nucleic acid sequence within 0 to 25 nucleotides of the labeled primer;
- That method can be of further advantage by employing the additional step of monitoring the temperature dependent fluorescence of the sample.
- Data relating to the temperature dependent fluorescence of the biological sample can be used as basis for adjustment of the thermal cycling conditions to optimize yield or specificity of the reaction.
- step (e) adjusting the temperature and time parameters in accordance with the data generated from step (d) to optimize product yield or specificity.
- the resonance energy transfer pair comprises fluorescein as the donor and Cy5 as the acceptor
- the methods are carried out advantageously in a device designed to thermally cycle biological samples in optically transparent capillary tubes at high temperature ramp rates, with minimum hold times at a maximum temperature, and wherein sample fluorescence is measured or detected through the end of the capillary tube
- the present invention also provides a device for monitoring the fluorescence of a sample.
- the device comprises
- a capillary tube having a high surface area to volume ratio and comprising an optically transparent material
- a light source mounted in said chamber and positioned to illuminate the capillary tube through an end of the capillary tube; and a light detector mounted in said chamber and positioned to measure fluorescence from the capillary tube through an end of the capillary tube.
- the capillary tube holder is in the form of a carousel for holding a plurality of capillary tubes.
- the carousel is rotatably mounted in said chamber, and the device further comprises a stepper motor for rotating the carousel; and means for coupling said carousel to said motor.
- the device is also provided with a heater and a fan in air flow communication with the chamber. The heater and the fan are controlled by a programmable controller to rapidly cycle the temperature of the chamber .
- the present invention is also directed to a device for conducting PCR reactions.
- the device comprises
- a heater and a fan mounted in said device and in air flow communication with the chamber;
- carousel for holding a plurality of capillary tubes, said carousel being rotatably mounted in said chamber, said capillary tubes comprising an optically transparent material;
- a light source mounted in said chamber and positioned to illuminate at least one of the capillary tubes through an end of a capillary tube;
- a light detector mounted in said chamber and positioned to measure fluorescence from at least one of the capillary tubes through an end of a capillary tube.
- the method makes use of total internal reflection to optimize acquisition and monitoring of fluorescent emissions.
- the method comprises the steps of placing the sample in a capillary tube comprising an optically transparent material and detecting fluorescence from the sample through an end of the capillary tube.
- the ratio of he surface area to the volume of the capillary tube is preferably greater than or equal to 4mm -1 .
- the method further comprises the step of illuminating the sample through an end of the capillary tube, preferably along the optical path of the detected fluorescence.
- the fluorescence of the biological sample is temperature dependent and the method further comprises the step of heating or cooling the biological sample during detection of fluorescence to monitor the temperature dependent fluorescence in the sample.
- the sample can contain a fluorescence energy transfer pair, and the fluorescence of at least one fluorophore of the fluorescence energy transfer pair is detected.
- the sample comprises nucleic acids including nucleic acid probes. One of said probes is labeled with an acceptor fluorophore, and the other probe is labeled with a donor fluorophore of a fluorescence energy transfer pair. The fluorescence detected is that of the donor fluorophore or the acceptor fluorophore or both.
- the system comprises a capillary tube having a sample delivery port and a funnel cap for filling said capillary tube.
- the capillary tube comprises an optically transparent material, wherein the ratio of the surface area to the volume of the capillary tube is greater than or equal to 4mm -1 .
- the funnel cap has a sample receiving orifice and a sample transfer orifice and means for releasably engaging the sample delivery port of the capillary tube so that the sample transfer port of the funnel cap and the sample delivery port of the capillary tube are in alignment.
- the sample handling system can also include a plug for frictional fit sealing engagement with the sample receiving port of the funnel cap.
- Another important embodiment of this invention is a system for performing PCR and monitoring the reaction in real time.
- the system comprises
- a heater and a fan mounted in said device and in air flow communication with the chamber and a controller for cycling the temperature in the chamber according to initial predefined temperature and time parameters
- a carousel for holding a plurality of capillary sample tubes, said carousel being rotatably mounted in said chamber, said capillary tubes comprising an optically transparent material, and having a high surface area to volume ratio that provides for rapid thermal transfer; a light source mounted in said chamber and positioned to illuminate at least one of said capillary tubes through an end of the capillary tube; and
- a light detector mounted in said chamber and positioned to measure fluorescence from at least one of said capillary tubes through an end of the capillary tube;
- system further comprises means for adjusting the controller such that one or more reaction parameters are adjusted in real time.
- the capillary sample tubes can have an inner diameter ranging from about 0 . 02mm to about 1.0mm.
- device further comprises a stepper motor for rotating the carousel to position the capillary tubes held by said carousel for illumination and fluorescence detection, preferably through an end of the capillary sample tubes.
- Figure 1 shows a perspective view of a thermal cycling apparatus adapted for thermal cycling of biological samples and adapted especially for use in cyclic DNA amplification, according to the concepts of the present invention.
- Figure 2 is a side elevation view of the fluid chamber portion of the apparatus of Figure 1.
- Figure 3 is an interior plan view of the fluid chamber portion of the apparatus illustrated in Figure 1.
- Figure 4 shows an interior plan view of the fluid chamber of another embodiment of the present invention.
- Figure 5 shows an optimized temperature versus time profile for a polymerase chain reaction using the thermal cycling device of the present invention.
- Figure 6 shows graphically the effect of annealing time on polymerase chain reaction specificity and yields using the thermal cycling device of the present invention.
- Figure 7 shows graphically the effect of denaturation time on polymerase chain reaction yields using the thermal cycling device of the present invention.
- FIGS 8A-B which are perspective and elevational cross sectioned views, respectively, of another preferred embodiment of the present invention.
- Figure 8C is a diagrammatic representation of the relationship of the heat producing element and the capillary tubes holding the biological samples in the embodiment illustrated in Figures 8A-B
- Figure 9A shows the results of four different temperature/time profiles (A-D) and their resultant amplification products after thirty cycles (A-D).
- Figure 9B shows a cycle of another preferred temperature/time profile used by the present invention.
- Figures 9C-G show exemplary cycle of other preferred temperature/time profiles used by the present invention.
- Figure 10 provides a block diagram of a temperature slope control circuit in accordance with the present invention.
- Figure 11 is a schematic view of a preferred rapid temperature cycler with fluorescence detection in accordance with the present invention.
- Figure 11A is a temperature v. time chart of showing one preferred operation of the apparatus of Figure 11.
- Figure 12 is a chart showing 2D plots of temperature vs. time, fluorescence vs. time, and fluorescence vs. temperature also shown as a 3D plot.
- Figure 13 is a fluorescence vs. temperature projection for a 536 base pair fragment of the human ⁇ -globin gene.
- Figure 14 is a cycle number vs. fluorescence plot obtained in accordance with an aspect of the present invention.
- Figure 15 is a cycle number vs. fluorescence ratio plot obtained in accordance with an aspect of the present invention.
- Figure 16 is a fluorescence ratio vs. temperature plot obtained in accordance with the an aspect of the present invention.
- Figure 16A is a fluorescence ratio vs. cycle number plot obtained in accordance with an aspect of the present invention.
- Figure 17 is a fluorescence ratio vs. temperature plot obtained in accordance with an aspect of the present invention
- Figure 18 is a fluorescence vs. cycle number plot for a number of different initial template copies obtained in accordance with an aspect of the present invention.
- Figures 19A-D represent two preferred arrangements for providing sequence specific detection of PCR products in accordance with the present invention.
- Figure 20 is a fluorescence ratio (fluorescein/rhodamine) vs. cycle number plot of DNA amplification monitored with a dual-labeled hydrolysis probe obtained in accordance with an aspect of the present invention.
- Figures 21A-D provide a comparison of three fluorescence monitoring techniques for PCR, including dsDNA dye SYBR ® Green I (A), a dual-labeled fluorescein/rhodamine hydrolysis probe (B), and a fluorescein- labeled hybridization probe with a Cy5-labeled primer (C);
- Figure 21D shows the coefficient of variation for the three monitoring techniques represented in Figures 21A-C.
- Figure 22 provides plots showing the application of interpolation methods for quantification of PCR fluorescence curves.
- Figure 23A provides a plot showing a linear change in fluorescence ratio with temperature and a parallel increase in fluorescence as more probe is hydrolyzed.
- Figure 23B provides a plot showing that the fluorescence ratio from hybridization probes varies radically with temperature.
- Figure 24 provides a plot showing the temperature dependence of product strand status during PCR in accordance with the present invention.
- Figure 24A is a temperature vs. florescence plot of PCR with SYBR ® Green I.
- Figure 25 provides a plot showing the native and competitive components of a product melting curve in accordance with the present invention.
- Figure 26 provides a plot of rate of product reannealing for different concentrations of PCR product in accordance with the present invention.
- Figure 27 provides a plot showing the initial determination of a rate constant.
- Figure 28 is a graph representing an equilibrium PCR paradigm and a kinetic PCR paradigm.
- Figure 29 shows that monitoring over a 10-fold dynamic range in the log-linear portion of a routine amplification has been accomplished.
- Figure 30 shows an embodiment of the present invention configured for continuous monitoring of a single sample.
- Figure 31 shows the optical layout of another embodiment in accordance with the present invention to provide continuous monitoring of a PCR sample.
- Figure 32 sets forth charts showing the effectiveness of light piping by viewing the tip rather than the side of capillary sample tubes.
- Figure 33 is a chart showing that the observed polarization when using capillary sample tubes depends on the precise positioning of the tube with respect to the excitation beam.
- Figure 34 shows the results obtained using one polarization probe in accordance with the present invention.
- Figure 35 shows fluorescence PCR results from a probe with five intervening bases between fluorescein and rhodamine labels.
- Figure 36 shows the effect of probe concentration on sensitivity.
- Figure 37 plots cycle number vs. fluorescence ratio in PCR monitored by resonance energy transfer and hydrolysis probes in accordance with the present invention.
- Figure 38 is a plot of emission wavelength vs. fluorescence for resonance energy transfer of a dual labeled fluorescein/Cy5 probe in accordance with the present invention.
- Figure 39 is a plot showing cycle number vs. fluorescence ratio above background in PCR monitored by resonance energy transfer with hybridization probes.
- Figure 40 is a plot of temperature vs. fluorescence ratio in PCR monitored by adjacent hybridization probes.
- Figure 41 is a plot of temperature vs. fluorescence ratio in PCR monitored by hydrolysis probe.
- Figures 42A is a plot of time vs. fluorescence showing the inverse relationship between temperature and fluorescence.
- Figures 42B is a plot of time vs. temperature showing the inverse relationship between temperature and fluorescence.
- Figure 43A is a plot of temperature vs. fluorescence for the melting curves of three different purified PCR products.
- Figure 43 is a plot of temperature vs. fluorescence showing the apparent T m of PCR products is dependent on the heating rate.
- Figure 44 is a plot of temperature vs. relative fluorescence showing T m of PCR products is dependent on the dsDNA dye concentration.
- Figure 45 is a plot of temperature vs. fluorescence showing the melting curve obtained when two purified PCR products differing in T m by about 2°C are mixed.
- Figure 46 is a plot showing how the relative amount of each PCR product can be quantified.
- Figure 47 is a schematic representation of another embodiment of the present invention which is a rapid temperature cycler with fluorescence detection at the tip of capillary sample tubes.
- Figures 47A-D show composite plastic/glass containers into which samples are loaded.
- Figure 48 illustrates useful temperature vs. time segments for fluorescence hybridization monitoring.
- Figure 49 shows melting curve information displayed as melting peaks.
- Figure 50 plots fluorescence from dsDNA specific dyes as a function of temperature during PCR to allow monitoring of strand status during individual cycles of the reaction.
- Figure 51 plots a melting curve acquisition cycle.
- Figure 52A plots the absolute position of PCR product melting curves.
- Figure 52B plots how rapid temperature transitions through the denaturation temperature shifted melting curves to higher apparent T m
- Figure 53 plots melting curves for three different purified PCR products.
- Figure 54 plots the overlapping melting curves resulting when purified PCR products were mixed.
- Figure 55 plots the results after conversion into melting peaks showing that it is possible to resolve mixtures of reaction products that differed in T m by less than 2°C into separate peaks.
- Figure 56 plots a melting curve analysis used to differentiate intended product from nonspecific products such as primer dimers.
- Figure 57 plots relative fluorescence acquired once each cycle after polymerase extension of the product for a series of reactions varying in initial template concentration .
- Figure 58 plots melting peaks acquired for a number of samples
- Figure 59 plots the data points of Figure 57 multiplied by the appropriate ratio to give the corrected plot.
- Figure 60 shows the results of Figure 58 correlate well with electrophoresis results.
- Figure 61 shows melting curves represented in Figure 56 can be resolved into product peaks for estimates of the relative amount of different products present.
- the thermal cycling device 10 includes a closed loop fluid (most preferably air) chamber, generally designated at 11, which is adapted to accept samples to be cycled through vent door 14 .
- the closed loop fluid chamber 11 includes a plurality of compartments each of which will be described shortly.
- the device 10 also includes a controller 12 which can be programmed by means of input keys 25 and display 26 to cause the chamber 11 to be cycled through a series of temperatures over a predetermined period of time .
- the thermal cycling of chamber 11 can be used to carry out numerous procedures and is particularly suited for amplification of primer speci f ic DNA from samples containing reaction mixture as will be explained below .
- the closed loop fluid chamber 11 is enclosed in a generally box shaped configuration by housing 13 Blower mounting boards 16, if desired, can be located so as to section off a smaller rectangular section of the chamber 11 and function to support and secure a generally cylindrically shaped lower housing 15 thereto.
- the fan of the blower 28 may be housed integrally within chamber housing 13 .
- blower housing 15 contains the blades and shaft of the blower.
- the blower motor (not shown) is located externally of blower housing 15, and therefore exteriorly of the enclosed chamber 11 In this configuration, the blades and shaft are the only parts of the blower which become exposed to the circulating hot fluid within chamber 11. It would be disadvantageous to mount the motor within the chamber which would subject the motor to temperature variations and also would add the thermal mass of the motor to that which is subject to heating and cooling. The reduction of thermal mass exposed to the fluid in chamber 11 is important to the overall performance of the device 10 in its function of subjecting samples placed therein to predetermined temperature versus time profiles as will be more fully explained below.
- the blower 28 is a well known type blower usually identified as an "in line" type blower which preferably employs a propeller type fan due to its generally low thermal mass, or if desired, a squirrel cage type fan, the fan preferably having a 75 cubic feet per minute minimum capacity.
- the solenoid platform 17 has secured thereto a solenoid 18.
- the solenoid armature 19 is attached to upper end 21 of rod 20 which is rigidly attached to vent door 14 and rotatably attached to housing 13 at points above and below the vent door 14.
- the rod 20 therefore allows vent door 14 to freely rotate relative to the housing 13 about the rod ' s longitudinal axis.
- a spring 22 is attached at one of its ends to the housing 13 by support post 23.
- the opposite end of spring 22 is attached to the top end 21 of rod 20 directly adjacent the attachment of solenoid armature 19.
- the spring 22 is drawn between these two attachment points so as to be in tension.
- the spring 22 therefore tends to draw top end 21 toward the support post 23, which in turn tends to rotate vent door 14 to its closed position.
- solenoid 18 is actuated, armature 19 tends to pull top end 21 of the rod 20 in the direction of the solenoid 18, which is opposite the direction of pull of spring 22, and which tends to open the vent door 14.
- Controller is electrically attached to the chamber 11 by means of a transmission cable 24.
- the cable 24 also supplies power to the blower motor (not shown), and to the heat coil 31.
- the controller 12 also is connected to thermocouple sensor 35 for receiving signals corresponding to temperature data, and to solenoid 18 for triggering the solenoid armature.
- Controller 12 can be any well known type of temperature controller unit which is programmable to control the heat coil 31, vent door 14, and blower so as to achieve predetermined temperatures as a function of time within the chamber 11, and which is also capable of being programmed to actuate a relay output for driving a solenoid at predetermined time periods and chamber temperature levels.
- a preferred temperature controller 12 for use in the embodiment of Figures 1-3 is a Partlow MIC-6000 proportional temperature controller, available through Omega Engineering Inc, of Stanford, Connecticut, as the Model No. CN8600 process controller.
- blower compartment 28 is formed of the blower housing 15 and the blower mounting plates 16.
- the entirety of blower compartment 28 is filled with the fan and shaft portions of a blower as has been described above.
- the blower can be any of a number of well-known designs, as has been described above, and has therefore been omitted from Figure 3 for purposes of clarity. It is sufficient for the present invention to understand that the fan located in blower compartment 28 draws fluid into the blower compartment 28 through inlet opening 36 and pushes the fluid out of exit opening 37.
- the fluid be driven by the blower at a rate of at least 75 cubic feet per minute. It is important however, in regard to the present invention, to realize that the fluid located in chamber 11 only contacts the fan and a portion of the drive shaft of the blower, the blower motor itself being located outside of the blower housing 15 so as to avoid any contact thereof with fluid in the chamber 11. This is important since it is critical to the speed of operation of the invention to minimize the material which contacts the fluid inside the chamber 11 so as to minimize the thermal mass of material which must be heated and/or cooled thereby during the cycling process. By minimizing the thermal mass which must be heated or cooled by the fluid, the response time necessary to bring the contents of chamber 11 to a uniform temperature is greatly diminished.
- Heating coil 29 Fluid passing into heating compartment 29 must pass by heating coils 31. If heating coils 31 gets hotter than the fluid passing into heating compartment 29, the fluid will become heated thereby as it is forced through the compartment.
- the heating coil is preferably a 1 , 000 watt (125 VAC) nichrome wire coil wound around a microsupport.
- any heating unit suitable for heating the type of fluid present in the chamber may be used.
- the particular heating coil of embodiment of Figures 1-3 is manufactured by Johnstone Supply, of Portland, Oregon.
- the heating coil is activated by an output relay included in the controller 12.
- the preferred relay is a 25 A, 125 VAC solid state relay manufactured by Omega Engineering Inc. of Stanford, Connecticut as Model No. Omega SSR 240 D25.
- Baffles 32 and 33 tend to break up any laminar fluid flow and generate turbulence therein to effectively mix the fluid so that it arrives in reaction compartment 30 at an homogenous temperature.
- Thermocouple sensor 35 provides an electrical input signal to controller 12 which corresponds to the fluid temperature in the reaction compartment 30. Temperature monitoring during operation of the thermal cycling device 10 is preferably achieved by a 30 -gauge iron-constantan "J-type" thermocouple. The controller uses this information to regulate the heat coil 31 according to the predetermined temperature versus time profiles programmed therein and to actuate solenoid 18, as will be explained momentarily.
- sample compartment 27 The fluid passing from the reaction compartment 30 to the return air compartment 34 must pass through sample compartment 27 (as shown in dashed lines). Sample compartment 27 will also be explained momentarily.
- the fluid in return compartment 34 has been slightly cooled due to the heat transfer therefrom into samples located in sample compartment 27.
- the fluid in return compartment 34 is drawn through inlet opening 36 into blower compartment 28 where it is again forced, by action of the fan, out through outlet opening 37 into the heating compartment 39.
- the fluid chamber 11 when operating with vent door 14 closed, is a closed loop fluid chamber which continuously recirculates the fluid along a closed loop path through each compartment thereof in order to bring the contents therein to a uniform temperature. Continuous circulation of the air in the air chamber 11 allows the samples in sample compartment 27 to be brought to a predetermined temperature as quickly as possible, and then to be held at that temperature, if desired.
- the controller 12 can be programmed to actuate solenoid 18 to cause vent door 14 to open and allow large quantities of ambient fluid to immediately flood the compartment 11 while heated fluid therein simultaneously escapes.
- the sample compartment 27 is sized so as to allow a plurality of samples, such as hollow elongate glass tubes containing a sample therein, to be easily located in a space apart orientation so that fluid may pass evenly around each sample. If desired, sample compartment 27 may be sized and configured so as to allow insertion of a rack, basket, or the like which has been configured so as to accept a plurality of samples in uniform spaced apart configuration so as to simplify loading the samples into the sample chamber 27.
- Access to sample compartment 27 is accomplished by rotation of the vent door 14 to its open position. Once the vent door 14 is rotated to approximately 90 degrees from it's closed position, the sample compartment 27 is easily accessible therethrough. Also, as can be seen, rotation of vent door 14 approximately 90 degrees from its closed position causes return fluid compartment 34 to be substantially closed off from reaction compartment 30.
- the device 10 of the present invention when the device 10 of the present invention is in a "cooling" mode, ambient fluid enters directly into return fluid compartment 34 and is forced through the blower compartment 28, heating compartment 29, reaction compartment 30, and sample compartment 27 substantially along the same path as the closed loop fluid flow path described above. The fluid is then forced out of the air chamber 11 and prevented from passing back into air return compartment 34 by the positioning of the vent door 14 between the sample compartment 27 and the return fluid compartment 34.
- vent door 14 not only allows ambient fluid to enter the chamber 11, it can also prevent the fluid from recirculating in a loop fashion through the chamber 11. Instead, fluid is forced to pass through the sample compartment 27 and then out of the chamber 11 to aid in the rapid cooling of the sample contents and chamber 11.
- the device 10 of the present invention When the device 10 of the present invention is used for cyclic DNA amplification, repetitive cycling through a temperature versus time profile is required. Samples containing a reaction mixture for the polymerase chain reaction generally must be cycled approximately 30 times through a temperature versus time profile which corresponds to the denaturation, annealing and elongation phases of the amplification process.
- the device 10 of the present invention due to its lower overall thermal mass, is capable of cycling samples through significantly shortened temperature versus time profiles compared to the prior art.
- the DNA amplification application of the embodiment of Figures 1-3 can pass through a temperature versus time profile cycle in 30-60 seconds (see Figure 5). This same cycle using prior art devices would take approximately 5-10 times longer. These low cycle times have proven also to increase yield and specificity of the polymerase chain reaction over prior art cycling.
- the polymerase chain reaction was run in a 10 ⁇ l volume with 50 ng template DNA, 0.5 itiM of each deoxynucleotide 500 nM of each oligonucleotide primer in a reaction buffer consisting of 50 mM Tris- HCI (pH 8.5 at 25°C), 3.0 mM magnesium chloride, 20 mM HCI, and 500 ⁇ g/ml bovine serum albumin (5).
- Thermos aquatics polymerase (0/4 units of Taq polymerase - StratageneTM) was added, the samples placed in 8 cm long, thin-walled capillary tubes (manufactured by Kimble, Kimax 46485-1), and the ends fused with a laboratory gas burner so that an air bubble was present on both ends of each tube.
- the capillary tubes were then placed vertically in a holder constructed of 1 mm thick "prepunched perfboard" (manufactured by Radio Shack). The mixture was cycled 30 times through denaturation (90- 92°C), annealing (50-55°C), and elongation (72-75°C) for the times indicated in the temperature versus time profile of Figure 5. Temperature monitoring of the capillary tubes was done with a miniature thermocouple (IT-23, Sensortek, Clifton, NJ) placed in 10 ⁇ l of deionized water and connected to a thermocouple monitor (BAT- 12, Sensortek). Amplification products were fractionated by electrophoresis on a 1 . % agarose gel. Good results were obtained.
- the device 10 of the present invention cycles air as the heat transfer medium instead of water, it has the advantage that heat transfer occurs through a low heat capacity medium (air) which can be warmed very rapidly.
- the response time for sample cooling is very fast due to the use of thin walled glass capillary tubes for holding samples, instead of plastic microfuge tubes as has been done in the past with prior art processes, and by minimizing the thermal mass of material inside the chamber 11 (see Figure 5).
- Such response times can allow for optimization of the denaturation and annealing, and elongation steps in the polymerase chain reaction, in terms of time and temperature.
- shortened "ramp" times are obtained, i.e., the time required to bring the temperature of the sample from one temperature level to the next temperature level corresponding to phases in the amplification process is shortened. This decreases the time required for a complete amplification, as well as allowing specific study of annealing, denaturation and enzyme kinetics within a polymerase chain reaction protocol.
- baffles 32 and 33 may be used if desired to achieve adequate temperature homogeneity within the sample compartment 27. As shown in this embodiment, baffles 32 and 33 decrease the temperature variation in the reaction compartment 30 from about 10°C, to about 2°C. If desired, further (or more complicated) baffles may be used to further decrease the temperature variation in reaction compartment 30. Alternately, as shown in Figure 4 the fan may be positioned downstream from the heating coil 31, but before the sample compartment 27 to achieve more uniform mixing.
- Amplification products obtained through the use of apparatus 10 are qualitatively and quantitatively similar to those obtained through the manual water bath cycling method.
- advantages in specificity and yield are possible with rapid thermal control of the reaction mixture.
- Figure 6 shows the effect of varying the denaturation time of the temperature versus time profile of Figure 5 as used with the thermal cycling apparatus 10 of the present invention on DNA amplification yields.
- the brighter vertical lines each correspond to a particular time at a denaturation temperature.
- the yield is greatest at the shortest possible denaturation time Such a rapid response is not possible with prior art systems
- Figure 7 shows the effect of the temperature versus time profile of Figure 5 as used with the thermal cycling apparatus 10 on specificity (i.e., one specific product yield as opposed to a plurality of similar or "shadow" products) .
- specificity i.e., one specific product yield as opposed to a plurality of similar or "shadow” products.
- the shorter the ramp and annealing time the greater the product specificity.
- the rapid temperature response of the apparatus 10 allows improved specificity and yield which is not possible with prior art systems.
- capillary tubes 108 having inner diameters in the range from about 0.25mm to about 1.0mm can desirably be used In some applications, capillary tubes 108 having inner diameters in the range from about 0.02mm to about 0.1mm can also be desirably used .
- the apparatus 10 of the present invention is useful for amplifying DNA from any source. Although particular configurations and arrangements of the present invention have been discussed in connection with the specific embodiments of the thermal cycling device 10 as constructed in accordance with the teachings of the present invention, other arrangements and configurations may be utilized. For example, various fluids other than air, of generally low thermal mass, may alternatively be used in the device 10.
- Figure 8A is a perspective view and Figure 8B is an elevational cross sectioned view of the additional embodiment. It will be understood that many of the earlier explained components and teachings also have application in the embodiment illustrated in Figures 8A-C. Thus, only the pertinent additional information concerning this embodiment will be provided below Importantly, in the embodiment of Figures 8A-C, the heat producing element is adjacent to the biological sample containers allowing faster heating and cooling of biological samples as explained below.
- the apparatus of Figures 8A-C provides even greater improvement over the prior art in the speed at which thermal cycling can be carried out, e.g., 15 or 30 cycles of DNA amplification in 30, 15, 10 to 5, or even fewer, minutes Furthermore, the apparatus 100 provides better thermal homogenization throughout the samples than previously possible.
- FIG. 8A Shown in Figure 8A is the general configuration of the housing 102 of the embodiment.
- the housing 102 rests on feet 104 (best seen in Figure 8B) and functions to hold the other described structures in place and to isolate those structures which become hot from the surrounding environment .
- Included in the embodiment 100 of Figure 8A are input keys 25 and a display 26 as in the previously described apparatus 10.
- the previously described control structures can readily be modified or used as a pattern for a control means for use in the embodiment of Figures 8A-C.
- a sample chamber is designated by bracket 106.
- a lid 138 connected to the housing 102 by a hinge 131 can be opened to allow access to the sample chamber 106.
- the sample chamber 106 is preferably cylindrical in shape but can be of any shape or size required by the particular application.
- the sample chamber 106 is lined with a black colored foam material 110 whose surface has light absorbing characteristics with the bulk of the thickness of the foam having insulating characteristics.
- the black foam material can be one which is readily available in the art and one fabricated from a plastic material
- the foam 110 is preferably a material which is readily cooled by the air passing there over, i.e., the material has low thermal conductivity and a porous surface.
- the dark or black porous surface of the material converts shorter wavelength radiation striking the surface into longer wavelength radiation, i.e., heat, which is radiated into the sample chamber
- the foam 110 functions to thermally isolate the sample chamber from the surrounding air space in the housing and also to convert the light emitted by lamp 112 into thermal energy.
- the foam 110 can be replaced with other structures.
- a material having a black, dark, or other nonreflective surface such as a thin sheet of polycarbonate having one surface painted black, can be backed by an insulative material, such as a fiberglass or foam material.
- the black or dark surface which can be painted on a number of different substrates, converts shorter wavelength radiation striking it into thermal radiation while the insulative material thermally isolates the sample chamber from the surrounding environment.
- the lamp 112 is preferably a 500 watt halogen lamp. If appropriate control devices are used, higher power lamps or a plurality of lamps, such as four 500 watt halogen lamps, can be used.
- a lamp socket 112A is attached to the housing 102 by a support 112B. The lamp 112 is able to very rapidly and uniformly heat the sample chamber 106 to the desired temperature. Other sources of heat, i.e. infrared radiation, such as the earlier described nichrome wire element, can also be used within the scope of the present invention.
- FIG. 8B Represented in Figure 8B are two thin-walled capillary tubes 108 such as those described earlier. While two thin-walled capillary tubes 108 are shown, the sample chamber 106 can hold many such tubes.
- the thin-walled capillary tubes 108 have several important advantages over previously used devices as described earlier and, together with the sample chamber 106, function as the one presently preferred example of a means for holding a biological sample.
- the thin-walled capillary tubes 108 are preferably left partially extending out of the sample chamber through apertures 140 for ease of access but may be completely contained within the sample chamber 106 as may numerous other fluid holding structures which are suited to particular applications.
- the preferred thin-walled capillary tubes 108 have a capacity of about 10 ⁇ l. As will be understood, the volume of the sample should be keep small, and the surface area of the sample holding structure relatively large, and together they should present a relatively small thermal mass.
- sample holding structure contain a volume anywhere from about 0.1 ⁇ l to about 10,000 ⁇ l but those skilled in the art will appreciate that other volumes of samples can also be used within the scope of the present invention if the different thermal mass of the structure is considered .
- a thermocouple 134 is included within the sample chamber 106 to sense the temperature within the chamber and is used to maintain the desired temperature within the sample chamber as earlier described.
- thermocouple 134 is preferably one available in the art whose thermal response substantially matches the thermal response of the biological sample and the container holding the same.
- Such thermocouples can be commercially obtained from sources such as Idaho Labs which manufactures a line of thermocouples referred to as metal sheathed, J-type thermocouples .
- the matching of the thermal response of the thermocouple to that of the biological sample and container can be preferably carried out by inserting a micro thermocouple, such as the model IT-23 thermocouple available from PhysiTemp as known in the art, into a typical biological sample being held by the chosen container and subjecting the sample and the thermocouple under test to the same temperature changes.
- the thermocouple under test, or some external criteria, can be changed until the thermal response of the thermocouple suitably matches the thermal response of the sample and its container .
- the arrangement represented in Figure 8B provides more uniform heating and cooling of the sample than previously available devices .
- transfer of heat throughout the sample is carried out by convection through the sample.
- Convection induced movement of the sample within whatever structure is used to hold the sample is caused by temperature gradients or differences in the generally small biological samples (e.g., 10-100 ⁇ l) .
- the apparatus 100 is capable of providing heating and cooling such that thermal differences within a 10 ⁇ l sample are maintained at not greater than ⁇ 1°C at all times during a 30 second cycle.
- the thin-walled capillary tubes 108 be at least somewhat uniformly spaced from the heat source, for example, lamp 112 in apparatus 100.
- Figure 8C provides a diagrammatic top view of the lamp 112 and the plurality of thin-walled capillary tubes 108 as arranged in the apparatus 100 represented in Figures 8A-B.
- the thin-walled capillary tubes 108 which are farthest from the lamp 112 are preferably no more than substantially 40%, and more preferably no more than substantially 25%, farther from the lamp 112 than the distance between the lamp 112 and those thin-walled capillary tubes 108 which are closest to the lamp 112 (as indicated by line N).
- the distance indicated by line N can be about 7.3 cm while the distance indicated by line F can be about 8.5 cm.
- the arrangement of the thin-walled capillary tubes 108 can be other than that represented in the figures, for example, circular or semi-circular.
- the point from which to measure the distance between the heat producing element and the sample containers will vary as the type and size of the heat producing element varies.
- the heat producing element may comprise a plurality of lamps or electric resistive elements which vary in shape and size. In some embodiments. it may also become important to consider the distance from the sample chamber wall the sample containers are positioned.
- the apertures 140 (see Figure 8A) function as a means for holding the sample containers but other structures performing equivalent functions can also be used in accordance with the present invention.
- the apparatus 100 also cools the samples contained in the capillary tubes 108 very rapidly and uniformly.
- air from outside the housing 102 is draw into the interior of the housing through a lower housing portal 114 by a fan 116 which is connected to a motor shaft 122 driven by a motor 118. Since rapid cooling of the sample chamber is desired, it is preferred that the combination of the motor 118 and the fan 116 be able to move sufficient volumes of air into the sample chamber 106 and then disperse that air inside the sample chamber 106, as will be explained shortly.
- Arrangements other than the motor 118 and fan 116 illustrated in Figure 8B can also be used within the scope of the present invention.
- the use of air as the thermal transfer medium in contrast to other gases and liquids, has the advantages of being inexpensive, readily available, easily mixed, and never making a mess.
- the high surface area-to-volume ratio of the sample containing capillary tubes provides for rapid thermal transfer using air as the thermal transfer medium.
- a vent door 128, articulating on hinge 129, is provided.
- the vent door 128 is automatically opened by way of a solenoid 132 so that the interior of the housing 102 is sealed off from the upper housing portal 130.
- the solenoid 132 is preferably replaced by a stepper motor as is known in the art.
- the use of a stepper motor allows the vent door 128 to be accurately and incrementally opened and closed in accordance with the needs for heating and cooling the samples.
- a stepper motor for example an SC-149 stepper motor controller (available from Alpha Products) as known in the art, using the information set forth herein.
- a paddle 124 which is connected to the motor shaft 122.
- the paddle 124 should rotate at a relatively high rate, for example, fast enough to create air velocities of around preferably about 250, more preferably 500, and most preferably 1000 meters per minute within the sample chamber 106.
- the paddle 124 which can be a single or a multivane paddle, rotating at a high speed, air is moved, or drawn, into the sample chamber 106 and vented out of the sample chamber 106 following the path indicated by the dashed line 136.
- the rotation of the paddle 124 also promotes mixing of the air entering the sample chamber 106 and ensures the most efficient transfer of thermal energy from the surfaces of the thin-walled capillary tubes 108 to the air passing through the sample chamber 106. It will be appreciated that structures other than those illustrated herein can perform equivalent functions.
- Figure 9A shows the results of four different temperature/time profiles (A-D) and their resultant amplification products after thirty cycles (A-D).
- the profiles A and B in Figure 9A were obtained using a prior art heating block device using the prior art microfuge tube.
- the transitions between temperatures are slow and many nonspecific bands are present in profiles A and B
- Profile B shows improvement in eliminating some of the nonspecific bands (in contrast to profile A) by limiting the time each sample remains at each temperature thus indicating that shorter times produce more desirable results.
- the embodiments of the present invention subject the samples placed therein to rapid thermal cycling wherein the temperature of the sample is increased and decreased at a rate preferably at least as great as 0.5°C/second.
- the temperature change is preferably carried out over an approximate range of between 30°C to 50oC. It is preferred that the thermal cycles be carried out quickly enough to complete at least thirty thermal cycles in forty minutes and more preferably complete thirty thermal cycles in twenty minutes and most preferably complete thirty thermal cycles in ten minutes.
- the apparatus 100 more preferably increases and decreases the temperature of the sample at a rate at least as great as 1.0°C/second and even more preferably at a rate at least as great as 4.0°C/second and most preferably at a rate at least as great as 10.0°C/second.
- the biological sample not just the surrounding medium and/or the sample container, must undergo the specified thermal change.
- the previously available devices while having the drawback of not able to perform thermal changes as rapidly as the present invention, also did not recognize the problem of changing the temperature of the sample, not just the temperature of the surrounding medium and container, rapidly and uniformly.
- the method of the present invention can desirably achieve thermal cycling preferably at a rate at least as great as 10°C/sec, and more preferably at a rate at least as great as 20°C/sec, over a temperature range of greater than about 20°C, more preferably over a temperature range of greater than about 30°C, and most preferably over a temperature range of about 40°C
- Figure 9B shows the temperature in °C of the biological sample, not just the surrounding air or container, as the biological sample undergoes the thermal cycle.
- Figure 9B shows a PCR sample beginning at about 74°C and being heated to a denaturation temperature, indicated at D, of about 92°C for 2 seconds.
- the sample is then cooled to an annealing temperature, indicated at A, of about 55°C for two seconds .
- the transition between the denaturation temperature and the annealing temperature covers a range of 37°C in just under 4 seconds providing a rate at least as great as 10°C/sec.
- the sample is then warmed to an extension temperature of 74°C for five seconds as indicated at E in Figure 9B.
- the cycling of the sample through the denaturation temperature, the annealing temperature, and the extension temperature is repeated thirty time or as many times as desired.
- Figures 9C-G show exemplary cycles of other preferred temperature/time profiles which are achieved by the present invention It will be understood that those skilled in the art can alter the represented temperature/time profiles to carry out specific processes in accordance with the present invention.
- the lamp (112 in Figures 8A and 8B) be rated at 2000 watts or a plurality of lamps be included which provide similar output
- a temperature slope control circuit which is represented in Figure 10 in conjunction with an A-bus controller/acquisition system using an 8052 micro controller board with a clock and high level program interpreter available f rom Alpha Products (model no SP-127) of Darian, Connecticut.
- Exemplary programming code used in connection with the described microcontroller is included in the Programming Code Appendix attached hereto and incorporated herein.
- the programming code provided in the Appendix is a BASIC52 file for serial downloading into the microcontroller and provides exemplary temperature slope control during thermal cycling.
- Use of the 2000 watt heat producing device and the describe control structures allows rates of 20°C/sec to be desirably obtained.
- the temperature slope control circuit of Figure 10 includes a thermocouple 200 matched to the sample temperature response as explained earlier.
- the thermocouple 200 is connected to an integrated circuit 206, which preferably is one known in the art as an AD595, whose output is conveyed to a 4th order low pass filter 208 with a cutoff frequency of 100 Hz and to a 12 bit analog-to-digital convertor 210 whose output is used to provide a digital display of the temperature.
- the output of the circuit 206 is also conveyed to a measured slope circuit 212.
- the measured slope circuit 212 preferably includes a 353 operational amplifier 218, a 100 K ⁇ potentiometer 214, a 1 M ⁇ potentiometer 230, and a 22 ⁇ F capacitor
- the measured slope circuit 212 outputs a signal to the inverting input of a 353 operational amplifier 246.
- a slope set circuit 222 includes a positive slope set digital-to- analog converter 226 and a negative slope set digital-to-analog converter 224.
- the digital-to-analog converters 224 and 226 are preferably 8-bit digital-to-analog converters referred to in the art as DA147.
- the slope set circuit can preferably receive instructions from another digital device (not illustrated in Figure 10) such as a personal computer.
- the output of the slope set circuit 228 is communicated to a summing circuit 240.
- the summing circuit 240 preferably includes 100 K ⁇ resistors 236, 238, and 244 and a 353 operational amplifier 242
- the output of the summing circuit 240 is conveyed to the non-inverting input of the operational amplifier 246 and represents the desired slope of the temperature change.
- the output of the operational amplifier 246 is provided to a transistor 248 contained within a power switching circuit 262.
- the power switching circuit 262 includes a 5 VDC supply 250 providing current to the transistor 248.
- the transistor 248 has its emitter connected to a 3010 circuit 254 by way of resistor 252 which is preferably a 330 ⁇ resistor.
- the 3010 circuit 254 includes an output connected in series with a resistor 256 which preferably is a 180 ⁇ resistor.
- a triac 258 is preferably used to control the current delivered to a lamp 262, or other heat producing device, from a source of AC current 260.
- the temperature slope control circuit represented in Figure 10 in cooperation with the other described system components, provides thermal cycling of biological samples as great as 20°C/sec over a temperature range of 30°C, and most preferably over a temperature range of 40°C, with homogeneity being maintained throughout the biological sample.
- the apparatus described herein can readily be used for many different applications including: polymerase chain reaction processes; cycle sequencing; and, other amplification protocols such as the ligase chain reaction.
- the present invention also advantageously provides an apparatus for accurately controlling the temperature of samples located in the sample chamber and quickly and accurately varies the temperature of samples located in a chamber according to a predetermined temperature versus time profile.
- the polymerase chain reaction can be performed rapidly.
- the necessary number of temperature cycles can routinely be completed in much less than time than possible with the prior art, for example in less than 15 minutes.
- the specificity and yield of rapidly cycled amplifications are also improved to an extent not previously possible.
- the use of optically clear capillary tubes allows for continuous fluorescence monitoring DNA amplification in accordance with the present invention.
- Fluorescent probes can be used to detect and monitor DNA amplification.
- Useful probes include double-stranded-DNA-specific dyes and sequence-specific probes. With the intercalater ethidium bromide, UV-excited red fluorescence increases after amplification in capillary tubes or microfuge tubes. Sequence-specific fluorescence detection is possible with oligonucleotide hybridization probes. For example, dual-labeled fluorescein/rhodamine probes can be cleaved during polymerase extension by 5'-exonuclease activity, separating the fluorophores and increasing the fluorescein/rhodamine fluorescence ratio.
- Fluorescence can be measured after temperature cycling is complete, once per cycle as a monitor of product accumulation, or continuously within each cycle.
- the previously available sequence-specific methods have been limited to endpoint analysis.
- the present invention allows cycle-by-cycle monitoring for quantification of initial template copy number.
- fluorescence is acquired during the extension or combined annealing/extension phase of each cycle and related to product concentration.
- a quantitative assay for hepatitis C RNA using the intercalater , YO- PRO- 1 TM is known in the art . See Ishiguro, T., J. Saitch, H. Yawata, H. Yamagishi, S. Iwasaki, and Y. Mitoma, 1995, Homogeneous quantitative assay of hepatitis C virus RNA by polymerase chain reaction in the presence of a fluorescent intercalater, Anal. Biochem. 229:207-213. Prior to the present invention, continuous fluorescence monitoring within each cycle has not been efficiently and accurately carried out.
- a rapid temperature cycler integrated with 2-color fluorescence optics that provides continuous fluorescence monitoring.
- three different preferred fluorescence techniques for following DNA amplification are provided herein as specific examples of the present invention.
- Those skilled in the art will be familiar with the use of ethidium bromide in fluorescence techniques which can be used in accordance with the present invention.
- SYBR ® Green I which is well known in the art and available from Molecular Probes of Eugene, Oregon, be used as a double-strand-specific dye.
- time, temperature and fluorescence is acquired every 200 msec.
- a forced air hot air source 302 is preferably a commercially available device including a 1600 watt heating coil and fan.
- a forced air cool air source 304 is preferably a 2200 rpm shaded pole blower available in the art from Dayton of Niles, Illinois, model no. 4C006B. It is preferred that the cool air source 304 provide ambient temperature air, but it is within the scope of the present invention to utilize means for providing fluid that is at a temperature lower than ambient air temperature.
- corrugated black nylon tubing 306 and 308 having a 2.5 cm diameter is used to connect the forced air hot air source 302 and the forced air cool air source 304, respectively, to a sample chamber 310.
- a vent 312 and an exhaust fan 314 move air out of the sample chamber 310.
- the interior of the sample chamber 310 is shielded from outside light.
- Temperature of the samples within the sample chamber 310 is monitored by a tubular, metal-sheathed thermocouple 316, available from Idaho Technology of Idaho Falls, Idaho, model no. 1844, matched in thermal response to samples held in capillary tubes. Temperature homogeneity within the sample chamber 310 is achieved by a central sample chamber fan 318.
- the sample chamber fan preferably includes a 1.7 X 11 cm fan blade available from Idaho Technology, model no. 1862, and a motor available from Idaho Technology, model no. 1861, which creates air velocities of at least 800 to 1000 m/minute within the sample chamber 310.
- a plurality of samples held in capillary tubes, some of which are indicted at 320, are placed vertically on a rotatable carousel 322.
- the carousel 322 is preferably 14 cm in diameter and rotated by a 400 step/rev stepper motor 324 controlled by a microstepping drive module 326
- the stepper motor 324 is preferably one available from New England affiliated Technologies of Lawrence, Massachusetts, model no. 2198364, and the microstepping drive module 326 is preferably on also available from New England affiliated Technologies, model no. MDM7 microstepping drive module, which provides 12,800 steps per rotation of the carousel 322.
- the fluorescence excitation source 328 is preferably a 75 watt xenon arc source focused with an elliptical reflector, the xenon arc source being preferably available from Photon Technology International of South Brunswick, New Jersey, model no A1010, with f/2.5 elliptical reflector.
- a light emitting diode can be used.
- the light emitted by the fluorescence excitation source 328 is focused to about 2 mm using an adjustable iris 334 such a one available in the art from Rolyn (Covina, California), model no.
- the light emitted from the fluorescence excitation source 328 impinges upon a cold mirror 330, which is preferably available from Rolyn, model no. 60.4400, and passes through heat absorbing glass 332, which is preferably one available from Rolyn, model no. 65.3130.
- a planoconvex lens 336 preferably available from Rolyn, model no. 10.0260
- a 450-490 nm bandpass interference filter 338 preferably available from Omega Optical of Brattleboro, Vermont
- model no. 470RDF40 a focusing planoconvex lens 340, preferably available from Rolyn, model no.
- the optics of the collection path include a 1 mm silica window 344 also included to prevent condensation on the other optical components.
- Two opposed aspheric lenses 346A&B preferably available from Rolyn, model no. 17.1175, which function to focus emitted fluorescence onto a 2 x 10 mm slit 348, which can be fabricated from cutting exposed X-ray film, which functions as a spatial filter.
- the emitted fluorescence is imposed upon a 35 mm electronic shutter 350 operated via an electronic shutter control 352.
- the 35 mm electronic shutter 350 is preferably a Uniblitz shutter model no. VS35 and the electronic shutter control 352 is preferably driver model no. D122, both available from Vincent Associates of Rochester, New York.
- a collimating aspheric lens 354, preferably on available from Rolyn model no. 17.1175, is also provided.
- a filter 356 is also included when detection of SYBR ® Green I emissions is desired.
- the filter 356 is a 520-580 nm band pass filter, available from Omega model no. 550RDF60, used for single color acquisition.
- a combination of dichroic filter 358 and wavelength filters 358A and 358B are used in a filter block.
- a dichroic filter 358 is used which preferably consists of a 560 nm long pass dichroic filter, preferably available from Omega, model no 560 DRLP, and a 520-550 nm band pass filter (358A), preferably available from Omega, model no.
- the dichroic filter 358 preferably is a 590 nm long pass dichroic filter, available from Omega, model no. 590 DRLP, and filters 358A&B preferably consist of a 520-550 nm band pass filter (358A), available from Omega, model no. 535DF30, for detection of fluorescein, and a 660-680 nm band pass filter (358B), available from Omega, model no. 670DF20, for Cy5 detection.
- the fluorescence is focused through two planoconvex lenses 360A & 360B, each preferably available from Edmund of Bamngton, New Jersey, model no. 32970, onto photomultiplier tubes 362A and 362B.
- the photomultiplier tubes 362A and 362B are preferably ones available from Hamamatsu of Middlesex, New Jersey, model no. R928, and are housed in a housing, preferably one available from Photon Technology International, model no. 714, with analog acquisition
- a PMT and data acquisition control module 364 is also preferably provided.
- Manual PMT shutters 366A and 366B are also provided.
- optical components are preferably 5 cm in diameter and mounted in 5 cm universal lens mounts, such as those available from Rolyn, model no. 90.0190.
- 5 cm universal lens mounts such as those available from Rolyn, model no. 90.0190.
- many of the necessary structural components were machined from black DelrinTM.
- DNA amplification was performed in 50 mM Tris, pH 8.5 (25oC), 3 mM MgCl 2 , 500 ⁇ g/ml bovine serum albumin, 0.5 ⁇ M of each primer, 0 5 mM of each deoxynucleoside triphosphate and 0.2 U of Taq polymerase per 5 ⁇ l sample unless otherwise stated in the following examples Human genomic DNA (denatured for 1 min by boiling) or purified amplification product was used as DNA template. Purified amplification product was obtained by phenol/chloroform extraction and ethanol precipitation, see Wallace, D.M. 1987. Large- and small-scale phenol extractions and precipitation of nucleic acids, p.
- Primers were synthesized by standard phosphoramidite chemistry as known in the art, namely, using Pharmacia Biotech Gene Assembler Plus (Piscataway, New Jersey).
- the 180 base pair fragment of the hepatitis B surface antigen gene was amplified using primers 5'- CGTGGTGGACTTCTCTCAAT-3' (SEQ ID NO: 1), and 5'-AGAAGATGAGGCATAGCAGC- 3' (SEQ ID NO: 2) (Genbank sequence HVHEPB).
- SYBR ® Green I was obtained from Molecular Probes (Eugene, Oregon).
- the ⁇ -actin primers and fluorescein/rhodamine dual probe were obtained from Perkin Elmer (Foster City, California) (no.
- the single labeled probes 5'-CAAACAGACACCATGGTGCACCTGACTCCTGAOGA- fluorescein-3' (SEQ ID NO: 3) and 5'-Cy5-AAGTCTGCCGTTACTGCCCTGTGGGGCAAG- phosphate-3' (SEQ ID NO: 4) were synthesized using a fluorescein phosphoramidite (available from Glen Research of Sterling, Virginia, no. 10-1963) a Cy5TM phosphoramidite (available from Pharmacia no. 27- 1801-02), and a chemical phosphorylation reagent (available from Glen Research no. 10-1900). These adjacent probes hybridize internal to the PC03/PC04 ⁇ -globin primer pair on the same DNA strand and are separated by one base pair.
- Probes were purified by reverse phase C-18 high pressure liquid chromatography and homogeneity checked by polyacrylamide electrophoresis and absorbance (A 260 and the absorbance maximum of the fluorophore). Hybridization probes ( ⁇ -actin and ⁇ - globin) were used at 0.2 ⁇ M each.
- amplification samples of 5 ⁇ l were loaded into capillary sample tubes 230.
- the capillary sample tubes preferably are those available from Idaho Technology, model no. 1705, having dimensions of 1.02 mm O.D. and 0.56 mm I.D.
- the capillary sample tubes were sealed with a butane flame.
- the surface of the capillary sample tube was cleaned with optical grade methanol before it was loaded into the carousel 322 of the rapid temperature cycler with fluorescence detection 300.
- Control of the components represented in Figure 11 was achieved by use of a graphical programming language known as LabView (available from National Instruments, Austin, Texas) and a 12-bit multifunction input/output card (available from National Instruments under the designation AT-MIO-E2) in a PC compatible computer 366 utilizing an 80486 Inttl ® microprocessor running at a clock speed of 120 MHZ.
- Analog output channels on the input/output card were used to control the sensitivity, i.e. the PMT voltage, of each photomultiplier tube 362A&B.
- Analog input channels on the input/output card receive the signals from each photomultiplier tube 362A&B.
- the PC compatible computer controls the position, rate and direction of movement of the carousel.
- the carousel 322 rapidly positions each capillary sample tube 320 sequentially at the monitoring location for 100 msec acquisitions.
- data are averaged and acquired every 200 msec.
- Time, temperature, and 2 channels of fluorescence are continuously displayed as fluorescence vs. cycle number and fluorescence vs. temperature plots.
- the carousel should be positioned where maximal fluorescence and signals are acquired.
- the signals were acquired every 200 msec with an integrating time constant on the photomultiplier tubes 364 being set at 50 msec.
- the time constant was set at 0.5 msec and the carousel rotated once to locate the precise position where each capillary sample tube 320 provided maximum fluorescence in each channel.
- the sensitivity of each PMT 362A&B was adjusted and the carousel rotated again to count and locate the position of all the capillary sample tubes 320.
- Temperature control programming was modified from a commercial rapid temperature cycler available from Idaho Technology under the designation Rapidcycler using an 8051 cross compiler available from Systronics, Salt Lake City, Utah, designated BCI51 and Dallas development system (also available from Systronics under the designation DPB2).
- the temperature response of the rapid temperature cycler with fluorescence detection 300 is similar to response obtained with the embodiment of the present invention disclosed in Figures 8A&B allowing 20-30 second cycles (30 cycles in 10-15 min) as represented in the temperature vs. time chart of Figure 11A.
- fluorescence generally increases as more double stranded product is made, see Higuchi, R., G. Dollinger, P.S. Walsh, and R. Griffith, 1992, Simultaneous amplification and detection of specific DNA sequences, Bio/Technology 10:413-417.
- the 3D curve represented in Figure 12 is also projected in Figure 12 as 2D plots of temperature vs. time, fluorescence vs. time, and fluorescence vs. temperature.
- the temperature vs. time projection of Figure 12 repeats each cycle and provides essentially the same information as set forth in Figure 11A. Because fluorescence varies inversely with temperature, the fluorescence vs.
- time projection shown in Figure 12 at early cycles is a scaled mirror image of the temperature vs. time plot.
- the fluorescence vs. temperature projection of double stranded dyes shown in Figure 12 eliminates the time axis and shows the temperature dependence of strand status during DNA amplification.
- the fluorescence vs. temperature projection shown in Figure 12 is for a 180 base pair fragment of hepatitis B virus DNA.
- the fluorescence vs. temperature projection shown in Figure 13 is for a 536 base pair fragment of human ⁇ -globin DNA.
- Early cycles represented in Figure 13 appear identical, with a nonlinear increase in fluorescence at lower temperatures. As amplification proceeds, later cycles appear as rising loops between annealing and denaturation temperatures that show significant hysteresis. That is, the observed fluorescence during heating is greater than that during cooling.
- fluorescence is high until denaturation occurs (apparent as a sharp drop in fluorescence).
- double strand signal increases rapidly. Fluorescence continues to increase during extension while the temperature is held constant.
- sequence-specific probes have a similar dynamic range but, as shown in the plot of Figure 15, appear to discriminate even a single initial template copy from negative controls.
- Signal generation with 5'-exonuclease probes is dependent not only on DNA synthesis, but requires hybridization and hydrolysis between the fluorophores of the dual-labeled probe. This hydrolysis reduces quenching and the fluorescence ratio of fluorescein to rhodamine emission increases. Whereas the fluorescence from double strand dyes levels off with excess cycling, the signal from exonuclease probes continues to increase with each cycle. Even though no net product is being synthesized, probe hybridization and hydrolysis continue to occur. As the template copy number decreases below 10 3 , signal intensity decreases, but low copy numbers can still be quantified because the negative control signal is stable.
- Fluorescence vs. temperature plots of 5'-exonuclease probes confirm that probe hydrolysis is the mechanism of signal generation.
- a fluorescence vs. temperature plot of 2-temperature cycling is shown with the ⁇ -actin exonuclease probe. Each cycle the fluorescence ratio varies linearly with temperature and there is little if any hysteresis. The signal increases each cycle during the annealing/extension phase when probe hydrolysis is presumed to occur. Although the fluorescence of both fluorescein and rhodamine decreases with increasing temperature (data not shown), the rate of change is greater for rhodamine, resulting in an increasing ratio with increasing temperature. No temperature-dependent hybridization effects are apparent with the 5'-exonuclease probe.
- Figure 16A shows a plot of fluorescence ratio vs. cycle number plot for different initial template copy number, according to the legend in Figure 18.
- fluorescence ratio vs. temperature plots show a different pattern with obvious hysteresis during 2-temperature cycling, as plotted in Figure 17.
- Two adjacent hybridization probes are present, an upstream probe labeled 3' with fluorescein and a downstream probe labeled 5' with Cy5TM.
- the probes are separated by a 1 base pair gap.
- the probes hybridize to accumulating product and the Cy5TM to fluorescein fluorescence ratio increases.
- the probes appear to dissociate between 65 and 75°C, returning the fluorescence ratio to background levels.
- the change in fluorescence ratio during hybridization is largely due to an increase in Cy5TM fluorescence from resonance energy transfer.
- fluorescence monitoring during DNA amplification is an extraordinarily powerful analytical technique.
- sequence-specific detection and quantification can be achieved in five to twenty minutes, depending on the number of initial template copies present.
- Double-strand-specific dyes such as ethidium bromide or SYBR ® Green I can be used as generic indicators of amplification.
- SYBR ® Green I dye is preferred over ethidium bromide in many applications because it has an excitation maximum near fluorescein and often provides a stronger signal with DNA than visible excitation of ethidium bromide.
- Double strand dyes depend on the specificity inherent in the amplification primers. As will be appreciated by those skilled in the art, nonspecific amplification at high cycle numbers can limit detection sensitivity to about one hundred initial template copies (see Figure 14) while the present invention may provide further improvements in amplification specificity that could further improve this performance.
- hybridization can be detected directly through resonance energy transfer as outlined by Morrison. See Morrison, L.E., 1992, Detection of energy transfer and fluorescence quenching, p. 311-352, In L.J. Kricka (Ed.), Nonisotopic DNA probe techniques, Academic Press, San Diego, which is now incorporated herein by reference.
- energy transfer to C ⁇ 5 TM increases with product accumulation each amplification cycle ( Figure 17).
- probe synthesis is relatively simple because amidites for both fluorescein and Cy5 TM are available for direct incorporation during automated synthesis.
- the present invention can also monitor fluorescence throughout each temperature cycle.
- continuous fluorescence monitoring with double-strand-speciflc dyes can be used to control temperature cycling parameters.
- Amplification can be stopped after a certain amount of product is synthesized, avoiding over amplification of alternative templates.
- the extension phase of each cycle need only continue as long as fluorescence increases.
- Product denaturation can be assured in real time, increasing the temperature until the fluorescence reaches baseline. Limiting the time product is exposed to denaturation temperatures is especially useful for amplification of long products.
- Figures 12 and 13 shows that use of shorter denaturation times is effective.
- many causes of the known "plateau effect” have been proposed, but few data are available to distinguish between alternatives.
- product reannealing is very rapid. In fact, during later cycles of amplification, a majority of product is reannealed each cycle during cooling before the primer annealing temperature is reached. This occurs with cooling rates of
- double-stranded-DNA-specific dyes be used.
- SYBR ® Green I is a preferred sensitive dye for following PCR product accumulation.
- quantification of initial template copy number is possible over a one hundred and eight fold range.
- the fluorescence curves are displaced horizontally according to the initial template concentration.
- the sensitivity is limited at low initial template concentrations because amplification specificity is not perfect.
- undesired products such as primer dimers are eventually amplified. Thus, there is little difference between 0, 1, and 10 average initial template copies.
- dsDNA dyes Although quantification of very low copy numbers has not previously been achieved with dsDNA dyes, the present invention can utilize such dyes, which is advantageous because, inter alia , of the simplicity of using these dyes.
- the dsDNA dyes can be used for any amplification and custom fluorescently-labeled oligonucleotides are not necessary when using such dyes. Quantification of very low copy numbers with dsDNA dyes requires very good amplification specificity or, as provided by the present invention, means to differentiate the desired product from nonspecific amplification.
- a fluorescence vs. cycle number plot of DNA amplification monitored with the dsDNA dye SYBR ® Green I dye is provided.
- the plot of Figure 18 was obtain using a 536 base pair fragment of the human ⁇ -globin gene which was amplified from 0 to 10 9 average template copies in the presence of a 1:10,000 dilution of SYBR ® Green I.
- Purified template DNA was obtained by PCR amplification, phenol/chloroform extraction, ethanol precipitation, and ultrafiltration (Centricon 30 available from Amicon of Danvers, Massachusetts) and quantified by absorbance at 260 nm.
- Each temperature cycle was 28 seconds long (95°C maximum, 61°C minimum, 15 seconds at 72°C, average rate between temperatures 5.2°C/second). All samples were amplified simultaneously and monitored for 100 milliseconds between seconds 5 and 10 of the extension phase. The display was updated each cycle for all samples and forty-five cycles were completed in 21 minutes. The data for each capillary sample tube were normalized to a percentage of the difference between minimum and maximum values for each tube (represented by the Y-axis in Figure 18)
- sequence specific fluorescence monitoring is also provided. Sequence specific detection of PCR products is obtained by the present invention by way of including two different fluorophores on oligonucleotide probes Two arrangements are presently preferred within the present invention as represented in Figures 19A-D Both arrangements require a donor with an emission spectrum that overlaps the absorbance spectrum of an acceptor.
- Figures 19 A-D depict two different preferred arrangements for sequence-specific fluorescence monitoring during PCR
- Figure 19A shows a donor (D) which is initially quenched by an acceptor (A) because both are together on a single oligonucleotide probe. After hydrolysis by polymerase 5'-exonuclease activity, the donor and acceptor are separated and the fluorescence of the donor increases (Figure 19B) In the arrangement shown in Figure 19C, the donor is on a probe and the acceptor is on one of the primers. The dyes on the probe and primer are approximated by hybridization. This results in resonance energy transfer to the acceptor, increasing the acceptor fluorescence ( Figure 19D).
- the acceptor dye quenches the fluorescence of the donor because of their proximity ( Figure 19A)
- some of the probe hybridizes to single stranded PCR product and may be hydrolyzed by polymerase 5'-exonuclease activity. Because the donor and acceptor are no longer linked, the donor is released from acceptor quenching and the donor fluorescence increases. Because the fluorescence signal is dependent on probe hydrolysis instead of hybridization, this class of probes is referred to herein as "hydrolysis" probes.
- acceptor fluorescence Whether the donor fluorescence is merely quenched or actually increases acceptor fluorescence depends on the specific fluorophores and solvent conditions. An increase in donor fluorescence is usually observed during PCR with hydrolysis probes, whereas an increase in acceptor fluorescence is usually monitored with hybridization probes.
- sequence specific probes can quantify very low initial template numbers as represented by Figure 20.
- a single template copy can be distinguished from the absence of template.
- the efficiency of amplification decreases as the initial copy number drops below 1,500.
- the fluorescence signal continues to increase even after many cycles because hydrolysis is cumulative and not strictly related to product concentration.
- a fluorescence ratio (fluorescein/rhodamine) vs. cycle number plot of DNA amplification monitored with a dual-labeled hydrolysis probe is plotted.
- the thin lines indicate the log-linear portion of each curve.
- a 280 base pair fragment of the human ⁇ -actin gene was amplified from 0.15 to 15,000 (average) copies of human genomic DNA per tube.
- the hydrolysis probe which was utilized (included at 0.2 ⁇ M) is available from Perkin Elmer of Foster City, California.
- Each temperature cycle was 26 sec long (94°C maximum, 60oC for 15 seconds, average rate between temperatures 6.2oC/sec). All samples were amplified simultaneously and monitored for 100 milliseconds between seconds 5 and 10 of the annealing/extension phase.
- the display was updated each cycle for all tubes and 45 cycles completed in under 20 min.
- hybridization probes In contrast to hydrolysis probes, the fluorescence signal from hybridization probes is not cumulative and develops anew during each annealing phase.
- the fluorescence is a direct measure of product concentration because the hybridization is a pseudo-first order reaction (see Young B. and Anderson M., (1985), Quantitative analysis of solution hybridization, In: Nucleic Acid Hybridization. A Practical Approach, Hames B., Higgins S., eds., pp. 47-71, Washington D.C. IRL Press). Because the concentration of probe is much greater than the product, the fraction of product hybridized to probe is independent of product concentration.
- Figures 21A-D provide comparison of three fluorescence monitoring techniques for PCR.
- the fluorescence probes are the dsDNA dye SYBR ® Green I ( Figure 21A), a dual-labeled fluorescein/rhodamine hydrolysis probe ( Figure 21B), and a fluorescein- labeled hybridization probe with a Cy5-labeled primer ( Figure 21C). All amplifications were performed in ten replicates with 15,000 template copies (50 ng of human genomic DNA/10 ⁇ l). The temperature cycles were 31 sec long (94°C maximum, 60°C for 20 sec, average rate between temperatures 6.2oC/sec). Fluorescence was acquired for each sample between seconds 15 and 20 of the annealing/extension phase.
- the hybridization probe, TCTGCCGTTACTGCCCTGTGGGGCAAG-fluorescein (SEQ ID NO: 5) (from fluorescein- CPG available from Glen Research of Sterling, Virginia) was used with KM29 and the Cy5-labeled primer CAACTTCATCCACGTNCACC (SEQ ID NO: 6) where N was an amino-modifier C6dT (Glen Research) labeled with Cy5 (Mono Reactive available from Amersham of Arlington Heights, Illinois).
- the precision of the three fluorescence monitoring techniques are compared in Figure 21D.
- the data are plotted as the coefficient of variation (standard deviation/mean) of the fluorescence ratio above baseline (taken as the average of cycles 11-15) .
- plots are provided that compare interpolation methods for quantification of PCR fluorescence curves. Illustrated in Figure 22 is endpoint interpolation which compares the fluorescence of unknowns and standards at a given cycle number. Also illustrated in Figure 22 is threshold interpolation which determines the cycle number at which each curve exceeds a given fluorescence value.
- One preferred method is to interpolate entire curves, attempting to use all relevant data points. This method of curve fitting approach provides the most accurate results.
- Another preferred method is to interpolate the unknown along single vertical or horizontal lines. Single vertical interpolation is similar to conventional endpoint analysis. At a certain cycle number, the unknown fluorescence is interpolated between known values. Provided below in Table 1 is a list resulting from vertical interpolation of cycles 20-24. Interpolation along horizontal lines requires establishing a fluorescence threshold. Interpolation from thresholds of 10, 20, 30 and 40% are also listed in Table 1.
- endpoint or threshold interpolations do not use much of the available data and can be highly affected by single aberrant data points, e . g. endpoint interpolation at cycle 20.
- the gene copy number in 50 ng of genomic DNA is 1.7 x 10 4 , near the middle of values in Table 1 and close to the accepted value of 1.5 x 10 4 .
- Other curve fits may be better than the exponential example given above.
- the exponential fit necessarily relies on only the log-linear cycles (7 out of 45) and these fall in a region where the fluorescence precision is poor (Figure 21D).
- a sigmoidal curve is used which includes parameters that describe the lag phase, the log-linear phase, and the plateau phase, thus using all the available data.
- the fit is weighted to reflect the expected precision of the data points. Different parameters are necessary for different fluorescence probes because of variation in the curve shapes ( Figures 21A-D).
- the present invention provides the important advantage of providing continuous monitoring throughout the PCR cycle. Temperature is important because fluorescence changes as a function of temperature. However, in accordance with the present invention, monitoring fluorescence during temperature changes is very informative. For example, if fluorescence is acquired continuously throughout temperature cycling, hydrolysis probes show a linear change in fluorescence ratio with temperature and a parallel increase in fluorescence as more probe is hydrolyzed (See Figure 23A) . In contrast, the fluorescence ratio from hybridization probes varies radically with temperature (See Figure 23B). During probe hybridization at low temperatures, the ratio increases, followed by a decrease to baseline when the hybridization probe melts off the template.
- a 536 base pair fragment of the human ⁇ -globin gene was amplified from 10 5 copies of purified template and a 1 :30,000 dilution of SYBR ® Green I. Other conditions are essentially the same as those described in connection with Figure 18 Cycles 15-25 are displayed .
- the fluorescence vs. temperature data have been transformed to remove the effect of temperature on fluorescence.
- the present invention 's ability to monitor product denaturation and product reannealing leads to even additional methods for DNA quantification.
- These additional methods of the present invention for DNA quantification require fluorescence monitoring within individual temperature cycles and cannot be used when fluorescence is only acquired once per cycle.
- PCR products have characteristic melting curves dependent on product GC/AT ratio and length (See Figure 25) .
- PCR products have characteristic melting curves dependent on product GC/AT ratio and length (See Figure 25) .
- various PCR products should melt over a 50°C range. Since nonspecific products will melt differently than the desired PCR product, dsDNA fluorescence can be separated into specific and nonspecific components.
- Figure 25 shows the melting curves of three purified PCR products PCR products were purified and quantified as explained in connection with Figure 18 A 1.10,000 dilutions of SYBR ® Green I was added to 50 ng of DNA in 10 ⁇ l of 50 nM Tris, pH 8.3 and 3 mM MgCl 2 . The temperature was increased to 0.2°C/second and the fluorescence acquired and plotted against temperature.
- generic dsDNA dyes like SYBER ® Green I or ethidium bromide
- Figure 25 shows the melting curves of three purified PCR products PCR products were purified and quantified as explained in connection with Figure 18 A 1.10,000 dilutions of SYBR ® Green I was added to 50 ng of DNA in 10 ⁇ l of 50 nM Tris, pH 8.3 and 3 mM MgCl 2 . The temperature was increased to 0.2°C/second and the fluorescence acquired and plotted against temperature.
- a 3°C shift in the melting temperature is enough to separate the native and competitive components of the product melting curve (see Figure 25) .
- These melting curves, acquired during amplification, are differentiated to melting peaks (see Hillen, W ., Goodman T., Benight, A., Wartell R. and Wells, R. , (1981), High resolution experimental and theoretical thermal denaturation studies on small overlapping restriction fragments containing the Esche ⁇ chia coli lactose genetic control region, J. Biol . Chem. 256, 2761-2766, which is now incorporated herein by reference) and used to determine the relative amounts of competitor and template. Using this method should eliminate the need to analyze the sample after temperature cycling.
- the hybridization kinetics for absolute quantification in accordance with the present invention will now be discus sed .
- the present invention also allows monitoring of product-product reannealing after denaturation and provides a method for direct, absolute DNA quantification. If the sample temperature is quickly dropped from the denaturation temperature and held at a lower temperature, the rate of product reannealing will follow second order kinetics (see Young, B. and Anderson, M., 1985, Quantitive analysis of solution hybridization, In: Nucleic Acid Hybridization: A Practical Approach, Hames, B., Higgins, S. eds., pp. 47-71, Washington, D.C . IRL Press, which is now incorporated herein by reference).
- Figure 26 shows reannealing curves for different concentrations of PCR product .
- Different amounts of a purified 536 base pair fragment of DNA (see Figure 18) were mixed with a 1:30,000 dilution of SYBR® Green I in 5 ⁇ l of 50 mM Tris, pH 8.3 and 3mM MgCl 2 .
- the samples were denatured at 94°C and then rapidly cooled to 85°C.
- a second order rate constant can be measured. Once the rate constant is known, an unknown DNA concentration can be determined from experimental reannealing data Initial determination of a rate constant is demonstrated in Figure 27.
- Cooling is not instantaneous, and some reannealing occurs before a constant temperature is reached. Rapid cooling, which can be carried out by the apparatus of the present invention, maximizes the amount of data available for rate constant or DNA concentration determination.
- Figure 27 shows determination of a second order reannealing rate constant The curve was fit by nonlinear least squares regression with F max , F m ⁇ n , t 0 and k as the floating parameters. With the rate constant (k) determined, DNA concentrations can subsequently be determined on unknown samples
- This method of the present invention requires pure PCR product, but this can be assured by melting curves also obtained during temperature cycling.
- the present invention's method of quantification by reannealing kinetics is advantageously independent of any signal variation between capillary sample tubes.
- the present invention provides single-color fluorescence methods to monitor product purity, quantify template, and detect mutations during PCR.
- dsDNA double-stranded DNA
- fluorescent dyes Within each cycle, fluorescence decreases when dsDNA is denatured and increases with product reannealing and primer extension.
- these dyes are not sequence specific, product purity can be assessed by analysis of the shape of DNA melting curves. Pure PCR products have sharp melting transitions, while impurities melt over a broad temperature range.
- Melting curves can also be used for mutation detection during PCR.
- the heteroduplexes formed during amplification of heterozygous DNA melt at lower temperatures than completely complementary products.
- the ability to identify deletions and single base mutations will be demonstrated using melting curve analysis.
- Continuous monitoring of dsDNA formation is used for direct, absolute DNA quantification. If denatured DNA is rapidly cooled and then held at a constant reannealing temperature, the absolute DNA concentration is determined by the rate of reannealing.
- the present invention also provides dual - color fluorescence methods that depend on probe hybridization (not hydrolysis) for sequence-specific detection during PCR.
- the annealing kinetics and melting of hybridization probes provides information not available with probes that rely on exonuclease hydrolysis between fluorophores.
- Initial template copy number will be quantified by competitive amplification using probe melting temperature to discriminate between templates.
- Single base mutations will be detected by probe melting temperature shifts. Determination of absolute product concentration is demonstrated by analysis of probe annealing kinetics.
- the present invention provides an inexpensive instrument that can be used in commercial applications and that continuously monitors fluorescence during rapid cycle amplification.
- the thermal cycler of the present invention is capable of amplification in 10-20 minutes and is coupled to optics modules that detect one, two or three fluorophores.
- the preferred embodiments of the present invention monitor 24 samples 1 to 10 times/second. In accordance with the present invention, it is preferred that samples are prepared in a 96 well format in composite plastic/capillary vessels and then transferred to the apparatus (see Figure 11) for thermal cycling and analysis.
- the preferred embodiments include a user friendly graphical interface, which analyzes and displays fluorescence data continuously on a display.
- the present invention also uses fluorescence feedback for real time control and optimization of amplification. Fluorescence is used to control temperature cycling. With continuous monitoring of dsDNA- specific dyes, extension will be terminated each cycle after fluorescence stops increasing. Denaturation conditions are automatically controlled by increasing the temperature only until the product is completely melted. Primer annealing is monitored with resonance energy transfer to Cy5-labeled oligonucleotides. Temperature cycling is automatically terminated after a certain amount of product is made.
- Rapid temperature cycling improves quantitative PCR and increases the discrimination of allele specific amplification. Rapid cycling for cycle sequencing reduces sequencing ambiguities and minimizes "shadow banding" in dinucleotide repeat amplifications. For long PCR up to 35 kb, yield is improved when the sample is exposed as little as possible to high denaturation temperatures.
- a kinetic paradigm for PCR is appropriate. Instead of thinking about PCR as three reactions (denaturation, annealing, extension) occurring at three different temperatures, a kinetic paradigm for PCR may be more appropriate (Figure 28). With a kinetic paradigm, the temperature vs. time curve consists of continuous transitions between overlapping reactions. A complete analysis would require knowledge of all relevant rate constants over all temperatures. If rate constants of all reactions were known, a "physicochemical description of PCR" could be developed. Determining these rates would require precise sample temperature control and would be aided by reaction monitoring during temperature cycling.
- the present invention also provides the advantages that accrue from continuous monitoring of a sample. Providing fluorescence monitoring every cycle for quantitative PCR provides benefits and works well with ethidium bromide. In once-per-cycle monitoring, fluorescence is acquired once per cycle during a combined annealing/extension phase and gives a relative measure of product concentration.
- time, temperature and dsDNA fluorescence are acquired every 200 msec and fine details of product denaturation and reannealing can be observed during rapid temperature cycling. These details allow product identification by melting curves, and provide means for relative and absolute product quantification, mutation detection, and immediate feedback for temperature control. In addition with continuous monitoring, the melting of sequence specific probes can be determined by resonance energy transfer. Probe melting occurs at a characteristic temperature that can also be exploited for product quantification and single base mutation detection.
- Double-stranded DNA (dsDNA) dyes can be used in any amplification and are inexpensive.
- SYBR ® Green I generally costs 0 . 01 cents per 10 ⁇ l reaction .
- product specificity can be obtained by analysis of melting curves.
- fluorescent oligonucleotide probes must be synthesized for each sequence under study.
- the "TaqMan" probes promoted by Perkin Elmer incorporate 2 fluorophores into each probe. Fluorescence is generated when the probe is hydrolyzed by polymerase exonuclease activity.
- probes are difficult to make and expensive to buy; their current cost from the manufacturer is $1,200 for 0.1 ⁇ mol of a custom probe.
- Two probes are necessary for competitive quantification of a target.
- fluorescent hybridization probes that are not dependent on hydrolysis can be designed. These hybridization probes require only a single fluorophore per probe and are much easier to synthesize. Because their fluorescence results from hybridization, not hydrolysis, the temperature dependence of probe fluorescence can be used for mutation detection and quantification.
- the present invention thus provides real time fluorescence analysis in a cost effective manner.
- Real time fluorescence control of temperature cycling improves amplification quality. For example, if the temperature of samples is increased only until denaturation occurs, product exposure to high temperatures is minimized. This increases yield by limiting product and enzyme degradation and increases specificity by limiting amplification of products with a high melting temperature.
- Figure 29 shows that monitoring over a 10-fold dynamic range in the log-linear portion of a routine amplification has been fully accomplished. Furthermore, it has been accomplished not only for routine amplifications (15,000 copies of genomic DNA/ sample tube), but also for more difficult amplifications with smaller amounts of template. As shown in Figure 29, the fluorescence ratio increases with cycle number and with initial template concentration. The log-linear portions of each curve (straight, thin lines) span 4 cycles (about 24, or a 16-fold range in DNA concentration). Duplicate samples track very closely. Figure 29 shows that a single copy of template can be distinguished from no template (presumably, one of the 0.15 average copy samples included a single copy).
- Figure 30 shows an embodiment of the present invention configured for continuous monitoring of a single sample.
- a single sample was placed at the intersection of a temperature- controlled air stream and a linear optical path.
- One side of the capillary was illuminated with a light emitting diode, and the other side was observed with a photodiode.
- Air was constantly forced over the sample and the temperature was controlled by an upstream heating coil.
- the geometry and orientation of the sample and container were studied with human genomic DNA stained with the dsDNA dye, SYBR ® Green I.
- Figure 31 shows the optical layout of another embodiment in accordance with the present invention to provide continuous monitoring of a PCR sample.
- Total internal reflection (“light piping") along the length of the capillary sample tube was exploited to increase both excitation and emission yields.
- the optical path has been changed from linear, to epifluorescent, that is, both the excitation and emission light follow the same optical path.
- the optical axis is parallel to the length of the capillary (paraxial) with the capillary tip as the focal point. Assuming a refractive index of 1.33 for the sample, 12.3% of emitted light should be guided to the tip.
- Figure 32 displays charts showing the effectiveness of light piping as a 10-fold increase in signal intensity by viewing the tip (closed diamonds) rather than the side (open circles) of capillaries.
- two different size capillary sample tubes are preferred which were filled to different lengths with dsDNA stained with SYBR ® Green I. The observed fluorescence increases as more sample is added to the tube, although the fluorescence efficiency decreases
- a rapid temperature cycler with fluorescence detection 300 can be used for continuous monitoring as will now be further explained.
- the rapid temperature cycler with fluorescence detection 300 can advantageously be constructed using light emitting diodes (LEDs) and photodiodes in place of similarly functioning components represented in Figure 11.
- the fluorescence excitation source 328 can be carried out by light emitting diodes.
- the photomultiplier tubes 362A&.B can also be replaced with photodiodes Technique sensitivity is limited by background fluorescence, most of which comes from the probes, not the detection system. Stability is more important than absolute sensitivity.
- the present invention also overcomes the challenges which arise due to polarization effects when using capillary sample tubes. Observing the fluorescence polarization of a sample requires that the optical system not randomize polarized light. Epifluorescence monitoring from the tip of capillaries will randomize any polarization because of multiple reflections. When round glass capillaries are illuminated with polarized light from the side, the observed polarization depends on the precise positioning of the tube with respect to the excitation beam as set forth in Figure 33.
- fluorescence polarization probes can be used.
- Polarization probes were synthesized as 30-mers with a 5'-fluorescein connected by aminolinkers of different lengths. During PCR, the 5'-exonuclease activity of the polymerase was expected to cleave the probe and decrease its polarization during amplification. The intact probes had a polarization of about 90 millipolarization units (mP) that was decreased to 35 mP when extensively hydrolyzed with phosphodiesterase I.
- Figure 34 shows the results obtained using one probe that was included at 0.2 ⁇ M in the amplification of a single copy gene with genomic DNA as template. Polarization decreased between 20 and 30 cycles and continued to decrease at least to 50 cycles.
- the decrease, expressed as a ratio of parallel to perpendicular fluorescence was about 11%.
- the length of the linker, the type of aminolinker and the presence/absence of a 5' noncomplementary tail did not significantly alter the observed changes during PCR.
- Adding sucrose to increase the viscosity of the solution increased the polarization of both intact and hydrolyzed probes, but did not change the signal difference generated after amplification.
- hybridization without hydrolysis increases polarization.
- a 15-mer peptide nucleic acid labeled with fluorescein was used. Because of its amide backbone, it cannot be hydrolyzed by exonuclease activity. When hybridized to a 10 fold excess of purified complementary single-stranded PCR product, its polarization only increased from 85 to 97 mP.
- fluorescein labeled probes do show polarization changes when hybridized or hydrolyzed. These changes can be used to monitor PCR, but the changes are small.
- the present invention can be used in a method for increasing the small polarizat ion signal of hybridization for strand displacement amplification.
- a genetically altered form of the endonuclease EcoRI that lacks cleavage activity but retains binding specificity was used to increase the polarization of the complex.
- Resonance energy transfer probes can also be used in accordance with the present invention.
- Resonance energy transfer probes are superior to polarization probes for PCR monitoring because of greater signal intensity.
- Prior art uses of resonance energy transfer in PCR have been limited to only endpoint analysis.
- One probe design depends on exonuclease hydrolysis for signal generation.
- Dual-labeled fluorescein/rhodamine probes are cleaved during polymerase extension by 5'-exonuclease activity, separating the fluorophores and increasing the fluorescein/rhodamine emission ratio.
- Figure 35 shows fluorescence PCR results from a probe with five intervening bases between fluorescein and rhodamine labels.
- the forty-five cycle amplification was completed in 20 minutes using the rapid temperature cycler with fluorescence detection 300 of Figure 11. By monitoring the fluorescence ratio once per cycle, a 10 9 fold range of initial template concentration could be distinguished. The amplification curves are shifted approximately 3-4 cycles for each 10-fold change in initial template concentration. Although efficiency decreases when the initial template concentration is low, a single copy can be distinguished from no template.
- the signal generated by monitoring hydrolysis is cumulative and only indirectly related to product concentration. Hence, as shown by Figure 35, the fluorescence ratio continues to increase even after the amount of product has reached a plateau. Nevertheless, the fluorescence signal correlated well with the amount of PCR product as measured by 32 P-dATP incorporation, at least up to the plateau phase.
- the concentration of the probe has very little effect on sensitivity as shown in Figure 36. Changing the probe concentration by a factor of 40 only shifts the curve by about 2 cycles. Lower probe concentrations are slightly more sensitive, but are also more variable because of lower signal strengths.
- the data in Figure 36 are normalized to the maximum signal at each probe concentration. Although decreasing the probe concentration would give a greater signal for the same amount of hydrolyzed probe, this advantage is offset by lower hybridization rates. The rate of probe hybridization to target depends directly on the probe concentration.
- the present invention provides that many different hydrolysis probes can be used, including those labeled with fluorescein and either rhodamine, eosin or BODIPY dyes (available from Molecular Probes).
- fluorescein and either rhodamine, eosin or BODIPY dyes (available from Molecular Probes).
- rhodamine eosin
- BODIPY dyes available from Molecular Probes.
- Resonance energy transfer probes that require hydrolysis have some characteristics which must be noted. One characteristic is that some probes are resistant to hydrolysis. Another characteristic is that synthesis is difficult, requiring manual addition of at least one label and high pressure liquid chromatography for purification.
- Cy5 is a red dye that recently became available as an amidite for direct incorporation into oligonucleotides. Working in the red/infrared region of the spectrum is advantageous when choosing optical compoments. Laser diodes can be used for illumination, photodiode detectors have excellent sensitivity, and most materials have minimal autofluorescence in the pertinent spectral region.
- a Cy5/Cy7 probe has been developed in connection with the present invention. Amplification was detectable with this probe, although the signal was weak When the probe was completely hydrolyzed with phosphodiesterase, only a 2-fold increase in signal was observed. Between cycles 20 and 40 of PCR, a 1.3-fold increase in signal occurred as represented in Figure 37. Synthesis of the Cy5/Cy7 probe required manual addition of the Cy7.
- Dual-labeled, fluorescein and Cy5 probes can be easily made on automated oligonucleotide synthesizers These fluorescein/Cy5 probes show excellent fluorescence ratio changes when completely hydrolyzed with phosphodiesterase.
- the emission wavelengths of fluorescein and Cy5 are well separated, and efficient resonance energy transfer occurs between the fluorophores as shown in Figure 38.
- the spectral overlap is small, the molar absorption coefficient and absorption wavelengths of Cy5 are high Spectral overlap, acceptor absorptivity, and acceptor wavelength all contribute to the overlap integral that determines energy transfer rates. Because Cy5 has low absorbance at fluorescein excitation wavelengths, direct excitation of Cy5 is also minimal.
- the present invention's feasibility using two different methods for resonance energy transfer detection of hybridization during PCR is shown in Figure 39.
- the first method uses two adjacent hybridization probes, one labeled 3' with fluorescein and the other labeled 5' with Cy5. As product accumulates during PCR, the probes hybridize next to each other during the annealing segment of each cycle.
- the second method uses a primer labeled with Cy5 and a single hybridization probe. The labeled primer is incorporated into the PCR product during amplification and only a single hybridization is necessary.
- fluorescence energy transfer to Cy5 increases with hybridization and is plotted as a ratio of Cy5 to fluorescein fluorescence. The fluorescence is monitored once each cycle near the end of a 2-temperature annealing/extension segment.
- the sensitivity of these hybridization probes appears similar to hydrolysis probes (compare Figures 29 and 39) .
- the temperature dependence of the fluorescence from hybridization probes is best demonstrated with fluorescence vs. temperature plots as shown in Figure 40. These plots are generated by monitoring a single sample every 200 msec of temperature cycling. During the annealing/extension phase, the probes hybridize to single stranded product and the fluorescence ratio (Cy5/fluorescein) increases. During heating to product denaturation temperatures, the probes dissociate around 70-75°C, returning the fluorescence ratio to background levels. In contrast, hydrolysis probes do not show this temperature dependence (see Figure 41). As expected, fluorescence vs. temperature plots with hydrolysis probes show only the linear dependence of fluorescence with temperature. The ability to monitor hybridization with fluorescence during temperature cycling is a powerful tool. The melting temperature of sequence-specific probes can identify and discriminate products during PCR.
- Double strand specific dyes can also be used in accordance with various aspects of the present invention.
- the strand status of PCR products can be followed with dyes that fluoresce in the presence of dsDNA.
- SYBR ® Green I is present during amplification, fluorescence increases as more dsDNA is made.
- temperature cycling introduces a confounding effect because fluorescence is inversely proportional to temperature as shown in Figures 42A and 42B.
- fluorescence is continuously monitored as a function of temperature and time during PCR, the data form a three dimensional spiral represented in Figure 12.
- the 3D curve represented in Figure 12 can be projected onto 2D plots of temperature vs. time, fluorescence vs. time, and fluorescence vs. temperature.
- the temperature vs. time projection of Figure 12 repeats each cycle; its familiar form is more clearly shown in the bottom of Figure 42B.
- the fluorescence vs. time projection of Figure 12 is a scaled mirror image of the temperature vs. time plot at early cycles shown in Figure 42B. As product accumulates, the fluorescence increases except at denaturation temperatures, where the fluorescence returns to baseline as shown in Figure 12.
- Fluorescence vs. temperature projections show the temperature dependence of strand status during PCR (see Figure 24 and Figure 24A). As amplification proceeds, temperature cycles appear as rising loops between annealing and denaturation temperatures. As the sample is heated, fluorescence is high until denaturation occurs. As the sample cools, fluorescence from dsDNA formation increases, reflecting product reannealing. When the temperature is constant during extension, increasing fluorescence correlates with additional DNA synthesis. The fluorescence vs. temperature data can be transformed to remove the effect of temperature on fluorescence (see Figure 24). In accordance with the present invention, product Tm and melting curves are used to assess amplification specificity. In many cases, this method eliminates the need for synthesizing a hybridization probe. Discrimination based on hybridization temperatures is a powerful tool for identification and quantification, and can be used in conjunction with or instead of spectral discrimination by multicolor analysis.
- the following table compares dsDNA dyes, hydrolysis probes, and hybridization probes useful in continuous monitoring of PCR.
- the fluorescence of dsDNA dyes depends on the strand status of the DNA.
- the dual-labeled hydrolysis probes are quenched while intact.
- the fluorescence of the quenched fluorophore increases when the probe is hydrolyzed.
- Hybridization probes depend on increased resonance energy transfer when hybridization brings 2 fluorophores closer together.
- the rapid temperature cycler with fluorescence detection 300 represented in Figure 11 includes the beneficial characteristics of a fluorimetry device with rapid temperature control, a combination nowhere suggested or taught in the art.
- PCR can be performed and analyzed during ten to twenty minutes of temperature cycling.
- the present invention's combination of 1) continuous fluorescence monitoring within each temperature cycle and 2) analysis of the temperature and time dependence of hybridization provides advantages not otherwise obtainable.
- the present invention also provides single-color fluorescence methods to monitor product purity, quantify template, and detect mutations during PCR.
- Dyes that monitor DNA strand status are added to PCR reactions for observation during temperature cycling.
- SYBR ® Green I is a sensitive dye that is highly fluorescent only when complexed with double stranded DNA.
- the melting curve is characteristic of the product being denatured. For small PCR products, the melting transition occurs over a narrow temperature range; the midpoint of melting is referred to as the T m .
- the fluorescence melting curves of three different purified PCR products are shown in Figure 43A.
- the data of Figure 43A were obtained by fluorescence monitoring with SYBR ® Green I while increasing the temperature at a rate of 0.2°C/sec.
- the relative melting positions can be predicted from empirical equations relating GC content and length to T m .
- the apparent T m of PCR products is dependent on the heating rate such as shown in Figure 43. As the heating rate decreases, the melting curve shifts to lower temperatures and becomes sharper. For maximum detail of melting curves and accurate estimates of T m , the kinetic effects of heating rate need to minimized.
- the apparent T m of PCR products is also dependent on the dsDNA dye concentration as shown in Figure 44. Higher concentrations of dye increase the stability of the duplex and the observed T m .
- dsDNA dyes The characteristics of different dsDNA dyes will be discussed, first, to select an optimal dye for melting curves during PCR, and then a discussion of the melting curves to assess PCR product purity and to detect mutations during amplification will be provided. Finally, the use of dsDNA dyes in competitive quantitative PCR and absolute product quantification will be explained.
- dsDNA dyes There are many double strand-specific dyes which can be used in accordance with the present invention.
- One preferred dye is SYBR ® Green I which is more preferred over the more common ethidium bromide because its excitation spectrum is similar to fluorescein.
- a variety of double strand dyes were tested for: 1) inhibition of PCR, 2) detection sensitivity, 3) heating rate effects on the melting curve, and 4) dye concentration effects on the melting curve.
- the highest concentration of dye compatible with rapid cycle PCR was determined. This concentration can be used to assess detection sensitivity by continuous monitoring during PCR with optimal optical filters.
- the effect of transition rates and dye concentration on melting curves are dye specific. Data will be acquired and presented as in Figures 43 and 44. The dyes listed below will be compared to SYBR Green I: Alternate dsDNA dyes for melting curves
- SYBR Green I it is preferred to use dilutions of 1:7,000- 1:30,000 with heating rates of 0.1-0.5°C/second. Melting curves of purified PCR products with high GC content and low GC content are obtained for each dye. Melting curves with different dyes may vary depending on their AT/GC preference and mode of binding. Dyes may redistribute during the melting of different DNA domains, as is known for ethidium bromide. In accordance with the present invention, the best dye, its concentration, and the heating rate required for melting curves can be determined.
- PCR products can melt over a 40-50°C range.
- primer dimers should melt at low temperatures
- heterogeneous nonspecific products should melt over a large range
- pure PCR product should melt sharply at a specific T m .
- Mutation detection should also be considered in accordance with the present invention.
- the ability of melting curves to detect genetic polymorphism and mutations will be determined.
- Repeat polymorphisms VNTRs, dinucleotide repeats
- VNTRs Repeat polymorphisms
- Homozygous point mutations (base substitutions) in DNA fragments can be detected by denaturing gradient gel electrophoresis and temperature gradient gel electrophoresis, but the temperature shift is usually ⁇ 1°C, a difference which can only be detected using precision techniques.
- the DNA target in PCR is heterozygous, heteroduplexes are formed during cooling, and the observed temperature shifts are 1-5°C.
- a majority of heterozygous mutations can be detected by simple melting curves during PCR using the present invention.
- the region surrounding the 3-base pair deletion site of the most common cystic fibrosis mutation ( ⁇ F 508 ) is amplified from previously typed DNA in accordance with the present invention. Melting curves from homozygous wild type, heterozygous ⁇ F 508 , and homozygous ⁇ F 508 is also compared herein.
- the homozygous samples will be nearly indistinguishable but the heterozygote curve shows a low ⁇ ra heteroduplex melt followed by a normal "homoduplex" melt. The effect is more pronounced with smaller amplicons.
- the most common known genetic risk factor for thrombosis is a single point mutation in the factor V gene.
- Previously typed homozygous and heterozygous DNA surrounding the mutation is amplified and melting curves obtained. Homozygous mutations will be detected by coamplification with an equal amount of wild type DNA. The observed mixed melting curve should appear identical to that from a heterozyote amplification. If wild type DNA is routinely mixed with test samples in a 1:2 ratio, heterozygotes should show a 2:1 wild type:mutant melt and a homozygous mutant would be 1:2 wild type: mutant.
- BRCAl is the first breast cancer susceptibility gene identified, accounting for about 5% of breast cancers. Most mutations are substitutions, insertions or deletions of only one or two bases and susceptibility is conferred by being heterozygous for a mutation. Heterozygotes can be detected by automated sequencing, but a clinical test that sequences over 5,000 coding bases is expensive and difficult using prior art apparatus and methods. Ten known BRCA1 mutations are tested using the present invention by amplifying the affected amplicons, observing melting curves, and comparing to wild type. The primers and known DNA samples are available in the art from Myriad Diagnostics.
- a competitive template is generated for amplification of a 180 base pair fragment of the hepatitis B surface antigen gene from primers previously described.
- a competitive template with a 3°C difference in T m can be obtained by either changing the template length, GC content, or a combination of both.
- the alternate templates were quantified by their A 260 and amplification efficiencies determined by monitoring with SYBR ® Green I once each cycle.
- Competitive quantification of wild type DNA by all three alternative templates will be compared herein to a standard clinical method using hybridization.
- Absolute quantification of product is also advantageously carried out using the present invention.
- Continuous monitoring of double stranded DNA formation allows direct, absolute DNA quantification by reannealing kinetics.
- the sample temperature is quickly dropped from the denaturation temperature and held constant at a lower temperature that is still high enough to prevent primer annealing.
- the rate of product reannealing then follows second order kinetics.
- the shape of the reannealing curve is characteristic of the DNA concentration (see Figure 26).
- a second order rate constant can be measured. Once the rate constant is known, any unknown DNA concentration can be determined from experimental reannealing data. The principle is demonstrated in Figure 27.
- the curves can be fit by non-linear least squares regression during temperature cycling in real time using the LabView programming environment explained previously. Cooling is not instantaneous, and some reannealing occurs before a constant temperature is reached, but regression analysis allow for this in accordance with the present invention (see Figure 27) .
- the technique requires pure PCR product, but such can be assured by melting curves also obtained during temperature cycling. Quantification by reannealing kinetics is independent of signal level and not affected by minor sample differences.
- the present invention also provides dual-color fluorescence methods that depend on probe hybridization (not hydrolysis) for sequence-specific detection during PCR.
- the resonance energy transfer between adjacent hybridization probes labeled with fluorescein and Cy5 can be used to monitor amplification.
- the effect of probe length, probe concentration, and optimal distance between the probes should also be considered when utilizing embodiments of the present invention.
- the present invention also provides for optimization of adjacent hybridization probes. The effect of distance between the probes is determined.
- the probes are designed to hybridize to the same strand in the ⁇ -globin region with inter-probe distances between fluorescein and Cy5 of 0 to 25 bases.
- High Performance Liquid Chromotography (HPLC) with tandem absorbance and fluorescence monitors are used for purification.
- Probes will be included at 0.2 ⁇ M during PCR, and 2- temperature cycling will be used. The fluorescence ratio change during PCR is be plotted against the inter-probe distance to determine the optimal distance between probes.
- probe lengths of 20, 25, and 35 bases are synthesized and compared to the 30- mer probes.
- the melting temperature of these probes is observed during PCR and plotted against probe length.
- Use of longer probes allows use of a 3-temperature cycle with a probe annealing step preceding a primer annealing step.
- the effect of probe concentration on detection sensitivity and signal strength during PCR is measured.
- a labeled primer for resonance energy transfer to a hybridization probe is in accordance with one aspect of the present invention.
- One of the adjacent resonance energy transfer probes can be incorporated into a PCR primer as shown in Figure 39.
- one labeled probe hybridizes to a single stranded PCR product that incorporates the labeled primer.
- the labeled primers are synthesized with a modified dT amidite with an aminolinker (available from Glen Research) for manual coupling to Cy5 (available from Amersham/BDS).
- the present invention also includes determining how close the modified Cy5-dT can be to the 3' end of the primer without inhibiting PCR. This determination requires several labeled primers with the labeled base at different positions. Next, the optimal distance between fluorophores by synthesizing and testing several 3'- fluorescein-labeled probes is found.
- the adjacent hybridization probe scheme is referred to as a "noncompetitive format.” This is in contrast to a “competitive format” where two complementary oligonucleotides are singly labeled with fluorophores.
- the probes either hybridize to each other (resulting in energy transfer or quenching) or to a competing target, which in our case would be accumulating PCR product. Synthesis and testing of 20-, 25-, and 30-mer 5'-Cy5-labeled and 3'-fluorescein- labeled complementary probes in PCR can be carried out in accordance with the present invention.
- the "intercalater format" of Morrison requires a labeled probe that interacts with a double strand-specific dye when it hybridizes See Morrison L.E., Detection of energy transfer and fluorescence quenching, in L.J Kricka (ed ), Nonisotopic DNA probe techniques, Academic Press, San Diego, pp 311-352, 1992 which is now incorporated herein by reference. Synthesize of 20-, 25-, and 30-mer probes dual- labeled with Cy5 at the 3' and 5' ends and use of SYBR ® Green I as the double strand-specific dye is within the scope of the present invention. PCR product formation results in hybridization observable as increased emission of Cy5. This method has the advantage that both sequence-specific product and double stranded DNA can be monitored at the same time.
- the present invention also applies dual-color, sequence - specif ic methods for mutation detection, competitive quantitative PCR, and product quantification.
- the T m of hybridization probes shifts about 10°C if a single base mismatch is present. If a hybridization probe is placed at a mutation site, single base mutations are detectable as a 10°C shift in probe melting. Heterozygous mutations should give an intermediate melting curve. Single base discrimination will be demonstrated using the factor V mutation mentioned above and adjacent fluoresce ⁇ n/Cy5 probes.
- Figure 47 is a schematic representation of a rapid temperature cycler with fluorescence detection at the tip of capillary sample tubes, which is generally indicated at 400.
- Figure 47 Provided below is a comparison of the different embodiments of the features of the present invention disclosed herein which include fluorescence detection.
- the rapid temperature cycler with fluorescence detection at the tip of capillary sample tubes represented in Figure 47 is particularly advantageous.
- a 400 W heating cartridge available from Reheat, Inc.
- the cartridge is proportionally controlled and the fan is run at a low speed (12 V, 0.5 A) to provide temperature homogeneity throughout the sample chamber.
- the heating cartridge is disabled and the fan is run at maximum speed (27 V, 1.4 A). The fan forces air in the central opening and out the exhaust ports.
- the heating and cooling elements are symmetrical around a central axis, as are up to 24 samples that are placed in a circular carousel that is positioned with a stepper motor.
- the stepper motor is microstepped (using devices available from New England affiliated Technologies) to provide over 10,000 steps per revolution of the carousel.
- the optical design of the embodiment represented in Figure 47 is based on paraxial epifluorescent illumination of the capillary tip as previously described (see Figure 31).
- the excitation source is a "super bright" blue light emitting diode (available from LEDtronics) . Fluorescence signals are acquired from integrated detector/filter modules (available from Ealing Electrooptics - 0.5 inch interference filters with high performance silicon photodiodes in TO5 packages).
- the excitation and detection components are mounted directly on one circuit board with associated electronics. All optics are 0.5 inches in diameter.
- Samples can be added to the composite plastic/glass sample containers and centrifuged in a 96-well format, but are loaded into the instrument individually.
- the composite plastic/glass sample containers fit into brass sleeves that align the tip to the optical focal point as represented in Figure 47. This fit is off-axis, allowing precise alignment of each sleeve at the time of fabrication.
- the composite plastic/glass sample containers provide a convenient, inexpensive sample holder is provided.
- Glass capillary tubes having 0.8 mm ID, 1.0 mm OD, which are sealed on one end and flared at the other end (for receiving a plastic sealing device shown in Figures 47A-D) can be fabricated inexpensively.
- the plastic components can also be fabricated inexpensively. It is preferred that these components are assembled and placed into 96-well racks for protection and ease of loading.
- the shape of the tip of the capillary tube is optimized for optical efficiency. Flat tips as well as tips with various outside curvatures and inside curvature are all within the present invention. With the embodiment of Figure 47 acquiring fluorescence from each sample 1-10 times/seconds, the samples need to be rotated relatively rapidly. With stepper motor positioning of 24 samples, each sample would be allotted 4.2-42 msec.
- the user interface and instrument control for the embodiment represented in Figure 47 is the same or similar to that explained in connection with the embodiment of Figure 11.
- the controller for the embodiment represented in Figure 47 provides digital I/O control of the light emitting diode, the direction of the stepper motor, the heater, and the chamber fan. An efficient user interface is provided.
- Figure 48 illustrates useful temperature vs. time segments for fluorescence hybridization monitoring.
- Product melting curves are obtained during a slow temperature increase to denaturation. By quickly lowering the temperature after denaturation to a constant temperature, product, probe, or primer annealing can optionally be followed. Probe melting curves are obtained by slowly heating through temperatures around the probe T m .
- the embodiment represented in Figure 47 provides all analysis during temperature cycling with immediate real time display.
- the embodiment represented in Figure 47 is particularly adapted for 3-color analysis by adding another dichroic and photodiode/filter assembly to the collection optics (see Figure 31). Moreover, it is within the scope of the present invention to allow simultaneous separation of wavelengths onto a linear photodiode array for multicolor acquisition.
- the collection optics represented in Figure 47 will be replaced with a prism or diffraction grating, a lens, and a photodiode array or CCD for multiple wavelength detection.
- the linear photodiode array collects 15-30 wavelength bins of 10-20 nm each between 500 and 800 nm.
- the present invention also utilizes fluorescence feedback for real time control and optimization of amplification.
- Real time fluorescence monitoring is used to control temperature cycling. With double strand-specific dyes, extension can be terminated each cycle after fluorescence stops increasing. For denaturation, the temperature needs to increase only until the product is completely melted. Finally, temperature cycling can be automatically terminated after a certain amount of product is made.
- Real time monitoring and control of annealing is also provided by the present invention.
- one of the primers is 3'-labeled with Cy5, no extension can occur. If labeled primer (1-10%) is mixed with unlabeled primer (90-99%), amplification efficiency will be slightly decreased, but annealing is observable as fluorescence energy transfer from a double strand-specific dye to Cy5. This is the "intercalater format" previously described above.
- the primer with the lowest T m (as determined by nearest neighbor thermodynamics) will be labeled with SYBR ® Green I as the double strand-specific dye. Amplification efficiency and Cy5 fluorescence during annealing are compared against the percentage of labeled primer.
- Direct monitoring with the embodiment of the present invention can be carried out directly with a Cy5-labeled primer or indirectly with equivalent complementary oligonucleotides.
- An oligonucleotide of the same length and T m as the lowest melting primer is designed with no complementarity to the amplified sequence.
- This oligonucleotide is 5'-labeled with Cy5 and its complement is 3'-labeled with fluorescein. Hybridization of this pair is followed by resonance energy transfer to Cy5.
- the fluorescein-labeled oligonucleotide (0.005 ⁇ M) and Cy5- labeled oligonucleotide (0.5 ⁇ M) anneals with pseudo first order kinetics that approximates primer annealing kinetics.
- the efficiency of annealing can be monitored and used to control annealing temperature and times.
- a control of annealing conditions by monitoring annealing efficiency is optionally included in the control device.
- Conventional PCR is performed by programming all cycling parameters before amplification. For continuous monitoring, determination of temperature cycling requirements occurs during amplification, based on continuous observation of annealing, extension, and denaturation. Using complementary oligonucleotides equivalent to the lowest melting primer, the annealing efficiency is controlled even during early cycles.
- extension and denaturation can only be monitored with dsDNA dyes during later cycles when enough product has been made. This is not usually a problem because denaturation and extension conditions are made permissive enough to amplify most products, and data from the first amplification can be used to optimize subsequent runs.
- PCR was performed in 50 mM Tris, pH 8.5 (25°C). 3 mM MgC12, 500 ⁇ g/ml bovine serum albumin, 0.5 mM of each deoxynucleoside triphosphate, 0.5 ⁇ M primers, and 0.2 U of Taq polymerase per 5 ⁇ l sample. SYBR ® Green I was also included at a 1:20,000 dilution unless otherwise specified.
- Amplification product used as templates were purified by phenol/chloroform extraction and ethanol precipitation, followed by repeated washing through a Centricon 30 microconcentrator (available from Amicon of Danvers, Massachusetts). Template concentrations were determined by absorbency at 260 nm and had A 26O /A 280 ratios greater than 1.7.
- Primers were synthesized by standard phosphoamidite chemistry (available from Pharmacia Biotech Gene Assembler Plus of Piscataway, New Jersey).
- the primers for the 180 base pair hepatitis B surface antigen gene amplification were 5'-CGTGGTGGAC TTCTCTCAAT-3' (SEQ ID NO: 1) and 5'-AGAAGATGAG GCATAGCAGC-3' (SEQ ID NO : 2) .
- the primers for the 292 base pair prostate specific antigen gene amplification were 5'- CTGTCCGTGA CGTGGATT-3' (SEQ ID NO: 7) and 5'-AAGTCCTCCG AGTATAGC-3' (SEQ ID NO: 8).
- the primers for the 536 base pair human ⁇ -globin gene amplification were RS42 and KM29.
- DNA melting curves were acquired on a microvolume fluorimeter integrated with a 24 sample thermal cycler using the embodiment of Figures 8A&B and fitted with an optics module (model no. 2210 available from Idaho Technology of Idaho Falls, Idaho) for acquisition of fluorescence from SYBR ® Green I.
- PCR reagents (5 ⁇ l volume) were pipetted into the open plastic reservoir of composite glass/plastic reaction tubes, centrifuged at low speed to place the sample at the tip of the glass capillary, and sealed inside with a plastic plug. PCR was performed in one of the embodiments previously described. Fluorescence data for melting curves was acquired by integrating the signal over 0.25 - 2.0 seconds during a linear temperature transition to 95°C at 0.1 - 10.0°C/second. The data was continuously displayed using the control devices discussed earlier.
- the present invention's approach to product purity determination was used to improve quantitative PCR based on once-per-cycle monitoring of fluorescence of dsDNA specific dyes. Fluorescence was acquired once each cycle after polymerase extension of the product for a series of reactions varying in initial template concentration (see Figure 57). The log-linear increase above background fluorescence begins at a cycle number dependent on initial template concentration. The plots of the five reactions ranging from 10 6 to 10 2 copies per reaction were separated by about four cycles. The reaction with an average 10 2 copies per reaction showed a decrease in reaction efficiency, and the reactions with initial copy number below 100 gave fluorescence profiles that were less useful.
- the ratio of intended product to total product ranged from 0.28 for 10 5 copies to 0.0002 for zero initial template copies.
- Each data point of Figure 57 was multiplied by the appropriate ratio to give the corrected plot ( Figure 59). This procedure extends the effective dynamic range of quantitation to between 10 and 1 initial template copies.
- PCR product detection and analysis would occur simultaneously with temperature cycling during amplification. If a fundamental property of DNA such as product size, sequence, or melting profile could specifically identify the product during PCR, no further analysis would be required.
- Sequence-specific detection during amplification can be obtained with fluorescent probes.
- a single probe can be labeled with two fluorescence resonance energy transfer (FRET) dyes.
- FRET fluorescence resonance energy transfer
- Hydrolysis of the probe by polymerase exonuclease activity releases the donor dye from quenching. As the amplification proceeds, the fluorescence from the donor dye increases cumulatively.
- FRET dyes can be placed on 2 single-labeled probes which hybridize adjacently. Both hydrolysis and hybridization techniques allow simultaneous amplification and sequence-specific product detection. However, unique probes are required for each target. Probe synthesis and purification are not trivial, particularly for dual-labeled probes.
- Helix/coil stability can also be used to specifically identify PCR products. For example, single-strand conformation polymorphism, denaturing gradient gel electrophoresis, and temperature gradient gel electrophoresis, all separate products based on the stability of different conformations. Hybridization stability can be monitored in real time with FRET. Monitoring of melting curves has also been used as an additional discriminating dimension in sequencing by hybridization techniques.
- Ethidium homodimer and ethidium bromide is used to monitor DNA denaturation.
- PCR is compatible with many dsDNA specific dyes, including ethidium bromide and SYBR ® Green I. These dyes are readily available and inexpensive; probe synthesis is not required. If ethidium bromide is included in PCR, an increase in fluorescence from samples in glass capillary sample tubes occurs. It is within the scope of the present invention to monitor PCR reactions as they occurred with ultraviolet illumination and a CCD camera. As product identity is established, monitoring with these generic dyes would eliminate the need for a separate analysis step after amplification. Absolute sequence specificity is seldom needed, but product differentiation is usually required.
- PCR products can be differentiated during amplification by analysis of melting curves whose shape is a function of GC content, length, and sequence.
- the temperature at which PCR products melt varies over a large range.
- T m melting temperature
- the effect of GC content on the melting temperature (T m ) of DNA predicts that a 0% GC duplex would melt 41°C lower than a 100% GC duplex.
- T m melting temperature
- primer dimers usually melt at a lower temperature than desired PCR products. Heterogeneous products melt over a wider range than pure PCR products. Long PCR products may have internal melting domains that could be used as a fingerprint for identification, although smaller PCR products, including those tested here (see Figure 53), melt in one major transition.
- melting curve analysis can distinguish products of the same length but different GC/AT ratio.
- two products with the same length and GC content, but differing in their GC distribution would have very different melting curves. Small sequence differences may even be observable for example, in the amplification of heterozygous DNA where heteroduplexes are formed. Single base differences in heterozygous DNA result in temperature shifts of 1-5°C for heteroduplexes compared to the fully complementary DNA.
- PCR products separated by less than 2°C can be distinguished within mixtures using the present invention (see Figure 56). Furthermore, these melting curves can be resolved into product peaks for estimates of the relative amount of different products present (see Figure 61).
- the ability to determine the relative amounts of different PCR products is very useful. For example, knowledge of the relative amount of intended product compared to total dsDNA can correct for nonspecific amplification when reactions are monitored by dsDNA dyes. Using ethidium bromide or SYBR ® Green I, quantitation over 6-8 orders of magnitude of initial template concentration is possible. However, sensitivity is limited by nonspecific amplification at low initial template copy number (see Figure 57).
- Melting curve analysis can be used to extend the dynamic range of quantification to lower initial copy number. More importantly, melting peak analysis provides a greater level of certainty that the fluorescence derives from the intended product rather than nonspecific amplification. The usefulness of fluorescence monitoring in PCR is limited if gel electrophoresis is required to check the identity of the product. Melting peak analysis allows product identification during PCR without subsequent electrophoresis.
- the ability to resolve the relative amounts of 2 PCR products should is also useful in competitive quantitative PCR.
- Competitive templates with the same primers are designed in accordance with the present invention with a melting temperature 2 - 3°C away from the natural amplicon by changing the GC/AT ratio or the length of the product.
- Known amounts of competitor would be added to unknown amounts of natural template, the templates amplified, melting curves acquired, and product peaks resolved. Assuming that the products amplify with the same efficiency, the ratio between products is the ratio between the initial templates.
- Melting curve analysis has several limitations. The absolute position and width of melting curves are affected by temperature transition rates (see Figure 52B) and dye concentration (Figure 52A). The addition of intercalaters like ethidium bromide increases the melting temperature and broadens the melting transition. Although melting curves are often obtained at rates of about 0.5°C/minute to ensure equilibrium, rates of 12°C/minute (0.2°C/second) can be used to differentiate products differing by 2°C or less in melting temperature (see Figure 53). Finer resolution is possible with slower transition rates and/or greater sample temperature homogeneity.
- the melting peak analysis of the present invention offers a product differentiation method fully integrated with PCR. Similar to sizing by gel electrophoresis, melting peak analysis measures a fundamental characteristic of DNA and can be used to identify amplified products. The combination of fluorescence monitoring of PCR with melting curve analysis provides a promising approach for simultaneous amplification, detection, and differentiation of PCR products.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Clinical Laboratory Science (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Optical Measuring Cells (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Control Of Temperature (AREA)
- Selective Calling Equipment (AREA)
- Microscoopes, Condenser (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU31547/97A AU727296B2 (en) | 1996-06-04 | 1997-06-04 | System and methods for monitoring for DNA amplification by fluorescence |
EP97926890A EP0912760B1 (en) | 1996-06-04 | 1997-06-04 | System and methods for monitoring for dna amplification by fluorescence |
CA2256612A CA2256612C (en) | 1996-06-04 | 1997-06-04 | System and methods for monitoring for dna amplification by fluorescence |
JP50080798A JP4278712B2 (en) | 1996-06-04 | 1997-06-04 | System and method for fluorescence monitoring of DNA amplification |
DE69734587T DE69734587T2 (en) | 1996-06-04 | 1997-06-04 | DEVICE AND METHOD FOR FLUORESCENCE MEASUREMENT OF DNA AMPLIFICATION |
NZ333135A NZ333135A (en) | 1996-06-04 | 1997-06-04 | Systems and methods for monitoring for DNA amplification by fluorescence using acceptor fluorophore labeled nucleic acid probe and a donor fluorophore labeled nucleic acid probe which hybridise to adjacent regions of a target sequence |
AT97926890T ATE309388T1 (en) | 1996-06-04 | 1997-06-04 | DEVICE AND METHOD FOR FLUORESCENCE MEASUREMENT OF DNA AMPLIFICATION |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65899396A | 1996-06-04 | 1996-06-04 | |
US08/658,993 | 1996-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997046707A2 true WO1997046707A2 (en) | 1997-12-11 |
WO1997046707A3 WO1997046707A3 (en) | 1998-10-08 |
Family
ID=24643601
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/009856 WO1997046712A2 (en) | 1996-06-04 | 1997-06-04 | System and method for carrying out and monitoring biological processes |
PCT/US1997/009620 WO1997046707A2 (en) | 1996-06-04 | 1997-06-04 | System and method for monitoring for dna amplification by fluorescence |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/009856 WO1997046712A2 (en) | 1996-06-04 | 1997-06-04 | System and method for carrying out and monitoring biological processes |
Country Status (11)
Country | Link |
---|---|
EP (7) | EP1442794B1 (en) |
JP (2) | JP4281877B2 (en) |
AT (5) | ATE309388T1 (en) |
AU (2) | AU727296B2 (en) |
CA (2) | CA2256773C (en) |
DE (5) | DE69738605T2 (en) |
DK (1) | DK2298931T3 (en) |
ES (6) | ES2304573T3 (en) |
NZ (2) | NZ333135A (en) |
PT (1) | PT2298931E (en) |
WO (2) | WO1997046712A2 (en) |
Cited By (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999047702A2 (en) * | 1998-03-18 | 1999-09-23 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Method and device for identifying a tag |
WO1999060381A1 (en) * | 1998-05-16 | 1999-11-25 | The Perkin-Elmer Corporation | Instrument for monitoring polymerase chain reaction of dna |
DE19850593A1 (en) * | 1998-11-03 | 2000-05-04 | Biochip Technologies Gmbh | DNA hybridization assay comprises detecting fluorescent resonance energy transfer between fluorochromes on different DNA strands |
US6140054A (en) * | 1998-09-30 | 2000-10-31 | University Of Utah Research Foundation | Multiplex genotyping using fluorescent hybridization probes |
WO2001013096A1 (en) * | 1999-08-13 | 2001-02-22 | Zeptosens Ag | Device and method for determining multiple analytes |
WO2001023607A2 (en) * | 1999-09-28 | 2001-04-05 | Cytonet Gmbh & Co. Kg | Multiplex pcr for detecting ehec infections |
US6303305B1 (en) | 1999-03-30 | 2001-10-16 | Roche Diagnostics, Gmbh | Method for quantification of an analyte |
WO2001084463A2 (en) * | 2000-05-01 | 2001-11-08 | Cepheid | Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction |
US6387621B1 (en) | 1999-04-27 | 2002-05-14 | University Of Utah Research Foundation | Automated analysis of real-time nucleic acid amplification |
WO2002000347A3 (en) * | 2000-06-28 | 2002-10-10 | 3M Innovative Properties Co | Sample processing devices, systems and methods |
WO2003009100A2 (en) | 2001-07-16 | 2003-01-30 | Cepheid | Methods, apparatuses, and computer programs for verifying the integrity of a probe |
US6593093B1 (en) | 2002-02-20 | 2003-07-15 | Mayo Foundation For Medical Education And Research | Detection of group a Streptococcus |
EP1384789A1 (en) * | 2002-07-23 | 2004-01-28 | Roche Diagnostics GmbH | Fluorescent hybridization probes with reduced background |
US6691041B2 (en) | 2000-03-31 | 2004-02-10 | Roche Molecular Systems, Inc. | Method for the efficiency-corrected real-time quantification of nucleic acids |
US6730501B2 (en) | 2002-02-12 | 2004-05-04 | University Of Utah Research Foundation | Multi-test analysis of real-time nucleic acid amplification |
US6734401B2 (en) | 2000-06-28 | 2004-05-11 | 3M Innovative Properties Company | Enhanced sample processing devices, systems and methods |
WO2004053155A1 (en) | 2002-12-06 | 2004-06-24 | Roche Diagniostics Gmbh | Multiplex assay detection of pathogenic organisms |
GB2399776A (en) * | 2003-03-24 | 2004-09-29 | Pa Knowledge Ltd | Cyclical heating and cooling device and associated methods |
WO2004087950A2 (en) | 2003-04-04 | 2004-10-14 | Roche Diagnostics Gmbh | Improved system for multi color real time pcr |
US6818437B1 (en) | 1998-05-16 | 2004-11-16 | Applera Corporation | Instrument for monitoring polymerase chain reaction of DNA |
US6830888B2 (en) | 2001-05-07 | 2004-12-14 | Mayo Foundation For Medical Education And Research | Detection of Legionella |
US6849407B2 (en) | 2000-08-31 | 2005-02-01 | Mayo Foundation For Medical Education And Research | Detection of varicella-zoster virus |
EP1513949A1 (en) * | 2002-05-30 | 2005-03-16 | Corbett Life Science Pty Ltd | Improved dna amplification apparatus and method |
US6875850B2 (en) | 2000-09-08 | 2005-04-05 | Roche Diagnostics Operations, Inc. | Reagent for labelling nucleic acids |
EP1564300A1 (en) * | 2002-11-13 | 2005-08-17 | Hitachi High-Technologies Corporation | Hethod of amplifying nucleic acid and apparatus therefor |
US6958210B2 (en) | 2001-01-31 | 2005-10-25 | Mayo Foundation For Medical Education And Research | Detection of herpes simplex virus |
US6965105B2 (en) | 2000-07-14 | 2005-11-15 | Applera Corporation | Scanning system and method for scanning a plurality of samples |
EP1627921A1 (en) * | 2004-08-18 | 2006-02-22 | Roche Diagnostics GmbH | Method for detecting nucleic acid amplification in real-time comprising positioning a reaction vial relative to a detection unit |
GB2418018A (en) * | 2004-09-01 | 2006-03-15 | Perkinelmer Singapore Pte Ltd | A method of analysing a sample of biological material that includes modifying fluorescent labels in the sample or the environmental conditions of the sample |
EP1634965A1 (en) | 2004-09-09 | 2006-03-15 | Roche Diagnostics GmbH | Real time PCR with the addition of pyrophosphatase |
US7074599B2 (en) | 2002-09-27 | 2006-07-11 | Mayo Foundation For Medical Education And Research | Detection of mecA-containing Staphylococcus spp. |
US7074598B2 (en) | 2002-09-25 | 2006-07-11 | Mayo Foundation For Medical Education And Research | Detection of vancomycin-resistant enterococcus spp. |
EP1701275A2 (en) | 2005-03-11 | 2006-09-13 | Roche Diagnostics GmbH | PCR elbow determination by rotational transform |
EP1700922A2 (en) | 2005-03-10 | 2006-09-13 | Roche Diagnostics GmbH | Nitroindole derivatives and labeled oligonucleotide probes containing them |
US7125691B2 (en) * | 2000-03-31 | 2006-10-24 | Roche Molecular Systems, Inc. | Method for determining the efficiency of nucleic acid amplifications |
EP1762618A1 (en) | 2005-09-07 | 2007-03-14 | Roche Diagnostics GmbH | Method for the preparation of nucleic acids from whole blood and its application in the diagnosis of TSE using real-time PCR |
EP1801114A1 (en) | 2005-11-23 | 2007-06-27 | Roche Diagnostics GmbH | Polynucleotides with a phosphate mimetic |
WO2007102892A3 (en) * | 2005-11-09 | 2007-12-27 | Applera Corp | Device for monitoring polymerase chain reactions |
US7369227B2 (en) | 2005-01-18 | 2008-05-06 | Roche Diagnostics Operations, Inc. | Imaging fluorescence signals using telecentricity |
US7387891B2 (en) | 1999-05-17 | 2008-06-17 | Applera Corporation | Optical instrument including excitation source |
US7410793B2 (en) | 1999-05-17 | 2008-08-12 | Applera Corporation | Optical instrument including excitation source |
US7423750B2 (en) | 2001-11-29 | 2008-09-09 | Applera Corporation | Configurations, systems, and methods for optical scanning with at least one first relative angular motion and at least one second angular motion or at least one linear motion |
EP1978109A1 (en) | 2007-04-05 | 2008-10-08 | Roche Diagnostics GmbH | Rapid one-step RT-PCR |
US7476502B2 (en) | 2004-04-12 | 2009-01-13 | Willey James C | Methods and compositions for assaying analytes |
US7498164B2 (en) | 1998-05-16 | 2009-03-03 | Applied Biosystems, Llc | Instrument for monitoring nucleic acid sequence amplification reaction |
DE102007041864A1 (en) | 2007-09-04 | 2009-03-05 | Sirs-Lab Gmbh | Method for the detection of bacteria and fungi |
US7541448B2 (en) | 2003-12-02 | 2009-06-02 | Roche Diagnostis Operations, Inc. | Oligonucleotides containing molecular rods |
EP2103693A1 (en) | 2008-03-19 | 2009-09-23 | Roche Diagnostics GmbH | Nucleic acid amplification in the presence of modified randomers |
EP2107470A2 (en) | 2007-09-25 | 2009-10-07 | Roche Diagnostics GmbH | PCR elbow determination using quadratic test for curvature analysis of a double sigmoid |
US7615352B2 (en) | 2002-09-26 | 2009-11-10 | Mayo Foundation For Medical Education And Research | Detection of Epstein-Barr virus |
EP2130929A1 (en) | 2008-06-06 | 2009-12-09 | F. Hoffmann-Roche AG | Internally controlled multiplex detection and quantification of microbial nucleic acids |
US7635588B2 (en) | 2001-11-29 | 2009-12-22 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
EP2148187A1 (en) | 2008-07-25 | 2010-01-27 | Roche Diagnostics GmbH | Stimulation and optical display system for fluorescence detection |
US7668663B2 (en) | 2005-12-20 | 2010-02-23 | Roche Molecular Systems, Inc. | Levenberg-Marquardt outlier spike removal method |
US7680868B2 (en) | 2005-12-20 | 2010-03-16 | Roche Molecular Systems, Inc. | PCR elbow determination by use of a double sigmoid function curve fit with the Levenburg-Marquardt algorithm and normalization |
EP2163999A2 (en) | 2008-09-12 | 2010-03-17 | Roche Diagnostics GmbH | Real-time PCR elbow calling by equation-less algorithm |
EP2163556A1 (en) | 2008-09-09 | 2010-03-17 | Roche Diagnostics GmbH | Polyanion for improved nucleic acid amplification |
US7687260B2 (en) | 2005-01-18 | 2010-03-30 | Roche Diagnostics Operations, Inc. | Imaging fluorescence signals using telecentric optics |
EP2182357A1 (en) | 2008-10-17 | 2010-05-05 | Roche Diagnostics GmbH | Cell monitoring and molecular analysis |
US7718361B2 (en) | 2002-12-06 | 2010-05-18 | Roche Molecular Systems, Inc. | Quantitative test for bacterial pathogens |
EP2202302A1 (en) | 2008-12-19 | 2010-06-30 | Roche Diagnostics GmbH | Dry composition of reaction compounds with stabilized polymerase |
US7749736B2 (en) | 2003-05-08 | 2010-07-06 | Bio-Rad Labortories | Systems and methods for fluorescence detection with a movable detection module |
US7754474B2 (en) | 2005-07-05 | 2010-07-13 | 3M Innovative Properties Company | Sample processing device compression systems and methods |
US7759469B2 (en) | 2005-03-10 | 2010-07-20 | Roche Diagnostics Operations, Inc. | Labeling reagent |
US7763210B2 (en) | 2005-07-05 | 2010-07-27 | 3M Innovative Properties Company | Compliant microfluidic sample processing disks |
US7767937B2 (en) | 2005-07-05 | 2010-08-03 | 3M Innovative Properties Company | Modular sample processing kits and modules |
US7781165B2 (en) | 2005-10-19 | 2010-08-24 | Roche Diagnostics Operations, Inc. | Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification |
US7785776B2 (en) | 2002-05-13 | 2010-08-31 | Idaho Technology, Inc. | Genotyping by amplicon melting curve analysis |
US7794659B2 (en) | 2005-03-10 | 2010-09-14 | Gen-Probe Incorporated | Signal measuring system having a movable signal measuring device |
US7844403B2 (en) | 2005-12-20 | 2010-11-30 | Roche Molecular Systems, Inc. | Temperature step correction with double sigmoid Levenberg-Marquardt and robust linear regression |
WO2010146339A1 (en) | 2009-06-15 | 2010-12-23 | Bg Research Ltd | Nucleic acid detection |
WO2011023373A2 (en) | 2009-08-26 | 2011-03-03 | Roche Diagnostics Gmbh | Determination of elbow values for pcr for parabolic shaped curves |
US7920971B2 (en) | 2003-09-25 | 2011-04-05 | Roche Molecular Systems, Inc. | Quantification schemes for quantifying nucleic acids |
US7939018B2 (en) | 2000-06-28 | 2011-05-10 | 3M Innovative Properties Company | Multi-format sample processing devices and systems |
US7981606B2 (en) | 2005-12-21 | 2011-07-19 | Roche Molecular Systems, Inc. | Control for nucleic acid testing |
US7991562B2 (en) | 2005-12-20 | 2011-08-02 | Roche Molecular Systems, Inc. | PCR elbow determination using curvature analysis of a double sigmoid |
US7991558B2 (en) | 2005-09-29 | 2011-08-02 | Roche Molecular Systems, Inc. | Systems and methods for determining real-time PCR cycle thresholds using cluster analysis |
US7991561B2 (en) | 2005-09-29 | 2011-08-02 | Roche Molecular Systems, Inc. | Ct determination by cluster analysis with variable cluster endpoint |
US8003051B2 (en) | 2001-12-28 | 2011-08-23 | 3M Innovative Properties Company | Thermal structure for sample processing systems |
US8026058B2 (en) | 2006-02-27 | 2011-09-27 | Roche Diagnostics Operations, Inc. | PCR hot start by magnesium sequestration |
EP2374874A2 (en) | 2010-04-12 | 2011-10-12 | Roche Diagnostics GmbH | Detergent free polymerases |
US8097412B2 (en) | 2008-07-12 | 2012-01-17 | Biodiagnostics, Inc. | DNA-based test for detection of annual and intermediate ryegrass |
US8101362B2 (en) | 2008-02-08 | 2012-01-24 | Mayo Foundation For Medical Education And Research | Detection of Clostridium difficile |
WO2012013733A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Generic sample preparation |
WO2012013732A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Generic pcr |
WO2012013731A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Qualitative and quantitative detection of microbial nucleic acids |
WO2012013734A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Control nucleic acids for multiple parameters |
US8119345B2 (en) | 2007-02-06 | 2012-02-21 | Biomerieux S.A. | Method for discriminating single nucleotide polymorphisms |
US8119352B2 (en) | 2006-06-20 | 2012-02-21 | Cepheld | Multi-stage amplification reactions by control of sequence replication times |
WO2012045670A1 (en) | 2010-10-04 | 2012-04-12 | Roche Diagnostics Gmbh | Method for cell lysis in a pcr reaction buffer |
WO2012045668A1 (en) | 2010-10-04 | 2012-04-12 | Roche Diagnostics Gmbh | Method for cell lysis in a rt-pcr reaction buffer |
WO2012045669A1 (en) | 2010-10-04 | 2012-04-12 | Roche Diagnostics Gmbh | Method for cell lysis and pcr within the same reaction vessel |
EP2465947A1 (en) | 2010-12-17 | 2012-06-20 | F. Hoffmann-La Roche AG | Generic matrix for control nucleic acids |
US8293473B2 (en) | 2006-04-04 | 2012-10-23 | Labonnet Ltd. | Assessment of reaction kinetics compatibility between polymerase chain reactions |
US8304192B2 (en) | 2004-03-05 | 2012-11-06 | University Of Toledo | Methods and compositions for assessing nucleic acids and alleles |
US8313931B2 (en) | 2007-09-28 | 2012-11-20 | 3M Innovative Properties Company | Dual oligonucleotide method of nucleic acid detection |
WO2012159768A1 (en) | 2011-05-26 | 2012-11-29 | Roche Diagnostics Gmbh | Compositions and methods for detection of staphylococcus aureus |
US20120301875A1 (en) * | 2002-10-23 | 2012-11-29 | Wittwer Carl T | Amplicon melting analysis with saturation dyes |
US8346485B2 (en) | 2008-11-25 | 2013-01-01 | Quest Diagnostics Investments Incorporated | Methods and apparatuses for estimating initial target nucleic acid concentration in a sample by modeling background signal and cycle-dependent amplification efficiency of a polymerase chain reaction |
US8357490B2 (en) | 2008-01-23 | 2013-01-22 | Roche Diagnostics Operations, Inc. | Integrated instrument performing synthesis and amplification, and a system and method thereof |
US8386184B2 (en) | 2007-08-28 | 2013-02-26 | Becton, Dickinson And Company | Systems and methods for determining an amount of starting reagent using the polymerase chain reaction |
US8463526B2 (en) | 2007-12-28 | 2013-06-11 | Robert Bosch Gmbh | Method for detecting a periodically pulsing operating parameter |
US8535888B2 (en) | 2006-12-29 | 2013-09-17 | Mayo Foundation For Medical Education And Research | Compositions and methods for detecting methicillin-resistant S. aureus |
WO2013139860A1 (en) | 2012-03-21 | 2013-09-26 | Roche Diagnostics Gmbh | Methods for assessing rna quality |
US8546110B2 (en) | 1998-05-01 | 2013-10-01 | Gen-Probe Incorporated | Method for detecting the presence of a nucleic acid in a sample |
EP2674502A1 (en) | 2009-04-20 | 2013-12-18 | Longhorn Vaccines & Diagnostics, LLC | Biological specimen collection/transport compositions and methods |
US8623602B2 (en) | 2008-08-01 | 2014-01-07 | Roche Diagnostics Operations, Inc. | Lysis and reverse transcription for MRNA quantification |
WO2014027066A1 (en) | 2012-08-17 | 2014-02-20 | Roche Diagnostics Gmbh | Compositions and methods for detection of herpes simplex virus 1 and 2 |
US8718948B2 (en) | 2011-02-24 | 2014-05-06 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
EP2348320A3 (en) * | 2005-03-10 | 2014-06-25 | Gen-Probe Incorporated | Systems and methods for detecting multiple optical signals |
US8809040B2 (en) | 2002-05-17 | 2014-08-19 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
US8840848B2 (en) | 2010-07-23 | 2014-09-23 | Beckman Coulter, Inc. | System and method including analytical units |
US8900854B2 (en) | 2009-03-31 | 2014-12-02 | Kanagawa Academy Of Science And Technology | Liquid reflux high-speed gene amplification device |
US8973736B2 (en) | 2011-11-07 | 2015-03-10 | Beckman Coulter, Inc. | Magnetic damping for specimen transport system |
WO2015067790A1 (en) | 2013-11-11 | 2015-05-14 | Roche Diagnostics Gmbh | Detecting single nucleotide polymorphism using overlapped primer and melting probe |
US9046507B2 (en) | 2010-07-29 | 2015-06-02 | Gen-Probe Incorporated | Method, system and apparatus for incorporating capacitive proximity sensing in an automated fluid transfer procedure |
US9067205B2 (en) | 2011-05-18 | 2015-06-30 | 3M Innovative Properties Company | Systems and methods for valving on a sample processing device |
US9080204B2 (en) | 2006-09-12 | 2015-07-14 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for rapid, real-time detection of influenza a virus (H1N1) Swine 2009 |
US9290663B2 (en) | 2002-10-23 | 2016-03-22 | University Of Utah Research Foundation | Amplicon melting analysis with saturation dyes |
WO2016079078A1 (en) | 2014-11-19 | 2016-05-26 | Roche Diagnostics Gmbh | Photoblocked probes and methods for sequential detection of nucleic acids |
WO2016087438A1 (en) | 2014-12-02 | 2016-06-09 | Roche Diagnostics Gmbh | Compositions and methods for detecting mecc containing methicillin-resistant staphylococcus aureus |
US9388455B2 (en) | 2003-12-03 | 2016-07-12 | Abbott Molecular Inc. | Double stranded linear nucleic acid probe |
US9446418B2 (en) | 2011-11-07 | 2016-09-20 | Beckman Coulter, Inc. | Robotic arm |
US9482684B2 (en) | 2011-11-07 | 2016-11-01 | Beckman Coulter, Inc. | Centrifuge system and workflow |
US9506943B2 (en) | 2011-11-07 | 2016-11-29 | Beckman Coulter, Inc. | Aliquotter system and workflow |
WO2017059132A1 (en) | 2015-09-29 | 2017-04-06 | The General Hospital Corporation | Methods of treating and diagnosing disease using biomarkers for bcg therapy |
US9657347B2 (en) | 2004-04-20 | 2017-05-23 | University of Utah Research Foundation and BioFire Defense, LLC | Nucleic acid melting analysis with saturation dyes |
US9725762B2 (en) | 2011-05-18 | 2017-08-08 | Diasorin S.P.A. | Systems and methods for detecting the presence of a selected volume of material in a sample processing device |
WO2017153566A1 (en) | 2016-03-11 | 2017-09-14 | Roche Diagnostics Gmbh | Compositions and methods for detection of zika virus |
WO2017201315A1 (en) | 2016-05-18 | 2017-11-23 | Roche Sequencing Solutions, Inc. | Quantitative real time pcr amplification using an electrowetting-based device |
WO2017202895A1 (en) | 2016-05-27 | 2017-11-30 | Roche Diagnostics Gmbh | Compositions and methods for detection of mycoplasma genitalium |
WO2017202894A1 (en) | 2016-05-27 | 2017-11-30 | Roche Diagnostics Gmbh | Compositions and methods for detection of trichomonas vaginalis |
WO2017216204A1 (en) | 2016-06-14 | 2017-12-21 | Roche Diagnostics Gmbh | Internal control probes for improving pcr assay performance |
WO2018023094A1 (en) | 2016-07-29 | 2018-02-01 | Juno Therapeutics, Inc. | Methods for assessing the presence or absence of replication competent virus |
WO2018024562A1 (en) | 2016-08-02 | 2018-02-08 | Roche Diagnostics Gmbh | Helper oligonucleotide for improving efficiency of amplification and detection/quantitation of nucleic acids |
US9910054B2 (en) | 2011-11-07 | 2018-03-06 | Beckman Coulter, Inc. | System and method for processing samples |
WO2018086845A1 (en) | 2016-11-09 | 2018-05-17 | Roche Diagnostics Gmbh | Compositions and methods for detection of bk virus |
WO2018115411A1 (en) | 2016-12-22 | 2018-06-28 | Roche Diagnostics Gmbh | Cobra probes to detect a marker for epidemic ribotypes of clostridium difficile |
WO2018122157A1 (en) | 2016-12-28 | 2018-07-05 | Roche Diagnostics Gmbh | Reversibly protected nucleotide reagents with high thermal stability |
US10048284B2 (en) | 2011-11-07 | 2018-08-14 | Beckman Coulter, Inc. | Sample container cap with centrifugation status indicator device |
WO2018229173A1 (en) | 2017-06-14 | 2018-12-20 | Roche Diagnostics Gmbh | Compositions and methods for improving the thermal stability of nucleic acid amplification reagents |
US10176293B2 (en) | 2012-10-02 | 2019-01-08 | Roche Molecular Systems, Inc. | Universal method to determine real-time PCR cycle threshold values |
WO2019016253A1 (en) | 2017-07-18 | 2019-01-24 | Roche Diagnostics Gmbh | Compositions and methods for detection of babesia |
WO2019063661A1 (en) | 2017-09-29 | 2019-04-04 | Roche Diagnostics Gmbh | Compositions and methods for detection of trichomonas vaginalis |
WO2019102034A1 (en) | 2017-11-27 | 2019-05-31 | Roche Diagnostics Gmbh | Photocleavable nucleotide reagents with high stability |
WO2019152747A1 (en) | 2018-01-31 | 2019-08-08 | Juno Therapeutics, Inc. | Methods and reagents for assessing the presence or absence of replication competent virus |
WO2019180112A1 (en) | 2018-03-21 | 2019-09-26 | F. Hoffmann-La Roche Ag | Modified nucleoside phosphates with high thermal stability |
WO2019229128A1 (en) | 2018-05-31 | 2019-12-05 | F. Hoffmann-La Roche Ag | Reagents and methods for post-synthetic modification of nucleic acids |
WO2020114998A1 (en) | 2018-12-03 | 2020-06-11 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of candida auris |
WO2020221915A1 (en) | 2019-05-02 | 2020-11-05 | F. Hoffmann-La Roche Ag | UTILIZATION OF dITP FOR PREFERENTIAL/SELECTIVE AMPLIFICATION OF RNA VERSUS DNA TARGETS BASED ON STRAND-SEPARATION TEMPERATURE |
WO2020225231A1 (en) | 2019-05-07 | 2020-11-12 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of neisseria gonorroheae |
WO2021013972A1 (en) | 2019-07-25 | 2021-01-28 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of epstein barr virus (ebv) |
WO2021037399A1 (en) | 2019-08-27 | 2021-03-04 | F. Hoffmann-La Roche Ag | Compositions and methods for amplification and detection of hepatitis b virus rna, including hbv rna transcribed from cccdna |
WO2021099499A1 (en) | 2019-11-20 | 2021-05-27 | F. Hoffmann-La Roche Ag | Compositions and methods for rapid idenfication and phenotypic antimicrobial susceptibility testing of bacteria and fungi |
WO2021116037A1 (en) | 2019-12-09 | 2021-06-17 | F. Hoffmann-La Roche Ag | Dicationic fluorescent dyes |
US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
WO2021130199A2 (en) | 2019-12-27 | 2021-07-01 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting methicillin-resistant staphylococcus aureus |
WO2021180631A1 (en) | 2020-03-09 | 2021-09-16 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b |
US11338296B2 (en) | 2018-07-26 | 2022-05-24 | Lex diagnostics Ltd. | Variable temperature reactor, heater and control circuit for the same |
WO2022117784A1 (en) | 2020-12-04 | 2022-06-09 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of malaria |
WO2022124418A1 (en) | 2020-12-11 | 2022-06-16 | 東洋紡株式会社 | Antibody capable of binding specifically to 5'→3' exonuclease active domain of dna polymerase |
WO2022144351A2 (en) | 2020-12-30 | 2022-07-07 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of bacteria and fungi associated with bacterial and candida vaginosis |
WO2022167570A1 (en) | 2021-02-05 | 2022-08-11 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of human parainfluenza viruses 1-4 (hpiv 1-4) |
WO2022194756A2 (en) | 2021-03-15 | 2022-09-22 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2) variants having spike protein mutations |
WO2022233930A1 (en) | 2021-05-06 | 2022-11-10 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting hepatitis delta virus by a dual-target assay |
WO2023079032A1 (en) | 2021-11-05 | 2023-05-11 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of malaria |
WO2023089186A1 (en) | 2021-11-22 | 2023-05-25 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting vana and/or vanb genes associated with multidrug resistance |
WO2023102459A1 (en) | 2021-12-03 | 2023-06-08 | Medicinal Genomics Corporation | Psilocybe assay |
WO2024003260A1 (en) | 2022-06-30 | 2024-01-04 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting lymphogranuloma venereum (lgv) serovars of chlamydia trachomatis |
WO2024042042A1 (en) | 2022-08-24 | 2024-02-29 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting monkeypox virus |
WO2024059493A1 (en) | 2022-09-13 | 2024-03-21 | Medicinal Genomics Corporation | Psilocybe assay |
WO2024141442A1 (en) | 2022-12-25 | 2024-07-04 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting carbapenem resistant acinetobacter calcoaceticus-baumannii (crab) |
WO2024175749A1 (en) | 2023-02-25 | 2024-08-29 | F. Hoffmann-La Roche Ag | Compositions and methods for candida species detection |
WO2024184165A1 (en) | 2023-03-03 | 2024-09-12 | F. Hoffmann-La Roche Ag | Compositions and methods for the detection of group b streptococcus ( streptococcus agalactiae) and clindamycin resistance gene determinants |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2308995T3 (en) * | 1997-02-28 | 2015-08-03 | Cepheid | Chemical reaction unit with heat exchanger and optical detector |
US20050279949A1 (en) | 1999-05-17 | 2005-12-22 | Applera Corporation | Temperature control for light-emitting diode stabilization |
EP2264439A3 (en) * | 1999-11-12 | 2011-01-19 | E.I. Du Pont De Nemours And Company | Fluorometer with low heat-generating light source |
JP2005295877A (en) * | 2004-04-09 | 2005-10-27 | Taiyo Yuden Co Ltd | Method for analyzing nucleic acid, analyzer and disk for analysis |
TWI392863B (en) | 2004-08-05 | 2013-04-11 | Universal Bio Research Co Ltd | Reaction vessel, liquid introduction device of reaction vessel, device for detecting the introduced reaction liquid, and liquid introudction device |
DE102004043909A1 (en) * | 2004-09-10 | 2006-03-30 | Kendro Laboratory Products Gmbh | Heating device for samples in the field of life science |
WO2006038643A1 (en) | 2004-10-06 | 2006-04-13 | Universal Bio Research Co., Ltd. | Reaction container and reaction controller |
US20060094028A1 (en) * | 2004-11-04 | 2006-05-04 | Welch Allyn, Inc. | Rapid diagnostic assay |
US9017964B2 (en) | 2005-08-26 | 2015-04-28 | Denator Aktiebolag | Preparing biological samples for analysis |
US20070048877A1 (en) * | 2005-08-26 | 2007-03-01 | Karl Skold | Method and device for preparing a biological sample for biological analyses |
GB0522972D0 (en) * | 2005-11-11 | 2005-12-21 | Integrated Design Ltd | Thermal cycler |
US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
WO2008102772A1 (en) * | 2007-02-22 | 2008-08-28 | Toyo Boseki Kabushiki Kaisha | Nucleic acid amplification system |
JP4458133B2 (en) * | 2007-02-27 | 2010-04-28 | ソニー株式会社 | Nucleic acid amplification equipment |
US9475051B2 (en) | 2007-02-27 | 2016-10-25 | Sony Corporation | Nucleic acid amplifier |
US8418929B2 (en) | 2007-04-06 | 2013-04-16 | Universal Bio Research Co., Ltd. | Temperature controlling apparatus and temperature controlling method |
JP5444632B2 (en) * | 2007-04-26 | 2014-03-19 | 東洋紡株式会社 | Nucleic acid amplification method and container used therefor |
WO2008146754A1 (en) | 2007-05-23 | 2008-12-04 | Trust Co., Ltd. | Container for liquid reaction mixture, reaction-promoting device using the same and method therefor |
RU2540424C2 (en) | 2007-10-02 | 2015-02-10 | Теранос, Инк. | Cartridge for automatic detection of analyte in body fluid sample and system comprising it |
JP5178149B2 (en) * | 2007-10-31 | 2013-04-10 | キヤノン株式会社 | Real-time PCR method and apparatus for target nucleic acid |
US20090203022A1 (en) * | 2008-02-07 | 2009-08-13 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Analysis |
DE102008010436A1 (en) * | 2008-02-21 | 2009-09-03 | Berthold Technologies Gmbh & Co. Kg | Apparatus and method for measuring luminescence and fluorescence of transfected cells or organ parts |
JP2009201444A (en) * | 2008-02-29 | 2009-09-10 | Hitachi High-Technologies Corp | Nucleic acid analyzer |
GB0806676D0 (en) | 2008-04-12 | 2008-05-14 | Environment Agency The | Environmental monitoring |
EP2138588A1 (en) | 2008-06-23 | 2009-12-30 | Koninklijke Philips Electronics N.V. | Melting curve measurement during amplification |
CA2638458A1 (en) | 2008-07-31 | 2010-01-31 | Spartan Bioscience Inc. | Thermal recycling by positioning relative to fixed-temperature source |
KR101423936B1 (en) * | 2009-03-11 | 2014-07-29 | (주)바이오니아 | Universal automatic apparatus for real time monitoring of products of nucleic acid amplification reaction and method thereof |
US10288632B2 (en) | 2009-09-21 | 2019-05-14 | Pocared Diagnostics Ltd. | System for conducting the identification of bacteria in biological samples |
FI20096021A0 (en) | 2009-10-06 | 2009-10-06 | Wallac Oy | Optical measuring instrument |
US8834792B2 (en) | 2009-11-13 | 2014-09-16 | 3M Innovative Properties Company | Systems for processing sample processing devices |
CN103237880B (en) | 2010-10-15 | 2016-08-03 | 环球生物研究株式会社 | Utilize nucleic acid automatic processing device and the method thereof of multi-functional dispensing unit |
US8361720B2 (en) * | 2010-11-15 | 2013-01-29 | Exact Sciences Corporation | Real time cleavage assay |
CN106323876B (en) | 2011-01-21 | 2020-02-14 | 西拉诺斯知识产权有限责任公司 | System and method for maximizing sample usage |
USD684273S1 (en) | 2011-02-22 | 2013-06-11 | Universal Bio Research Co., Ltd. | Reaction vessel for amplifying nucleic acid |
KR20140022399A (en) | 2011-05-18 | 2014-02-24 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Systems and methods for volumetric metering on a sample processing device |
US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
US9810704B2 (en) * | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
SG11201401913YA (en) | 2011-09-30 | 2014-09-26 | Life Technologies Corp | Systems and methods for biological analysis |
DE102012108158B4 (en) | 2012-09-03 | 2016-03-17 | Johann Wolfgang Goethe-Universität | Capillary cell, assembly and method for receiving, positioning and examining a microscopic sample |
EP2722399A1 (en) | 2012-10-18 | 2014-04-23 | Roche Diagniostics GmbH | Method for preventing high molecular weight products during amplification |
MX2015009264A (en) | 2013-01-18 | 2016-03-31 | Biomeme Inc | Analytic device. |
US10399057B2 (en) | 2013-02-05 | 2019-09-03 | Phc Holdings Corporation | Analysis device, genetic analysis method, analysis receptacle, and control method for fuzzy control |
AU2013202788B2 (en) | 2013-03-14 | 2015-10-01 | Gen-Probe Incorporated | Indexing signal detection module |
US10626440B2 (en) | 2013-05-21 | 2020-04-21 | Universal Bio Research Co., Ltd. | Sequencer pretreatment device and method thereof |
FR3035411A1 (en) * | 2015-04-23 | 2016-10-28 | Morpho | METHOD FOR AMPLIFYING NUCLEIC ACID FOR ANALYSIS, CORRESPONDING AMPLIFICATION MACHINE, AND CARTRIDGE FOR THE MACHINE |
CN108350407B (en) | 2015-12-11 | 2022-07-08 | 杰诺玛迪克斯公司 | Tube sealing system and method for nucleic acid amplification |
CN107964507B (en) * | 2016-10-18 | 2022-09-27 | 财团法人工业技术研究院 | Thermal convection polymerase chain reaction device and optical detection method thereof |
US20190099758A1 (en) | 2016-12-28 | 2019-04-04 | Kabushiki Kaisha Dnaform | Analysis device |
JP7293236B2 (en) | 2017-09-15 | 2023-06-19 | バイオミーム インコーポレイテッド | Method and system for automated sample processing |
JP7524061B2 (en) | 2017-12-15 | 2024-07-29 | バイオミーム インコーポレイテッド | PORTABLE DEVICE AND METHOD FOR ANALYZING A SAMPLE - Patent application |
US20200398274A1 (en) * | 2018-02-07 | 2020-12-24 | Jaydeep BHATTACHARYA | A low cost microfluidic device for dna/rna isolation, purification and amplification using chip based pcr/ rt- pcr for biosensing applications |
JPWO2020032226A1 (en) | 2018-08-10 | 2021-08-10 | 株式会社Mirai Genomics | Analysis equipment |
CA3131142A1 (en) | 2019-03-21 | 2020-09-24 | Peter EISENHOWER | Multi-function analytic devices |
CN116786186A (en) * | 2019-05-01 | 2023-09-22 | 卢米耐克斯公司 | Device for thermal cycling and sample module |
WO2022061105A1 (en) | 2020-09-18 | 2022-03-24 | Biomeme, Inc. | Portable devices and methods for analyzing samples |
JP2022099005A (en) | 2020-12-22 | 2022-07-04 | 船井電機株式会社 | Micro fluid device and nucleic acid amplification method |
WO2022195289A2 (en) | 2021-03-19 | 2022-09-22 | Bg Research Ltd | An apparatus and associated methods for thermal cycling |
CN113355230B (en) * | 2021-07-06 | 2023-11-24 | 宁波胤瑞生物医学仪器有限责任公司 | Chip locking device |
US20240351044A1 (en) * | 2021-07-08 | 2024-10-24 | Ixensor Co., Ltd. | System and method to perform quantitative polymerase chain reaction |
DE202022002981U1 (en) * | 2021-09-23 | 2024-05-08 | N6 Tec, Inc. | Sample analysis systems |
CN115555060B (en) * | 2022-09-22 | 2024-11-05 | 冰山松洋生物科技(大连)有限公司 | Environmental test box |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3219416A (en) * | 1962-10-30 | 1965-11-23 | Scientific Industries | Apparatus for the automatic chemical sequential treatment and analysis of small quantities of material |
US3556659A (en) * | 1966-02-03 | 1971-01-19 | Applied Physics Corp | Laser-excited raman spectrometer |
EP0229943A2 (en) * | 1985-12-23 | 1987-07-29 | Molecular Biosystems, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization assays |
US4826319A (en) * | 1984-09-07 | 1989-05-02 | Olympus Optical Co., Ltd. | Method and apparatus for measuring immunological reaction with the aid of fluctuation in intensity of scattered light |
EP0566751A1 (en) * | 1992-03-23 | 1993-10-27 | F. Hoffmann-La Roche Ag | DNA detection method |
WO1994027137A2 (en) * | 1993-05-18 | 1994-11-24 | University Of Utah Research Foundation | Apparatus and methods for multianalyte homogeneous fluoroimmunoassays |
WO1995013399A1 (en) * | 1993-11-12 | 1995-05-18 | The Public Health Research Institute Of The City Of New York, Inc. | Hybridization probes for nucleic acid detection, universal stems, methods and kits |
WO1995021382A2 (en) * | 1994-02-01 | 1995-08-10 | Fields Robert E | Molecular analyzer and method of use |
US5449621A (en) * | 1989-07-31 | 1995-09-12 | Biotope, Inc. | Method for measuring specific binding assays |
US5455175A (en) * | 1990-06-04 | 1995-10-03 | University Of Utah Research Foundation | Rapid thermal cycling device |
WO1995030139A1 (en) * | 1994-04-29 | 1995-11-09 | Perkin-Elmer Corporation | System for real time detection of nucleic acid amplification products |
WO1995032306A1 (en) * | 1994-05-23 | 1995-11-30 | Biotronics Corporation | Method for detecting a target nucleic acid |
WO1996000901A1 (en) * | 1994-06-29 | 1996-01-11 | The Regents Of The University Of California | Luminescent lanthanide chelates and methods of use |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3616264A (en) | 1969-06-30 | 1971-10-26 | Beckman Instruments Inc | Temperature-controlled discrete sample analyzer |
US3718133A (en) * | 1971-01-12 | 1973-02-27 | Damon Corp | Container unit for liquid samples |
CH587486A5 (en) * | 1974-11-29 | 1977-05-13 | Hoffmann La Roche | |
AU528259B2 (en) * | 1978-09-14 | 1983-04-21 | Union Carbide Corp | Method and apparatus for assaying liquid materials |
IT1101295B (en) | 1978-11-22 | 1985-09-28 | Erba Strumentazione | GAS-CHROMATOGRAPHIC CHAMBER |
US4420679A (en) | 1982-02-26 | 1983-12-13 | Delta Associates, Inc. | Gas chromatographic oven using symmetrical flow of preheated - premixed ambient air |
JPS60241884A (en) * | 1984-05-15 | 1985-11-30 | Tokyo Daigaku | Automation cycling reaction apparatus and automatic analyzer using same |
US4740472A (en) * | 1985-08-05 | 1988-04-26 | The United States Of America As Represented By The United States Department Of Energy | Method and apparatus for automated processing and aliquoting of whole blood samples for analysis in a centrifugal fast analyzer |
US5268486A (en) * | 1986-04-18 | 1993-12-07 | Carnegie-Mellon Unversity | Method for labeling and detecting materials employing arylsulfonate cyanine dyes |
US4902624A (en) * | 1987-11-23 | 1990-02-20 | Eastman Kodak Company | Temperature cycling cuvette |
US4908112A (en) * | 1988-06-16 | 1990-03-13 | E. I. Du Pont De Nemours & Co. | Silicon semiconductor wafer for analyzing micronic biological samples |
DE69012887D1 (en) * | 1989-06-20 | 1994-11-03 | Claudio Bonini | Test tubes with a lenticular outer surface, especially for automatic clinical analyzes. |
US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
WO1992020778A1 (en) * | 1991-05-24 | 1992-11-26 | Kindconi Pty Limited | Biochemical reaction control |
US5340715A (en) * | 1991-06-07 | 1994-08-23 | Ciba Corning Diagnostics Corp. | Multiple surface evanescent wave sensor with a reference |
DE4234086A1 (en) † | 1992-02-05 | 1993-08-12 | Diagen Inst Molekularbio | METHOD FOR DETERMINING NUCLEIC ACID SEQUENCES AMPLIFIED IN VITRO |
EP1130117A3 (en) * | 1992-04-06 | 2003-12-03 | Abbott Laboratories | Method and device for detection of nucleic acid using total internal reflectance |
JPH0634546A (en) * | 1992-07-17 | 1994-02-08 | Tosoh Corp | Fluorescene detector |
US5798215A (en) * | 1993-02-18 | 1998-08-25 | Biocircuits Corporation | Device for use in analyte detection assays |
AU6104994A (en) * | 1993-03-18 | 1994-10-11 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture | Apparatus for the quantitative determination of particulate analytes |
JP3598123B2 (en) * | 1993-07-15 | 2004-12-08 | 浜松ホトニクス株式会社 | Nucleic acid denaturation detector |
EP0636413B1 (en) * | 1993-07-28 | 2001-11-14 | PE Corporation (NY) | Nucleic acid amplification reaction apparatus and method |
CA2129787A1 (en) * | 1993-08-27 | 1995-02-28 | Russell G. Higuchi | Monitoring multiple amplification reactions simultaneously and analyzing same |
US5654419A (en) * | 1994-02-01 | 1997-08-05 | The Regents Of The University Of California | Fluorescent labels and their use in separations |
CA2143365A1 (en) * | 1994-03-14 | 1995-09-15 | Hugh V. Cottingham | Nucleic acid amplification method and apparatus |
EP0711840B1 (en) * | 1994-11-09 | 2002-06-19 | Hitachi, Ltd. | DNA analyzing method and device therefor |
US5800996A (en) * | 1996-05-03 | 1998-09-01 | The Perkin Elmer Corporation | Energy transfer dyes with enchanced fluorescence |
-
1997
- 1997-06-04 ES ES04022352T patent/ES2304573T3/en not_active Expired - Lifetime
- 1997-06-04 DE DE69738605T patent/DE69738605T2/en not_active Expired - Lifetime
- 1997-06-04 AT AT97926890T patent/ATE309388T1/en active
- 1997-06-04 ES ES10174616T patent/ES2434258T3/en not_active Expired - Lifetime
- 1997-06-04 AT AT06004925T patent/ATE485397T1/en not_active IP Right Cessation
- 1997-06-04 PT PT101746162T patent/PT2298931E/en unknown
- 1997-06-04 EP EP03025810A patent/EP1442794B1/en not_active Expired - Lifetime
- 1997-06-04 WO PCT/US1997/009856 patent/WO1997046712A2/en active IP Right Grant
- 1997-06-04 AT AT03025810T patent/ATE321891T1/en not_active IP Right Cessation
- 1997-06-04 JP JP50087498A patent/JP4281877B2/en not_active Expired - Lifetime
- 1997-06-04 CA CA2256773A patent/CA2256773C/en not_active Expired - Lifetime
- 1997-06-04 EP EP06004925A patent/EP1674585B1/en not_active Expired - Lifetime
- 1997-06-04 CA CA2256612A patent/CA2256612C/en not_active Expired - Lifetime
- 1997-06-04 AT AT04022352T patent/ATE390491T1/en not_active IP Right Cessation
- 1997-06-04 NZ NZ333135A patent/NZ333135A/en unknown
- 1997-06-04 DE DE69734587T patent/DE69734587T2/en not_active Expired - Lifetime
- 1997-06-04 ES ES03025810T patent/ES2260562T3/en not_active Expired - Lifetime
- 1997-06-04 AU AU31547/97A patent/AU727296B2/en not_active Expired
- 1997-06-04 AU AU33800/97A patent/AU729644B2/en not_active Expired
- 1997-06-04 EP EP97926890A patent/EP0912760B1/en not_active Expired - Lifetime
- 1997-06-04 EP EP10174616.2A patent/EP2298931B2/en not_active Expired - Lifetime
- 1997-06-04 ES ES06004925T patent/ES2354902T3/en not_active Expired - Lifetime
- 1997-06-04 DE DE69727932T patent/DE69727932T2/en not_active Expired - Lifetime
- 1997-06-04 DK DK10174616.2T patent/DK2298931T3/en active
- 1997-06-04 DE DE69740030T patent/DE69740030D1/en not_active Expired - Lifetime
- 1997-06-04 NZ NZ333137A patent/NZ333137A/en not_active IP Right Cessation
- 1997-06-04 EP EP04022352A patent/EP1493826B1/en not_active Expired - Lifetime
- 1997-06-04 ES ES97929833T patent/ES2215230T3/en not_active Expired - Lifetime
- 1997-06-04 JP JP50080798A patent/JP4278712B2/en not_active Expired - Lifetime
- 1997-06-04 WO PCT/US1997/009620 patent/WO1997046707A2/en active IP Right Grant
- 1997-06-04 DE DE69735563T patent/DE69735563T2/en not_active Expired - Lifetime
- 1997-06-04 EP EP05020549A patent/EP1704922A3/en not_active Withdrawn
- 1997-06-04 AT AT97929833T patent/ATE260988T1/en not_active IP Right Cessation
- 1997-06-04 ES ES97926890T patent/ES2253778T3/en not_active Expired - Lifetime
- 1997-06-04 EP EP97929833A patent/EP0906449B1/en not_active Expired - Lifetime
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3219416A (en) * | 1962-10-30 | 1965-11-23 | Scientific Industries | Apparatus for the automatic chemical sequential treatment and analysis of small quantities of material |
US3556659A (en) * | 1966-02-03 | 1971-01-19 | Applied Physics Corp | Laser-excited raman spectrometer |
US4826319A (en) * | 1984-09-07 | 1989-05-02 | Olympus Optical Co., Ltd. | Method and apparatus for measuring immunological reaction with the aid of fluctuation in intensity of scattered light |
EP0229943A2 (en) * | 1985-12-23 | 1987-07-29 | Molecular Biosystems, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization assays |
US5449621A (en) * | 1989-07-31 | 1995-09-12 | Biotope, Inc. | Method for measuring specific binding assays |
US5455175A (en) * | 1990-06-04 | 1995-10-03 | University Of Utah Research Foundation | Rapid thermal cycling device |
EP0566751A1 (en) * | 1992-03-23 | 1993-10-27 | F. Hoffmann-La Roche Ag | DNA detection method |
WO1994027137A2 (en) * | 1993-05-18 | 1994-11-24 | University Of Utah Research Foundation | Apparatus and methods for multianalyte homogeneous fluoroimmunoassays |
WO1995013399A1 (en) * | 1993-11-12 | 1995-05-18 | The Public Health Research Institute Of The City Of New York, Inc. | Hybridization probes for nucleic acid detection, universal stems, methods and kits |
WO1995021382A2 (en) * | 1994-02-01 | 1995-08-10 | Fields Robert E | Molecular analyzer and method of use |
WO1995030139A1 (en) * | 1994-04-29 | 1995-11-09 | Perkin-Elmer Corporation | System for real time detection of nucleic acid amplification products |
WO1995032306A1 (en) * | 1994-05-23 | 1995-11-30 | Biotronics Corporation | Method for detecting a target nucleic acid |
WO1996000901A1 (en) * | 1994-06-29 | 1996-01-11 | The Regents Of The University Of California | Luminescent lanthanide chelates and methods of use |
Non-Patent Citations (2)
Title |
---|
BIO/TECHNOLOGY, vol. 14, 1 March 1996, pages 303-308, XP000196024 TYAGI S ET AL: "MOLECULAR BEACONS: PROBES THAT FLUORESCE UPON HYBRIDIZATION" * |
WITTWER C ET AL: "Rapid cycle DNA amplification; pages 174-181; in PCR: The polymerase chain reaction, (ED.) Mullis K. B., F. Ferre and R. A. Gibbs" 1994 , BIRKHAEUSER BOSTON INC. , NEW YORK, NEW YORK USA XP002044531 see the whole document * |
Cited By (274)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999047702A3 (en) * | 1998-03-18 | 1999-11-04 | November Ag Molekulare Medizin | Method and device for identifying a tag |
WO1999047702A2 (en) * | 1998-03-18 | 1999-09-23 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Method and device for identifying a tag |
US8569019B2 (en) | 1998-05-01 | 2013-10-29 | Gen-Probe Incorporated | Method for performing an assay with a nucleic acid present in a specimen |
US8546110B2 (en) | 1998-05-01 | 2013-10-01 | Gen-Probe Incorporated | Method for detecting the presence of a nucleic acid in a sample |
US8569020B2 (en) | 1998-05-01 | 2013-10-29 | Gen-Probe Incorporated | Method for simultaneously performing multiple amplification reactions |
US8883455B2 (en) | 1998-05-01 | 2014-11-11 | Gen-Probe Incorporated | Method for detecting the presence of a nucleic acid in a sample |
US9598723B2 (en) | 1998-05-01 | 2017-03-21 | Gen-Probe Incorporated | Automated analyzer for performing a nucleic acid-based assay |
US9150908B2 (en) | 1998-05-01 | 2015-10-06 | Gen-Probe Incorporated | Method for detecting the presence of a nucleic acid in a sample |
US7008789B2 (en) | 1998-05-16 | 2006-03-07 | Applera Corporation | Instrument for monitoring polymerase chain reaction of DNA |
US6818437B1 (en) | 1998-05-16 | 2004-11-16 | Applera Corporation | Instrument for monitoring polymerase chain reaction of DNA |
US9671342B2 (en) | 1998-05-16 | 2017-06-06 | Life Technologies Corporation | Instrument for monitoring polymerase chain reaction of DNA |
US9823195B2 (en) | 1998-05-16 | 2017-11-21 | Life Technologies Corporation | Optical instrument comprising multi-notch beam splitter |
US7498164B2 (en) | 1998-05-16 | 2009-03-03 | Applied Biosystems, Llc | Instrument for monitoring nucleic acid sequence amplification reaction |
US7183103B2 (en) | 1998-05-16 | 2007-02-27 | Applera Corporation | Instrument for monitoring polymerase chain reaction of DNA |
WO1999060381A1 (en) * | 1998-05-16 | 1999-11-25 | The Perkin-Elmer Corporation | Instrument for monitoring polymerase chain reaction of dna |
US6140054A (en) * | 1998-09-30 | 2000-10-31 | University Of Utah Research Foundation | Multiplex genotyping using fluorescent hybridization probes |
DE19850593A1 (en) * | 1998-11-03 | 2000-05-04 | Biochip Technologies Gmbh | DNA hybridization assay comprises detecting fluorescent resonance energy transfer between fluorochromes on different DNA strands |
US6303305B1 (en) | 1999-03-30 | 2001-10-16 | Roche Diagnostics, Gmbh | Method for quantification of an analyte |
US6503720B2 (en) | 1999-03-30 | 2003-01-07 | Roche Diagnostics Gmbh | Method for quantification of an analyte |
US6387621B1 (en) | 1999-04-27 | 2002-05-14 | University Of Utah Research Foundation | Automated analysis of real-time nucleic acid amplification |
US8557569B2 (en) | 1999-05-17 | 2013-10-15 | Applied Biosystems, Llc | Optical instrument including excitation source |
US7410793B2 (en) | 1999-05-17 | 2008-08-12 | Applera Corporation | Optical instrument including excitation source |
US8492138B2 (en) | 1999-05-17 | 2013-07-23 | Applied Biosystems, Llc | Optical instrument including excitation source |
US7599060B2 (en) | 1999-05-17 | 2009-10-06 | Applied Biosystems, Llc | Optical scanning configurations, systems, and methods involving at least one actuator for scanning a scan head |
US7387891B2 (en) | 1999-05-17 | 2008-06-17 | Applera Corporation | Optical instrument including excitation source |
US7708945B1 (en) | 1999-08-13 | 2010-05-04 | Bayer Technology Services Gmbh | Device and method for determining multiple analytes |
US7927868B2 (en) | 1999-08-13 | 2011-04-19 | Bayer Technology Services Gmbh | Device and method for determining multiple analytes |
WO2001013096A1 (en) * | 1999-08-13 | 2001-02-22 | Zeptosens Ag | Device and method for determining multiple analytes |
WO2001023607A3 (en) * | 1999-09-28 | 2001-12-06 | Cytonet Gmbh & Co Kg | Multiplex pcr for detecting ehec infections |
WO2001023607A2 (en) * | 1999-09-28 | 2001-04-05 | Cytonet Gmbh & Co. Kg | Multiplex pcr for detecting ehec infections |
US8744777B2 (en) | 2000-03-31 | 2014-06-03 | Roche Molecular Systems, Inc. | Method for real-time quantification of nucleic acids |
US7378241B2 (en) | 2000-03-31 | 2008-05-27 | Roche Diagnostics Operations, Inc. | Method for determining the efficiency of nucleic acid amplifications |
US7125691B2 (en) * | 2000-03-31 | 2006-10-24 | Roche Molecular Systems, Inc. | Method for determining the efficiency of nucleic acid amplifications |
US8024132B2 (en) | 2000-03-31 | 2011-09-20 | Roche Molecular Systems | Method for the efficiency-corrected real-time quantification of nucleic acids |
US6691041B2 (en) | 2000-03-31 | 2004-02-10 | Roche Molecular Systems, Inc. | Method for the efficiency-corrected real-time quantification of nucleic acids |
US6713297B2 (en) | 2000-05-01 | 2004-03-30 | Cepheid | Apparatus for quantitative analysis of a nucleic acid amplification reaction |
US6911327B2 (en) | 2000-05-01 | 2005-06-28 | Cepheid | Method for quantitative analysis of a nucleic acid amplification reaction |
WO2001084463A2 (en) * | 2000-05-01 | 2001-11-08 | Cepheid | Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction |
WO2001084463A3 (en) * | 2000-05-01 | 2003-03-13 | Cepheid | Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction |
US6783934B1 (en) | 2000-05-01 | 2004-08-31 | Cepheid, Inc. | Methods for quantitative analysis of nucleic acid amplification reaction |
US7435933B2 (en) | 2000-06-28 | 2008-10-14 | 3M Innovative Properties Company | Enhanced sample processing devices, systems and methods |
US6734401B2 (en) | 2000-06-28 | 2004-05-11 | 3M Innovative Properties Company | Enhanced sample processing devices, systems and methods |
US6987253B2 (en) | 2000-06-28 | 2006-01-17 | 3M Innovative Properties Company | Enhanced sample processing devices, systems and methods |
WO2002000347A3 (en) * | 2000-06-28 | 2002-10-10 | 3M Innovative Properties Co | Sample processing devices, systems and methods |
US7164107B2 (en) | 2000-06-28 | 2007-01-16 | 3M Innovative Properties Company | Enhanced sample processing devices, systems and methods |
US7939018B2 (en) | 2000-06-28 | 2011-05-10 | 3M Innovative Properties Company | Multi-format sample processing devices and systems |
US6965105B2 (en) | 2000-07-14 | 2005-11-15 | Applera Corporation | Scanning system and method for scanning a plurality of samples |
US7452984B2 (en) | 2000-08-31 | 2008-11-18 | Mayo Foundation For Medical Education And Research | Detection of varicella-zoster virus |
US6849407B2 (en) | 2000-08-31 | 2005-02-01 | Mayo Foundation For Medical Education And Research | Detection of varicella-zoster virus |
US6875850B2 (en) | 2000-09-08 | 2005-04-05 | Roche Diagnostics Operations, Inc. | Reagent for labelling nucleic acids |
US7893241B2 (en) | 2001-01-31 | 2011-02-22 | Mayo Foundation For Medical Education And Research | Articles of manufacture for detection of herpes simplex virus |
US6958210B2 (en) | 2001-01-31 | 2005-10-25 | Mayo Foundation For Medical Education And Research | Detection of herpes simplex virus |
US7667025B2 (en) | 2001-01-31 | 2010-02-23 | Mayo Foundation For Medical Education And Research | Articles of manufacture for detection of herpes simplex virus |
US6830888B2 (en) | 2001-05-07 | 2004-12-14 | Mayo Foundation For Medical Education And Research | Detection of Legionella |
US9464317B2 (en) | 2001-07-16 | 2016-10-11 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
US9206470B2 (en) | 2001-07-16 | 2015-12-08 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
US7226732B2 (en) | 2001-07-16 | 2007-06-05 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
WO2003009100A2 (en) | 2001-07-16 | 2003-01-30 | Cepheid | Methods, apparatuses, and computer programs for verifying the integrity of a probe |
EP1415152A4 (en) * | 2001-07-16 | 2005-03-23 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
EP1415152A2 (en) * | 2001-07-16 | 2004-05-06 | Cepheid | Methods, apparatus, and computer programs for verifying the integrity of a probe |
US7635588B2 (en) | 2001-11-29 | 2009-12-22 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
US7423750B2 (en) | 2001-11-29 | 2008-09-09 | Applera Corporation | Configurations, systems, and methods for optical scanning with at least one first relative angular motion and at least one second angular motion or at least one linear motion |
US8003051B2 (en) | 2001-12-28 | 2011-08-23 | 3M Innovative Properties Company | Thermal structure for sample processing systems |
US6730501B2 (en) | 2002-02-12 | 2004-05-04 | University Of Utah Research Foundation | Multi-test analysis of real-time nucleic acid amplification |
US7373253B2 (en) | 2002-02-12 | 2008-05-13 | Idaho Technology | Multi-test analysis of real-time nucleic acid amplification |
US6593093B1 (en) | 2002-02-20 | 2003-07-15 | Mayo Foundation For Medical Education And Research | Detection of group a Streptococcus |
US7785776B2 (en) | 2002-05-13 | 2010-08-31 | Idaho Technology, Inc. | Genotyping by amplicon melting curve analysis |
US8809040B2 (en) | 2002-05-17 | 2014-08-19 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
US9719925B2 (en) | 2002-05-17 | 2017-08-01 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
US10768110B2 (en) | 2002-05-17 | 2020-09-08 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
AU2009200693B2 (en) * | 2002-05-30 | 2011-03-03 | Qiagen Instruments Ag | Improved DNA amplification apparatus and method |
EP1513949A1 (en) * | 2002-05-30 | 2005-03-16 | Corbett Life Science Pty Ltd | Improved dna amplification apparatus and method |
EP1513949A4 (en) * | 2002-05-30 | 2006-02-15 | Corbett Life Science Pty Ltd | Improved dna amplification apparatus and method |
US9089851B2 (en) | 2002-05-30 | 2015-07-28 | Qiagen Instruments Ag | DNA amplification apparatus and method |
EP1384789A1 (en) * | 2002-07-23 | 2004-01-28 | Roche Diagnostics GmbH | Fluorescent hybridization probes with reduced background |
US7074598B2 (en) | 2002-09-25 | 2006-07-11 | Mayo Foundation For Medical Education And Research | Detection of vancomycin-resistant enterococcus spp. |
US7615352B2 (en) | 2002-09-26 | 2009-11-10 | Mayo Foundation For Medical Education And Research | Detection of Epstein-Barr virus |
US7074599B2 (en) | 2002-09-27 | 2006-07-11 | Mayo Foundation For Medical Education And Research | Detection of mecA-containing Staphylococcus spp. |
US9850381B2 (en) * | 2002-10-23 | 2017-12-26 | University Of Utah Research Foundation | Amplicon melting analysis with saturation dyes |
US20120301875A1 (en) * | 2002-10-23 | 2012-11-29 | Wittwer Carl T | Amplicon melting analysis with saturation dyes |
US9290663B2 (en) | 2002-10-23 | 2016-03-22 | University Of Utah Research Foundation | Amplicon melting analysis with saturation dyes |
EP1564300A1 (en) * | 2002-11-13 | 2005-08-17 | Hitachi High-Technologies Corporation | Hethod of amplifying nucleic acid and apparatus therefor |
EP1564300A4 (en) * | 2002-11-13 | 2007-09-05 | Hitachi High Tech Corp | Hethod of amplifying nucleic acid and apparatus therefor |
WO2004053155A1 (en) | 2002-12-06 | 2004-06-24 | Roche Diagniostics Gmbh | Multiplex assay detection of pathogenic organisms |
US7718361B2 (en) | 2002-12-06 | 2010-05-18 | Roche Molecular Systems, Inc. | Quantitative test for bacterial pathogens |
GB2399776A (en) * | 2003-03-24 | 2004-09-29 | Pa Knowledge Ltd | Cyclical heating and cooling device and associated methods |
WO2004087950A2 (en) | 2003-04-04 | 2004-10-14 | Roche Diagnostics Gmbh | Improved system for multi color real time pcr |
US8137616B2 (en) | 2003-04-04 | 2012-03-20 | Roche Molecular Systems, Inc. | System for multi color real time PCR |
EP2284278A1 (en) | 2003-04-04 | 2011-02-16 | Roche Diagnostics GmbH | Improved system for multi color real time PCR |
US7749736B2 (en) | 2003-05-08 | 2010-07-06 | Bio-Rad Labortories | Systems and methods for fluorescence detection with a movable detection module |
US10669576B2 (en) | 2003-05-08 | 2020-06-02 | Bio-Rad Laboratories, Inc. | Systems and methods for fluorescence detection with a movable detection module |
US10724084B2 (en) | 2003-05-08 | 2020-07-28 | Bio-Rad Laboratories, Inc. | Systems and methods for fluorescence detection with a movable detection module |
US8236504B2 (en) | 2003-05-08 | 2012-08-07 | Bio-Rad Laboratories, Inc. | Systems and methods for fluorescence detection with a movable detection module |
US8835118B2 (en) | 2003-05-08 | 2014-09-16 | Bio-Rad Laboratories, Inc. | Systems and methods for fluorescence detection with a movable detection module |
US7920971B2 (en) | 2003-09-25 | 2011-04-05 | Roche Molecular Systems, Inc. | Quantification schemes for quantifying nucleic acids |
US7541448B2 (en) | 2003-12-02 | 2009-06-02 | Roche Diagnostis Operations, Inc. | Oligonucleotides containing molecular rods |
US9388455B2 (en) | 2003-12-03 | 2016-07-12 | Abbott Molecular Inc. | Double stranded linear nucleic acid probe |
US10472668B2 (en) | 2003-12-03 | 2019-11-12 | Abbott Molecular Inc. | Double stranded linear nucleic acid probe |
US8304192B2 (en) | 2004-03-05 | 2012-11-06 | University Of Toledo | Methods and compositions for assessing nucleic acids and alleles |
US7476502B2 (en) | 2004-04-12 | 2009-01-13 | Willey James C | Methods and compositions for assaying analytes |
US9657347B2 (en) | 2004-04-20 | 2017-05-23 | University of Utah Research Foundation and BioFire Defense, LLC | Nucleic acid melting analysis with saturation dyes |
US10655169B2 (en) | 2004-04-20 | 2020-05-19 | University Of Utah Research Foundation | Nucleic acid melting analysis with saturation dyes |
US11332779B2 (en) | 2004-04-20 | 2022-05-17 | Biofire Defense, Llc | Nucleic acid melting analysis with saturation dyes |
EP1627921A1 (en) * | 2004-08-18 | 2006-02-22 | Roche Diagnostics GmbH | Method for detecting nucleic acid amplification in real-time comprising positioning a reaction vial relative to a detection unit |
GB2418018A (en) * | 2004-09-01 | 2006-03-15 | Perkinelmer Singapore Pte Ltd | A method of analysing a sample of biological material that includes modifying fluorescent labels in the sample or the environmental conditions of the sample |
GB2418018B (en) * | 2004-09-01 | 2007-09-12 | Perkinelmer Singapore Pte Ltd | A method of analysing a sample including fluorescent labels and apparatus therefor |
EP1634965A1 (en) | 2004-09-09 | 2006-03-15 | Roche Diagnostics GmbH | Real time PCR with the addition of pyrophosphatase |
US7369227B2 (en) | 2005-01-18 | 2008-05-06 | Roche Diagnostics Operations, Inc. | Imaging fluorescence signals using telecentricity |
US7687260B2 (en) | 2005-01-18 | 2010-03-30 | Roche Diagnostics Operations, Inc. | Imaging fluorescence signals using telecentric optics |
US9726607B2 (en) | 2005-03-10 | 2017-08-08 | Gen-Probe Incorporated | Systems and methods for detecting multiple optical signals |
EP1700922A2 (en) | 2005-03-10 | 2006-09-13 | Roche Diagnostics GmbH | Nitroindole derivatives and labeled oligonucleotide probes containing them |
US7964413B2 (en) * | 2005-03-10 | 2011-06-21 | Gen-Probe Incorporated | Method for continuous mode processing of multiple reaction receptacles in a real-time amplification assay |
EP2348320A3 (en) * | 2005-03-10 | 2014-06-25 | Gen-Probe Incorporated | Systems and methods for detecting multiple optical signals |
US9372156B2 (en) | 2005-03-10 | 2016-06-21 | Gen-Probe Incorporated | System for processing contents of a receptacle to detect an optical signal emitted by the contents |
US7759469B2 (en) | 2005-03-10 | 2010-07-20 | Roche Diagnostics Operations, Inc. | Labeling reagent |
US7897337B2 (en) * | 2005-03-10 | 2011-03-01 | Gen-Probe Incorporated | Method for performing multi-formatted assays |
US7932081B2 (en) | 2005-03-10 | 2011-04-26 | Gen-Probe Incorporated | Signal measuring system for conducting real-time amplification assays |
US8663922B2 (en) | 2005-03-10 | 2014-03-04 | Gen-Probe Incorporated | Systems and methods for detecting multiple optical signals |
US8008066B2 (en) | 2005-03-10 | 2011-08-30 | Gen-Probe Incorporated | System for performing multi-formatted assays |
US8349564B2 (en) | 2005-03-10 | 2013-01-08 | Gen-Probe Incorporated | Method for continuous mode processing of the contents of multiple reaction receptacles in a real-time amplification assay |
US7794659B2 (en) | 2005-03-10 | 2010-09-14 | Gen-Probe Incorporated | Signal measuring system having a movable signal measuring device |
US8501461B2 (en) | 2005-03-10 | 2013-08-06 | Gen-Probe Incorporated | System for performing multi-formatted assays |
US10006862B2 (en) | 2005-03-10 | 2018-06-26 | Gen-Probe Incorporated | Continuous process for performing multiple nucleic acid amplification assays |
EP1701275A2 (en) | 2005-03-11 | 2006-09-13 | Roche Diagnostics GmbH | PCR elbow determination by rotational transform |
US7680604B2 (en) | 2005-03-11 | 2010-03-16 | Roche Molecular Systems, Inc. | PCR elbow determination by rotational transform after zero slope alignment |
US7767937B2 (en) | 2005-07-05 | 2010-08-03 | 3M Innovative Properties Company | Modular sample processing kits and modules |
US8080409B2 (en) | 2005-07-05 | 2011-12-20 | 3M Innovative Properties Company | Sample processing device compression systems and methods |
US7763210B2 (en) | 2005-07-05 | 2010-07-27 | 3M Innovative Properties Company | Compliant microfluidic sample processing disks |
US7754474B2 (en) | 2005-07-05 | 2010-07-13 | 3M Innovative Properties Company | Sample processing device compression systems and methods |
US7569367B2 (en) | 2005-09-07 | 2009-08-04 | Roche Diagnostics Operations, Inc. | Nucleic acid preparation from whole blood for use in diagnosis of transmissible spongiform encephalopathy |
EP1762618A1 (en) | 2005-09-07 | 2007-03-14 | Roche Diagnostics GmbH | Method for the preparation of nucleic acids from whole blood and its application in the diagnosis of TSE using real-time PCR |
US7991561B2 (en) | 2005-09-29 | 2011-08-02 | Roche Molecular Systems, Inc. | Ct determination by cluster analysis with variable cluster endpoint |
US7991558B2 (en) | 2005-09-29 | 2011-08-02 | Roche Molecular Systems, Inc. | Systems and methods for determining real-time PCR cycle thresholds using cluster analysis |
US7781165B2 (en) | 2005-10-19 | 2010-08-24 | Roche Diagnostics Operations, Inc. | Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification |
US7875425B2 (en) | 2005-11-09 | 2011-01-25 | Applied Biosystems, Llc | Methods for monitoring polymerase chain reactions |
WO2007102892A3 (en) * | 2005-11-09 | 2007-12-27 | Applera Corp | Device for monitoring polymerase chain reactions |
US7741472B2 (en) | 2005-11-23 | 2010-06-22 | Roche Diagnostics Operations, Inc. | Polynucleotide containing a phosphate mimetic |
EP1801114A1 (en) | 2005-11-23 | 2007-06-27 | Roche Diagnostics GmbH | Polynucleotides with a phosphate mimetic |
US7991562B2 (en) | 2005-12-20 | 2011-08-02 | Roche Molecular Systems, Inc. | PCR elbow determination using curvature analysis of a double sigmoid |
US7668663B2 (en) | 2005-12-20 | 2010-02-23 | Roche Molecular Systems, Inc. | Levenberg-Marquardt outlier spike removal method |
US7844403B2 (en) | 2005-12-20 | 2010-11-30 | Roche Molecular Systems, Inc. | Temperature step correction with double sigmoid Levenberg-Marquardt and robust linear regression |
US7680868B2 (en) | 2005-12-20 | 2010-03-16 | Roche Molecular Systems, Inc. | PCR elbow determination by use of a double sigmoid function curve fit with the Levenburg-Marquardt algorithm and normalization |
US7981606B2 (en) | 2005-12-21 | 2011-07-19 | Roche Molecular Systems, Inc. | Control for nucleic acid testing |
US8026058B2 (en) | 2006-02-27 | 2011-09-27 | Roche Diagnostics Operations, Inc. | PCR hot start by magnesium sequestration |
US8293473B2 (en) | 2006-04-04 | 2012-10-23 | Labonnet Ltd. | Assessment of reaction kinetics compatibility between polymerase chain reactions |
US8119352B2 (en) | 2006-06-20 | 2012-02-21 | Cepheld | Multi-stage amplification reactions by control of sequence replication times |
US9080204B2 (en) | 2006-09-12 | 2015-07-14 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for rapid, real-time detection of influenza a virus (H1N1) Swine 2009 |
US8535888B2 (en) | 2006-12-29 | 2013-09-17 | Mayo Foundation For Medical Education And Research | Compositions and methods for detecting methicillin-resistant S. aureus |
US8119345B2 (en) | 2007-02-06 | 2012-02-21 | Biomerieux S.A. | Method for discriminating single nucleotide polymorphisms |
US8119353B2 (en) | 2007-04-05 | 2012-02-21 | Roche Diagnostics Operations, Inc. | Rapid one-step reverse transcriptase PCR |
EP1978109A1 (en) | 2007-04-05 | 2008-10-08 | Roche Diagnostics GmbH | Rapid one-step RT-PCR |
US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
US8386184B2 (en) | 2007-08-28 | 2013-02-26 | Becton, Dickinson And Company | Systems and methods for determining an amount of starting reagent using the polymerase chain reaction |
DE102007041864A1 (en) | 2007-09-04 | 2009-03-05 | Sirs-Lab Gmbh | Method for the detection of bacteria and fungi |
EP2107470A2 (en) | 2007-09-25 | 2009-10-07 | Roche Diagnostics GmbH | PCR elbow determination using quadratic test for curvature analysis of a double sigmoid |
US8652812B2 (en) | 2007-09-28 | 2014-02-18 | 3M Innovative Properties Company | Dual oligonucleotide method of nucleic acid detection |
US8313931B2 (en) | 2007-09-28 | 2012-11-20 | 3M Innovative Properties Company | Dual oligonucleotide method of nucleic acid detection |
US8463526B2 (en) | 2007-12-28 | 2013-06-11 | Robert Bosch Gmbh | Method for detecting a periodically pulsing operating parameter |
EP2238459B1 (en) * | 2008-01-23 | 2019-05-08 | Roche Diagnostics GmbH | Integrated instrument performing synthesis and amplification |
US8357490B2 (en) | 2008-01-23 | 2013-01-22 | Roche Diagnostics Operations, Inc. | Integrated instrument performing synthesis and amplification, and a system and method thereof |
US8101362B2 (en) | 2008-02-08 | 2012-01-24 | Mayo Foundation For Medical Education And Research | Detection of Clostridium difficile |
US8362227B2 (en) | 2008-02-08 | 2013-01-29 | Mayo Foundation For Medical Education And Research | Detection of clostridium difficile |
EP2103693A1 (en) | 2008-03-19 | 2009-09-23 | Roche Diagnostics GmbH | Nucleic acid amplification in the presence of modified randomers |
US8592184B2 (en) | 2008-03-19 | 2013-11-26 | Roche Diagnostics Operations, Inc. | Nucleic acid amplification in the presence of modified randomers |
EP2130929A1 (en) | 2008-06-06 | 2009-12-09 | F. Hoffmann-Roche AG | Internally controlled multiplex detection and quantification of microbial nucleic acids |
EP2402462A1 (en) | 2008-06-06 | 2012-01-04 | F. Hoffmann-La Roche AG | Internally controlled multiplex detection and quantification of microbial nucleic acids |
US8097412B2 (en) | 2008-07-12 | 2012-01-17 | Biodiagnostics, Inc. | DNA-based test for detection of annual and intermediate ryegrass |
EP2148187A1 (en) | 2008-07-25 | 2010-01-27 | Roche Diagnostics GmbH | Stimulation and optical display system for fluorescence detection |
US9714448B2 (en) | 2008-08-01 | 2017-07-25 | Roche Molecular Systems, Inc. | Lysis and reverse transcription for MRNA quantification |
US8623602B2 (en) | 2008-08-01 | 2014-01-07 | Roche Diagnostics Operations, Inc. | Lysis and reverse transcription for MRNA quantification |
US7910720B2 (en) | 2008-09-09 | 2011-03-22 | Roche Diagnostics Operations, Inc. | Polyanion for improved nucleic acid amplification |
EP2163556A1 (en) | 2008-09-09 | 2010-03-17 | Roche Diagnostics GmbH | Polyanion for improved nucleic acid amplification |
EP2163999A2 (en) | 2008-09-12 | 2010-03-17 | Roche Diagnostics GmbH | Real-time PCR elbow calling by equation-less algorithm |
EP2182357A1 (en) | 2008-10-17 | 2010-05-05 | Roche Diagnostics GmbH | Cell monitoring and molecular analysis |
US8346485B2 (en) | 2008-11-25 | 2013-01-01 | Quest Diagnostics Investments Incorporated | Methods and apparatuses for estimating initial target nucleic acid concentration in a sample by modeling background signal and cycle-dependent amplification efficiency of a polymerase chain reaction |
US9631233B2 (en) | 2008-12-19 | 2017-04-25 | Roche Diagnostics Operations, Inc. | Dry composition of reaction compounds with stabilized polymerase |
US9163286B2 (en) | 2008-12-19 | 2015-10-20 | Roche Diagnostics Operations, Inc. | Dry composition of reaction compounds with stabilized polymerase |
US8652811B2 (en) | 2008-12-19 | 2014-02-18 | Roche Diagnostics Operations, Inc. | Dry composition of reaction compounds with stabilized polymerase |
EP2202302A1 (en) | 2008-12-19 | 2010-06-30 | Roche Diagnostics GmbH | Dry composition of reaction compounds with stabilized polymerase |
US8900854B2 (en) | 2009-03-31 | 2014-12-02 | Kanagawa Academy Of Science And Technology | Liquid reflux high-speed gene amplification device |
EP2674502A1 (en) | 2009-04-20 | 2013-12-18 | Longhorn Vaccines & Diagnostics, LLC | Biological specimen collection/transport compositions and methods |
WO2010146339A1 (en) | 2009-06-15 | 2010-12-23 | Bg Research Ltd | Nucleic acid detection |
US8219366B2 (en) | 2009-08-26 | 2012-07-10 | Roche Molecular Sytems, Inc. | Determination of elbow values for PCR for parabolic shaped curves |
WO2011023373A2 (en) | 2009-08-26 | 2011-03-03 | Roche Diagnostics Gmbh | Determination of elbow values for pcr for parabolic shaped curves |
US10227642B2 (en) | 2010-04-12 | 2019-03-12 | Roche Diagnostics Operations, Inc. | Detergent free polymerases |
EP2374874A2 (en) | 2010-04-12 | 2011-10-12 | Roche Diagnostics GmbH | Detergent free polymerases |
US9285382B2 (en) | 2010-07-23 | 2016-03-15 | Beckman Coulter, Inc. | Reaction vessel |
US8996320B2 (en) | 2010-07-23 | 2015-03-31 | Beckman Coulter, Inc. | System and method including analytical units |
US9140715B2 (en) | 2010-07-23 | 2015-09-22 | Beckman Coulter, Inc. | System and method for controlling thermal cycler modules |
US9274132B2 (en) | 2010-07-23 | 2016-03-01 | Beckman Coulter, Inc. | Assay cartridge with reaction well |
US9046455B2 (en) | 2010-07-23 | 2015-06-02 | Beckman Coulter, Inc. | System and method including multiple processing lanes executing processing protocols |
US8956570B2 (en) | 2010-07-23 | 2015-02-17 | Beckman Coulter, Inc. | System and method including analytical units |
US8932541B2 (en) | 2010-07-23 | 2015-01-13 | Beckman Coulter, Inc. | Pipettor including compliant coupling |
US9519000B2 (en) | 2010-07-23 | 2016-12-13 | Beckman Coulter, Inc. | Reagent cartridge |
US8840848B2 (en) | 2010-07-23 | 2014-09-23 | Beckman Coulter, Inc. | System and method including analytical units |
US8962308B2 (en) | 2010-07-23 | 2015-02-24 | Beckman Coulter, Inc. | System and method including thermal cycler modules |
US9046507B2 (en) | 2010-07-29 | 2015-06-02 | Gen-Probe Incorporated | Method, system and apparatus for incorporating capacitive proximity sensing in an automated fluid transfer procedure |
EP2759604A2 (en) | 2010-07-29 | 2014-07-30 | F. Hoffmann-La Roche AG | Control nucleic acids for multiple parameters |
WO2012013734A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Control nucleic acids for multiple parameters |
WO2012013732A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Generic pcr |
DE112011102524T5 (en) | 2010-07-29 | 2013-07-11 | Roche Diagnostics Gmbh | Preparation of generic samples |
WO2012013733A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Generic sample preparation |
WO2012013731A1 (en) | 2010-07-29 | 2012-02-02 | F. Hoffmann - La Roche Ag | Qualitative and quantitative detection of microbial nucleic acids |
WO2012045668A1 (en) | 2010-10-04 | 2012-04-12 | Roche Diagnostics Gmbh | Method for cell lysis in a rt-pcr reaction buffer |
WO2012045669A1 (en) | 2010-10-04 | 2012-04-12 | Roche Diagnostics Gmbh | Method for cell lysis and pcr within the same reaction vessel |
WO2012045670A1 (en) | 2010-10-04 | 2012-04-12 | Roche Diagnostics Gmbh | Method for cell lysis in a pcr reaction buffer |
EP2465945A1 (en) | 2010-12-17 | 2012-06-20 | F. Hoffmann-La Roche AG | Generic matrix for control nucleic acids |
EP2465947A1 (en) | 2010-12-17 | 2012-06-20 | F. Hoffmann-La Roche AG | Generic matrix for control nucleic acids |
US10641707B2 (en) | 2011-02-24 | 2020-05-05 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
US8718948B2 (en) | 2011-02-24 | 2014-05-06 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
US9915613B2 (en) | 2011-02-24 | 2018-03-13 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
US9067205B2 (en) | 2011-05-18 | 2015-06-30 | 3M Innovative Properties Company | Systems and methods for valving on a sample processing device |
US9725762B2 (en) | 2011-05-18 | 2017-08-08 | Diasorin S.P.A. | Systems and methods for detecting the presence of a selected volume of material in a sample processing device |
WO2012159768A1 (en) | 2011-05-26 | 2012-11-29 | Roche Diagnostics Gmbh | Compositions and methods for detection of staphylococcus aureus |
US9446418B2 (en) | 2011-11-07 | 2016-09-20 | Beckman Coulter, Inc. | Robotic arm |
US10274505B2 (en) | 2011-11-07 | 2019-04-30 | Beckman Coulter, Inc. | Robotic arm |
US9482684B2 (en) | 2011-11-07 | 2016-11-01 | Beckman Coulter, Inc. | Centrifuge system and workflow |
US10048284B2 (en) | 2011-11-07 | 2018-08-14 | Beckman Coulter, Inc. | Sample container cap with centrifugation status indicator device |
US9910054B2 (en) | 2011-11-07 | 2018-03-06 | Beckman Coulter, Inc. | System and method for processing samples |
US9506943B2 (en) | 2011-11-07 | 2016-11-29 | Beckman Coulter, Inc. | Aliquotter system and workflow |
US8973736B2 (en) | 2011-11-07 | 2015-03-10 | Beckman Coulter, Inc. | Magnetic damping for specimen transport system |
US9932633B2 (en) | 2012-03-21 | 2018-04-03 | Roche Molecular Systems, Inc. | Methods for assessing RNA quality |
WO2013139860A1 (en) | 2012-03-21 | 2013-09-26 | Roche Diagnostics Gmbh | Methods for assessing rna quality |
WO2014027066A1 (en) | 2012-08-17 | 2014-02-20 | Roche Diagnostics Gmbh | Compositions and methods for detection of herpes simplex virus 1 and 2 |
US11615863B2 (en) | 2012-10-02 | 2023-03-28 | Roche Molecular Systems, Inc. | Universal method to determine real-time PCR cycle threshold values |
US10176293B2 (en) | 2012-10-02 | 2019-01-08 | Roche Molecular Systems, Inc. | Universal method to determine real-time PCR cycle threshold values |
WO2015067790A1 (en) | 2013-11-11 | 2015-05-14 | Roche Diagnostics Gmbh | Detecting single nucleotide polymorphism using overlapped primer and melting probe |
WO2016079078A1 (en) | 2014-11-19 | 2016-05-26 | Roche Diagnostics Gmbh | Photoblocked probes and methods for sequential detection of nucleic acids |
WO2016087438A1 (en) | 2014-12-02 | 2016-06-09 | Roche Diagnostics Gmbh | Compositions and methods for detecting mecc containing methicillin-resistant staphylococcus aureus |
WO2017059132A1 (en) | 2015-09-29 | 2017-04-06 | The General Hospital Corporation | Methods of treating and diagnosing disease using biomarkers for bcg therapy |
WO2017153566A1 (en) | 2016-03-11 | 2017-09-14 | Roche Diagnostics Gmbh | Compositions and methods for detection of zika virus |
WO2017201315A1 (en) | 2016-05-18 | 2017-11-23 | Roche Sequencing Solutions, Inc. | Quantitative real time pcr amplification using an electrowetting-based device |
WO2017202894A1 (en) | 2016-05-27 | 2017-11-30 | Roche Diagnostics Gmbh | Compositions and methods for detection of trichomonas vaginalis |
WO2017202895A1 (en) | 2016-05-27 | 2017-11-30 | Roche Diagnostics Gmbh | Compositions and methods for detection of mycoplasma genitalium |
WO2017216204A1 (en) | 2016-06-14 | 2017-12-21 | Roche Diagnostics Gmbh | Internal control probes for improving pcr assay performance |
WO2018023094A1 (en) | 2016-07-29 | 2018-02-01 | Juno Therapeutics, Inc. | Methods for assessing the presence or absence of replication competent virus |
US11421287B2 (en) | 2016-07-29 | 2022-08-23 | Juno Therapeutics, Inc. | Methods for assessing the presence or absence of replication competent virus |
WO2018024562A1 (en) | 2016-08-02 | 2018-02-08 | Roche Diagnostics Gmbh | Helper oligonucleotide for improving efficiency of amplification and detection/quantitation of nucleic acids |
WO2018086845A1 (en) | 2016-11-09 | 2018-05-17 | Roche Diagnostics Gmbh | Compositions and methods for detection of bk virus |
WO2018115411A1 (en) | 2016-12-22 | 2018-06-28 | Roche Diagnostics Gmbh | Cobra probes to detect a marker for epidemic ribotypes of clostridium difficile |
WO2018122157A1 (en) | 2016-12-28 | 2018-07-05 | Roche Diagnostics Gmbh | Reversibly protected nucleotide reagents with high thermal stability |
WO2018229173A1 (en) | 2017-06-14 | 2018-12-20 | Roche Diagnostics Gmbh | Compositions and methods for improving the thermal stability of nucleic acid amplification reagents |
WO2019016253A1 (en) | 2017-07-18 | 2019-01-24 | Roche Diagnostics Gmbh | Compositions and methods for detection of babesia |
WO2019063661A1 (en) | 2017-09-29 | 2019-04-04 | Roche Diagnostics Gmbh | Compositions and methods for detection of trichomonas vaginalis |
WO2019102034A1 (en) | 2017-11-27 | 2019-05-31 | Roche Diagnostics Gmbh | Photocleavable nucleotide reagents with high stability |
WO2019152747A1 (en) | 2018-01-31 | 2019-08-08 | Juno Therapeutics, Inc. | Methods and reagents for assessing the presence or absence of replication competent virus |
US11535903B2 (en) | 2018-01-31 | 2022-12-27 | Juno Therapeutics, Inc. | Methods and reagents for assessing the presence or absence of replication competent virus |
WO2019180112A1 (en) | 2018-03-21 | 2019-09-26 | F. Hoffmann-La Roche Ag | Modified nucleoside phosphates with high thermal stability |
WO2019229128A1 (en) | 2018-05-31 | 2019-12-05 | F. Hoffmann-La Roche Ag | Reagents and methods for post-synthetic modification of nucleic acids |
US11338296B2 (en) | 2018-07-26 | 2022-05-24 | Lex diagnostics Ltd. | Variable temperature reactor, heater and control circuit for the same |
WO2020114998A1 (en) | 2018-12-03 | 2020-06-11 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of candida auris |
WO2020221915A1 (en) | 2019-05-02 | 2020-11-05 | F. Hoffmann-La Roche Ag | UTILIZATION OF dITP FOR PREFERENTIAL/SELECTIVE AMPLIFICATION OF RNA VERSUS DNA TARGETS BASED ON STRAND-SEPARATION TEMPERATURE |
WO2020225231A1 (en) | 2019-05-07 | 2020-11-12 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of neisseria gonorroheae |
WO2021013972A1 (en) | 2019-07-25 | 2021-01-28 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of epstein barr virus (ebv) |
WO2021037399A1 (en) | 2019-08-27 | 2021-03-04 | F. Hoffmann-La Roche Ag | Compositions and methods for amplification and detection of hepatitis b virus rna, including hbv rna transcribed from cccdna |
WO2021099499A1 (en) | 2019-11-20 | 2021-05-27 | F. Hoffmann-La Roche Ag | Compositions and methods for rapid idenfication and phenotypic antimicrobial susceptibility testing of bacteria and fungi |
WO2021116037A1 (en) | 2019-12-09 | 2021-06-17 | F. Hoffmann-La Roche Ag | Dicationic fluorescent dyes |
WO2021130199A2 (en) | 2019-12-27 | 2021-07-01 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting methicillin-resistant staphylococcus aureus |
WO2021180631A1 (en) | 2020-03-09 | 2021-09-16 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b |
WO2022117784A1 (en) | 2020-12-04 | 2022-06-09 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of malaria |
WO2022124418A1 (en) | 2020-12-11 | 2022-06-16 | 東洋紡株式会社 | Antibody capable of binding specifically to 5'→3' exonuclease active domain of dna polymerase |
WO2022144351A2 (en) | 2020-12-30 | 2022-07-07 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of bacteria and fungi associated with bacterial and candida vaginosis |
WO2022167570A1 (en) | 2021-02-05 | 2022-08-11 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of human parainfluenza viruses 1-4 (hpiv 1-4) |
WO2022194756A2 (en) | 2021-03-15 | 2022-09-22 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2) variants having spike protein mutations |
WO2022233930A1 (en) | 2021-05-06 | 2022-11-10 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting hepatitis delta virus by a dual-target assay |
WO2023079032A1 (en) | 2021-11-05 | 2023-05-11 | F. Hoffmann-La Roche Ag | Compositions and methods for detection of malaria |
WO2023089186A1 (en) | 2021-11-22 | 2023-05-25 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting vana and/or vanb genes associated with multidrug resistance |
WO2023102459A1 (en) | 2021-12-03 | 2023-06-08 | Medicinal Genomics Corporation | Psilocybe assay |
WO2024003260A1 (en) | 2022-06-30 | 2024-01-04 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting lymphogranuloma venereum (lgv) serovars of chlamydia trachomatis |
WO2024042042A1 (en) | 2022-08-24 | 2024-02-29 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting monkeypox virus |
WO2024059493A1 (en) | 2022-09-13 | 2024-03-21 | Medicinal Genomics Corporation | Psilocybe assay |
WO2024141442A1 (en) | 2022-12-25 | 2024-07-04 | F. Hoffmann-La Roche Ag | Compositions and methods for detecting carbapenem resistant acinetobacter calcoaceticus-baumannii (crab) |
WO2024175749A1 (en) | 2023-02-25 | 2024-08-29 | F. Hoffmann-La Roche Ag | Compositions and methods for candida species detection |
WO2024184165A1 (en) | 2023-03-03 | 2024-09-12 | F. Hoffmann-La Roche Ag | Compositions and methods for the detection of group b streptococcus ( streptococcus agalactiae) and clindamycin resistance gene determinants |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2256612C (en) | System and methods for monitoring for dna amplification by fluorescence | |
US7081226B1 (en) | System and method for fluorescence monitoring | |
US7745205B2 (en) | Container for carrying out and monitoring biological processes | |
US8343754B2 (en) | Annealing curve analysis in PCR | |
KR100479782B1 (en) | Biological Process Monitoring Methods and Systems | |
KR100479767B1 (en) | DNA amplification monitoring by fluorescence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF |
|
WS | Later publication of a supplementary international search report | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997926890 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2256612 Country of ref document: CA Kind code of ref document: A Ref document number: 2256612 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 333135 Country of ref document: NZ Ref document number: 1019980709729 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997926890 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980709729 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019980709729 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997926890 Country of ref document: EP |